Biochemical studies of P97 AAA ATPase by Briggs , Louise Clare & Briggs , Louise Clare
BIOCHEMICAL STUDIES OF 
p97 AAA ATP AS E 
Louise Clare Briggs 
September 2006 
A dissertation submitted for the degree of Doctor of 
Philosophy of the University of London and 
for the Diploma of Imperial College 
Division of Molecular Biosciences 
Faculty of Natural Sciences 
Imperial College London 
Abstract 
The AAA ATPase, p97 (also known as valosin-containing protein), is involved in 
diverse cellular functions including the ER associated degradation pathway of the 
ubiquitin-proteasome system and organelle biogenesis following mitosis. It is thought to 
act in these processes as a form of chaperone that disassembles protein complexes. 
Although the method by which it does this remains obscure, it appears to involve 
binding to multiple proteins, many of which contain ubiquitin-like and ubiquitin binding 
folds. 
p97 is primarily constructed of three domains: an N domain that interacts with many 
proteins and two conserved tandem AAA domains with ATPase activity. p97 protomers 
assemble as a stable homo-hexamer that has been shown to undergo conformational 
rearrangement in the presence of different nucleotides. As p97 hexamer has twelve 
ATPase active sites there are many potential mechanisms by which these sites could 
operate through the ATP hydrolysis cycle but limited biochemical evidence to 
discriminate between these possibilities. 
For this first time, this work presents a systematic characterisation of the nucleotide 
binding properties of p97 D1 and D2 domains. ADP is found to bind with relatively 
high affinity to the D1 domains (Kj = 1 p.M) but with comparatively lower affinity to 
the D2 domains (Kd = 50 |iM). In contrast, an ATP analogue, ATPyS, binds with similar 
affinity to both D1 and D2 domains (IQ = 2 p,M). Additionally, it is shown that the six 
AAA domains of the D2 ring may bind only 3-4 molecules of ATPyS, similar to 
findings in other AAA+ ATPases. Preliminary kinetic measurements of the dynamics of 
ATP binding to p97 are also presented. The implications of this work are discussed with 
respect to the ATPase mechanism of p97. 
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Chapter 1 
Literature Review 
1.1 Introduction to p97 
p97 is an abundant ATPase that is essential for eukaryotic cellular life as deletion of p97 
is lethal and orthologues are found throughout eukaryotes (Frohlich et al, 1991; Koller 
and Brownstein, 1987; Peters et al, 1990; Pinter et al., 1998; Shi et al, 1995). p97 was 
originally misidentified as a short peptide found in pig intestines, valosin, which was 
later shown to be an artifact of the purification procedure (Schmidt et al, 1985). This 
led full length p97 to become known as valosin containing protein (VCP) as well as 
p97, a name relating to its apparent molecular weight as p97 is actually 92 kDa (Koller 
and Brownstein, 1987). The very close homology of p97 with Cdc48, a yeast cell 
division protein, and similarity to N-ethylamide sensitive factor (NSF), a protein 
implicated in Golgi membrane fusion, identified p97 as a member of a family of 
ATPases later named the ATPases associated with diverse cellular actions (AAA+) 
family (Frohlich et al, 1991). 
The AAA+ family, a subfamily of Walker NTPases, are key to many different cellular 
processes including proteolysis, DNA unwinding, membrane fusion, cellular transport 
and protein unfolding (reviewed by (Ogura and Wilkinson, 2001)). They are 
characterised by the presence of conserved AAA domains and generally act as 
molecular motors that transduce chemical energy of ATP hydrolysis to mechanical 
energy of molecular movement. For example, yeast Hspl04, has been shown to 
disassemble prion protein fibrils, bacterial ClpX is able to denature proteins prior to 
proteolysis and dynein is a motor protein that can transport cargos along microtubules 
(Ogura and Wilkinson, 2001). 
p97 is principally comprised of an N terminal domain followed two tandem AAA 
domains, D1 and D2, with ATP hydrolysis activity. Association between AAA 
domains, in particular the D1 domain, allows p97 to form a stable hexamer. The Dl and 
D2 domains form two stacked rings around a central pore and the N domains splay 
outwards from the Dl domains (Figure 1.1). There are many ideas about how the twelve 
ATPase active sites may work together but little work carried out that systematically 
characterises them (Section 1.6). 
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1.1a 1.1b 
Figure 1.1 The p97 hexamer 
a. & b. A top (a.) and side (b.) view of tine crystal structure of p97 hexamer with ADP bound to the D1 domain and AMPPNP bound to the 02 domain (DeLaBarre and Brunger, 2005). The N domains are 
shown in pink and protrude from the D1 domain shown in blue. The N domains position is flexible and likely to be able to vary from coplanar to above and below the plane of the D1 domain. The D2 domain 
is shown in light green and stacks beneath the D1 domain. Bound nucleotides are shown in orange. 
p97 has been shown to interact with many other cellular proteins predominantly through 
the N domains (Dreveny et al, 2004b). This led to p97 being assigned a bewildering 
array of cellular functions by association. Many p97 binding proteins have emerged as 
part of ubiquitin dependent processes, often containing ubiquitin binding or ubiquitin 
like domains and p97 has been increasingly assigned roles in ubiquitin dependent 
processes (Ye, 2006). 
Ubiquitin is a small protein that can be covalently attached to a lysine residue, altering a 
proteins cellular fate. Modification with a single ubiquitin moiety acts to control a 
proteins function and modification with a chain of ubiquitin (poly-ubiquitin) can mark a 
protein for degradation by the proteasome (reviewed by (Pickart, 1997; Sigismund et 
al., 2004)). The proteasome is a large protease complex composed of regulatory caps 
(that recognise poly-ubiquitin and unfold the substrate) capping either end of a 
cylindrical core particle which has broad spectrum proteolytic activity (reviewed by 
(Dahlmann, 2005)). Poly-ubiquitin chains are possibly formed through five lysine 
residues in ubiquitin but are best characterised through lysine 48. 
Attachment of ubiquitin to a protein typically requires at least three classes of enzymes 
named El, E2 and E3 (reviewed by (Kuhlbrodt et al., 2005)). The El enzyme activates 
the ubiquitin molecule in an ATP consuming reaction, forming a high energy thioester 
linkage between a cysteine residue on the El and C terminus of ubiquitin. Binding of 
the El to an E2-E3 enzyme complex allows the transferral of the activated ubiquitin 
molecule to a cysteine residue of the E2 by a transthiolation reaction The E3 member of 
the E2-E3 complex then mediates the transfer of the ubiquitin to the lysine of the 
substrate protein bound to the E3'. Poly-ubiquitin chains are formed through covalent 
isopeptide linkage of multiple ubiquitin molecules to a lysine residue of ubiquitin 
instead of the substrate protein possibly through sequential addition of ubiquitin by 
multiple rounds of the steps outlined above (reviewed by (Hochstrasser, 2006)). An 
' There are two types of E3 ubiquitin ligase, containing either HECT (homologous to E6-assciated protein 
C terminus) or RING (really interesting new gene) fmger motifs and each employ different methods of 
ubiquitin transfer. HECT E3s form a thioester bond with the ubiquitin molecule before passing it to the 
substrate, whereas RING E3s appear to act as adaptors which position the substrate protein close 
proximity to the ubiquitin thioester bond. 
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extra class of enzymes are additionally thought to aid poly-ubiquitination known as E4 
chain elongation factors. They show homology to E3 enzymes^ and in some cases, E3 
activity, but in conjunction El , E2, E3 enzymes, they can direct poly-ubiquitin chain 
formation (Aravind and Koonin, 2000; Hatakeyama et al, 2001; Koegl et al, 1999; 
Matsumoto et al, 2004). 
p97 and yeast orthologue Cdc48, are associated with three key cellular functions: (1) 
separation of stably bound protein complexes, (2) removal of damaged proteins and (3) 
activation or inactivation of key proteins such as transcription factors at specific points 
in the cell cycle or in response from external signals. All three functions are thought to 
be in response to ubiquitin modification: p97 is involved in the ER associated 
degradation pathway (ERAD) which removes abherent proteins in the ER lumen and 
membrane and targets them for degradation by the proteasome with poly-ubiquitin; p97 
activates transcription factors that have been tagged with mono-ubiquitin; and post-
mitosis, p97 and mono-ubiquitin modification are implicated in the separation of 
membrane fusion regulators (SNARE complexes) during organelle biogenesis and 
mitotic spindle assembly factors (Bar-Nun, 2005; Cao et al., 2003; Meyer, 2005; 
Uchiyama and Kondo, 2005) (Figure 1.2). 
Consistent with these reported functions, deletion of p97 or Cdc48 is lethal (Frohlich et 
al., 1991). Mutations in p97 or Cdc48 can lead to cell cycle arrest, swollen ER and the 
formation of vacuoles amongst other phenotypes (Dalai et al., 2004; Hirabayashi et al., 
2001; Moir et al., 1982). In humans, mutations in p97 have been shown to cause 
inclusion body myopathy associated with Paget disease of bone and frontotemporal 
dementia (IBMPFD), possibly as a consequence of defects in ERAD resulting in 
inclusions within cells (aggregates of misfolded proteins) (Watts et al., 2004; Weihl et 
al., 2006). In other forms of dementia, p97 is also observed colocalised with neuronal 
inclusions suggesting that p97 may be recruited to these inclusions as part of the UPS 
(Hirabayashi et al., 2001; Mizuno et al, 2003). 
Of the ensemble of accessory proteins that interact with p97 in these functions, the best 
characterised are p47 and Ufdl-Npl4 (ubiquitin fiision degradation i-nuclear 
^ E4 enzymes often contain U-box domains, a degenerate form of RING finger leading some to speculate 
they are a subgroup of E3 enzymes rather than a distinct class of enzyme. 
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Figure 1.2 A summary of the roles established for p97 and yeast orthologue Cdc48 
localisation grotein 4). Ufdl-Npl4 complex binds to p97 as a single heterodimer and is 
involved alongside p97 in ERAD and the activation of transcription factors and the 
separation of mitotic spindle assembly factors (Pye et al, 2006). p47 is a trimeric 
protein that predominantly functions with p97 in membrane fusion, although the yeast 
orthologue may be more promiscuous (Beuron et al., 2006; Hartmann-Petersen et al, 
2004; Schuberth et al., 2004). p97-p47 complex has been shown to bind specifically to 
mono-ubiquitin, the putative signal recruiting p97 to membrane fusion, whereas p97-
Ufdl-Npl4 complex has been shown to preferentially bind to lysine 48 linked poly-
ubiquitin chains (Meyer et al, 2002). 
Despite much interest in p97 and Cdc48, httle is known about their action. It is 
hypothesised that energy from ATP hydrolysis is transmitted as conformational change 
through the structure of p97. The movement is thought to be relayed through the bound 
interacting proteins such as p47 or Ufdl-Npl4, to target proteins tagged with ubiquitin. 
However, while large conformational changes have been observed in p97 and bound 
adaptors by structural studies, a complete system has not been identified or tested in 
vitro. It is also unclear what function the movement of p97 fulfils, whether chaperone, 
unfoldase, disassembler or retrotranslocase amongst others. 
In summary, p97 has essential functions in the cell often connected with proteins 
modified with ubiquitin. p97 plays roles in ERAD, the activation of transcription 
factors, post-mitotic organelle biogenesis and spindle disassembly. p97 is a AAA+ 
ATPase containing two AAA domains with ATP hydrolysis activity and an N domain 
that binds many proteins. p97 may be targeted to its diverse functions through these 
interacting proteins and their affinity for ubiquitin tags. The AAA domains associate to 
form a homohexamer of two stacked AAA rings, with N domains protruding from the 
D1 domain. As there is little understanding of how the twelve ATPase active sites may 
work together, the aim of this PhD has been to understand how the active sites function 
in the p97 hexamer, a problem approached using a variety of biophysical techniques. 
This introduction will first outline the cellular functions of p97 in more detail before 
focussing upon the current biochemical knowledge of p97s structure and action as a 
hexameric ATPase. 
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1.2 The cellular functions of p97 and Cdc48 
Regulation of many proteins is achieved by covalent modification with small molecules 
such as in phosphate and acetate or with small proteins such as ubiquitin. p97 and yeast 
orthologue Cdc48 function in ERAD, which directs the degradation of ER proteins 
through poly-ubiquitin modification and also are involved in other roles such as 
organelle biogenesis possibly through mono-ubiquitin modification. This section 
outlines these cellular functions of p97 and the consequential effects of malfunction of 
p97 in disease. 
1.2.1 The involvement of p97 and Cdc48 in ERAD 
1.2.1.1 The function of ERAD 
Proteins ultimately destined for secretion or to reside in the membranes and lumens of 
organelles such as the Golgi apparatus, endosome and lysosome are translocated into 
the ER lumen or membrane cotranslationally where they are folded, disulphide bonds 
formed and, in some cases, are glycosylated. The ERAD pathway is a degradation 
process that can act as quality control step to remove ER lumenal and transmembrane 
proteins that are not correctly folded (Romisch, 2005). It can also degrade proteins that 
may become destabilised by cellular cues as part of a regulated degradation process 
(Rumpf and Jentsch, 2006). The ERAD pathway also aids cell survival at times of 
cellular stress, the unfolded protein response (UPR) upregulates components of the 
ERAD pathway to degrade damaged proteins (Kaufman, 1999). The ERAD pathway is 
therefore well conserved between eukaryotes and many components have orthologues in 
both yeast and mammals. (As a consequence, many proteins have been named multiple 
times, a summary of common names is shown in Table 1.1) 
Substrate proteins targeted to the ERAD pathway are retrotranslocated through a protein 
pore in the ER membrane (translocon) back into the cytosol. Here, the substrate still 
associated with the cytoplasmic face of the ER membrane is poly-ubiquitinated and 
deglycosylated where necessary. The substrate is released from the membrane face and 
the poly-ubiquitin tag allows the protein to be recognised, unfolded and degraded by the 
proteasome (Figure 1.3). 
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1.3a 
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Figure 1.3 A simplified cartoon of BRAD and p97s involvement in this process 
a. The ERAD substrate (black curved line) in the ER lumen (below grey shading) is targeted to the translocon (orange cylinder) by luminal chaperones (yellow octagon). The emerging substrate is mono-
ubiquitinated at exposed lysine residues by E1, E2 and E3 enzymes (turquoise, in brackets). In conjunction with p97/Cdc48 (lemon hexagon) complexed with Ufd1-Npl4 (lime cresent) and Ufd2 (E4) (green 
semi-circle) the substrate is poly-ubiquitinated by E l , E2 and E3. (Continued on next page.) 
1Jb 
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Figure 1.3 A simplified cartoon of ERAD and p97s involvement in this process (continued from previous page) 
b. The poiy-ubiquitinated substrate is dissociated from the membrane surface and/or transiocon by the action of p97/Cdc48. A proteasomal shuttling factor (blue diamond) can be recruited by the E4 bound 
to p97/Cdc48 and binds to the poly-ubiquitin chain and the lid of the proteasome (purple and light blue cylinders). The proteasome lid unfolds and de-ubiquitinates the substrate and it is threaded into the 
cavity of the central section for degradation (purple cylinder). 
Table 1.1 A list of aliases and orthologues of ERAD pathway proteins 
Many proteins have several different names between species, and where possible only one name is used during 
discussion of ERAD to aid clarity (for example hHR23A/B are not used but instead known as human Rad23). 
Orthologues are shown on the same line. 
Function Homo Sapiens Sacchromyces cerevisiae 
AAA ATPases p97, VCP Cdc48 
p97/Cdc48 adaptors Ufd1L 
Npl4, KIAA1499 
Ufd1 
Npl4, Hrd4 
Hsp70 chaperones BiP, HspaS, Grp78" Kar2 
ER membrane translocons Sec61 complex 
Derlini 
Derlin2 
Derlin3 
Sec61 complex 
Deri 
Membrane anchors VIMP 
Ubx2, Sen 
Cuel 
E1 ubiquitin activating enzyme UBE1 UBA1 
E2 ubiquitin conjugating enzymes UBE2G2 
Hip2, E2-25K 
NCUBE1 and 2 
Ubc7 
Ubcl 
Ubc6 
E3 ligase complex members 
E4 poly-ubiquitination factors 
Glycanase 
Proteasome binding proteins 
Hrdi, SYNV1 
Sen 
Gp78, AMFR 
Fbsl 
TEB4 
Ufd2a, UBE4A 
PNGase 
Rad23A, HhR23A 
Rad23B, HhR23B 
PLIC2, Ubiquilin 2, Chapl 
S5a, PSMD4 
S6,' PSMC4, TBP7 
Hrd1, Der3 
Hrd3 
Doa10, Ssm4 
Ufd2 
PNGase 
Rad23 
Dsk2 
RpnIO 
Rpt5 
Ddl1, Mud1 
Ubiquitin chain editing Ataxin-3 
HDAC6, KIAA0901 
PLAA, PLAP Ufd3, Zzz4, Doal 
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p97 and Cdc48 and Ufdl-Npl4 adaptor are crucial to the degradation of many ERAD 
test substrates as mutation of p97, Cdc48, Ufdl-Npl4 causes stabilisation^ of these 
substrates (Doolman et al., 2004; Gnann et al, 2004; Huyer et al., 2004; Ravid et al., 
2006; Taxis et al., 2003; Wang and Chang, 2003; Ye et al., 2001). p97 and Cdc48 have 
been suggested to act in this context in retrotranslocation, separation of the substrate 
from the membrane, poly-ubiquitin chain length limitation, as a transfer factor and in 
presentation of substrates to the proteasome (Dai et al., 1998; Elkabetz et al., 2004; 
Rape et al., 2001; Richly et al., 2005; Ye et al., 2001). The following sections outline 
ERAD and p97s participation in the pathway in more detail and discuss the possible 
roles p97 may take. 
1.2.1.2 An overview of the ERAD process 
Identification and retrotranslocation of ERAD substrates 
Inside the ER, proteins fold, aided by the Hsp70 chaperone, BiP (Kar2 in yeast), and 
disulphide bridges are formed by protein disulphide isomerases (PDI) (reviewed by 
(Gething, 1999)). Those that are abherent (e.g. misfolded) are thought to be recognised 
by chaperones and targeted into the ERAD pathway. Many ERAD substrates are 
glycosylated and the most is known about how these proteins are targeted to the ERAD 
pathway. Glycosylation occurs through co-translational addition of an N-linked 
oligosaccharide. This is then rapidly trimmed by removing two of three glucose 
molecules. The addition of the oligosaccharide and the subsequent trimming of glucose 
is important to aid the folding of some proteins as the trimmed oligosaccharide allows 
the folding proteins to bind to ER chaperones calnexin and calreticulin (reviewed by 
(Parodi, 2000)). The discriminator between whether the protein is folded sufficiently or 
not is a cycle of removal and replacement the third glucose molecule of the 
oligosaccharide as loss of this final glucose causes the dissociation of the ER 
chaperones and the protein is competent for secretion. Loss of mannose may cause the 
protein to become a poor substrate for reglucosylation and it becomes a substrate for the 
lectin Html (yeast) and EDEM (ER degradation enhancing a-mannose-like protein) 
(mammals). The interaction of the substrate with these lectins may be the final 
determinant for targeting to ERAD, particularly as EDEM has been reported to 
The term "stablisation" refers to the accumulation of a test substrate due to slowed degradation 
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associate with translocons Derhn2 and DeriinS (reviewed by (McCracken and Brodsky, 
2003)). 
Four protein pores (translocons) have been identified through which both 
transmembrane and soluble proteins may be retrotranslocated out of the ER: Sec61, 
Berlin 1, Derlin2 and DerlinS. Sec61 is the translocon through which proteins are 
imported into the ER and may also be a route of export in ERAD. It has been shown 
that Sec61 can co-immunoprecipitate with an ERAD substrate and mutation of Sec61 
decreases the degradation of an ERAD substrate (Plemper et al., 1997). Initially, it was 
thought that Sec61 was the only translocon in the ER membrane, however, recently two 
groups simultaneously identified Derlinl (Deri in yeast) also as a translocon (Lilley and 
Ploegh, 2004; Ye et al., 2004). The yeast orthologue, Deri, was originally identified in 
a screen for mutants that stabilise degradation substrates. Later it was shown that Derlin 
I is a transmembrane protein through which MHC Class 1 heavy chains are dislocated 
from the ER lumen to the cytosol in response to human cytomegalovirus infection 
(Knop et al., 1996; Lilley and Ploegh, 2004; Ye et al., 2004). 
Derlinl has two solely mammalian homologues, Derlin2 and DerlinS, which have also 
been shown to participate in the ERAD of a glycosylated lumenal substrate, al-PI (Oda 
et al, 2006). When al-PI was mutated to prevent glycosylation, degradation was still 
rapid but did not require Derlin2 or DerlinS providing the first evidence that Derlin2 
and DerlinS may function specifically in the degradation of glycosylated substrates. 
Supporting this, it was also shown that Derlin2 and DerlinS but not Derlinl associate 
with EDEM, one of the final determinants for targeting glycosylated substrates to 
ERAD (Oda et al., 2006). Interestingly, hetero-oligomer formation between Derlinl and 
Derlin2 and also between Derlin2 and DerlinS could indicate a level of adaptation of the 
channel to the substrate presented and may also reflect the likelihood that a single 
monomer is too small to form a pore wide enough to transport a folded or glycosylated 
protein through (Lilley and Ploegh, 2005; Oda et al., 2006). 
As p97 is a cytosolic protein, it is not involved in the selection of an ERAD substrate 
but may be involved in powering retrotranslocation. Mutation of p97 to reduce its 
ATPase activity decreased the rate of appearance of a test substrate in the cytosol and 
led to accumulation of the substrate in the ER membrane associated fractions (Ye et al., 
2001). Alternatively, the lumenal chaperone BiP (Kar2 in yeast) has also been proposed 
to power retrotranslocation (Plemper and Wolf, 1999). 
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The translocon forms a hub to which other proteins cluster. In yeast, interaction of the 
Deri translocon with Ubx2 (a membrane anchor) enables recruitment of Cdc48-Ufdl-
Npl4 and E3 ligase complexes (Neuber et al, 2005; Schuberth and Buchberger, 2005). 
Similarly, in mammals, Derlinl, Derlin2 and DerlinS translocons interact with 
membrane anchor VIMP (VCP interacting membrane protein), p97-Ufdl-Npl4 and E3 
ligases and a glycanase (Katiyar et al, 2005; Lilley and Ploegh, 2005; Oda et al., 2006). 
This allows the emerging substrate to be met by other members of ERAD that 
deglycosylate, poly-ubiquitinate and release the substrate from the membrane. 
ERAD substrate deglycosylation, poly-ubiquitination and release from the 
ER membrane 
Once at the cytosolic face of the ER, N-linked oligosaccharides are removed by Peptide 
N glycanase (PNGase), possibly to prevent steric hindrance of the passage of the 
substrate into the proteasome by large attached oligosaccharides (Hirsch et al., 2003). 
Mammalian PNGase is recruited to the ER membrane through interactions with Derlinl 
(Katiyar et al., 2005). PNGase can also form a link to the poly-ubiquitination machinery 
as yeast two hybrid shows in mammals it interacts with Gp78, a ubiquitin ligase, and 
interestingly, also interacts with p97 and Cdc48 (Nita-Lazar and Lennarz, 2005; Park et 
al., 2001). 
Poly-ubiquitination in ERAD is best characterised in yeast although potential 
orthologues have been identified for most components in mammals (Table 1.1). In 
ERAD, there are two well characterised E3 ubiquitin ligases, Hrdl-Hrd3 complex and 
DoalO which act with three E2 enzymes, Ubcl, Ubc6 and Ubc7. These proteins are 
localised at the ER by integral transmembrane domains or membrane anchors such as 
Cuel in the case of Ubc7 (Biederer et al., 1997). The E3's also have been shown to 
interact directly or indirectly with the translocons, to bring them into close proximity 
with the ERAD substrates emerging from the translocon. 
The Hrdl-Hrd3 complex is formed through transmembrane domains linking the Hrdl 
ubiquitin ligase with the large ER lumenal domain of Hrd3 which may interact with 
chaperones inside the lumen (Gardner et al., 2000). Hrdl ubiquitin ligase acts with 
Ubcl and Ubc7 (Bays et al., 2001). DoalO is a multi-spanning transmembrane protein 
which partners with E2's, Ubc6, a transmembrane protein, and Ubc7 (Kreft et al., 2006; 
Sommer and Jentsch, 1993; Swanson et al., 2001). The degradation of many different 
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test substrates has shown that some substrates degradation is dependent upon only 
Hrdl-Hrd3 or DoalO whereas other substrates degradation may be mediated by either 
(Doolman et al., 2004; Gnann et al., 2004; Huyer et al., 2004; Ravid et al., 2006; Taxis 
et al., 2003; Wang and Chang, 2003; Zhang et al, 2001). In addition, DoalO has been 
shown to also ubiquitinate soluble, nuclear and cytoplasmic substrates, short lived 
regulators and soluble quality control substrates (Ravid et al., 2006). This suggests that 
ERAD machinery may be co-opted into non-ERAD ubiquitin proteasome system (UPS) 
processes. 
There is limited functional information about mammalian orthologues of these E2 and 
E3 proteins, however, several distinctly mammalian ubiquitin ligases, Gp78 and SCF-
Fbs, have been identified to also participate in ERAD. Gp78 is tethered to the ER by 
multiple transmembrane domains and contains a region homologous to yeast membrane 
anchor, Cuel, through which it can recruit mammalian Ubc7 to act as an E2 (Fang et 
al., 2001). Additionally, it can also interact with p97 and PNGase possibly allowing a 
means of association with the mammalian translocon (Park et al., 2001; Zhong et al., 
2004). SCF-Fbs can specifically interact with N-linked glycans in particular, high 
mannose glycoproteins. Fbsl and Fbs2 proteins bind to the innermost GlcNAc and also 
to p97 (Yoshida et al., 2002). No yeast orthologues have yet been identified for either of 
these ligases and, interestingly, Gp78 has been shown to interact with PNGase 
(although possibly mediated by a mutual interaction with p97), suggesting that both 
Gp78 and SCF-Fbs may be linked to the degradation of specialised mammalian 
glycoproteins (Park et al., 2001). 
It is thought that an additional E4 elongation factor, such as Ufd2, is required to form 
poly-ubiquitin chains. In vitro, the E4 activity of Ufd2 enables El , E2, E3 enzymes, 
which alone can only form chains of a few ubiquitin moieties, extend chains to longer 
than six ubiquitin molecules (Koegl et al., 1999). This effect was not mediated through 
direct binding of Ufd2 to any of the reaction components or indeed any typical ERAD 
components but through an interaction with ubiquitin and interestingly also Cdc48/p97 
(Kaneko et al., 2003; Koegl el al., 1999). Adding Cdc48-Ufdl-Npl4 to the in vitro assay 
mixture of El , E2, E3, E4 and substrate led to a restriction of poly-ubiquitination, to 
chains that didn't exceed six ubiquitin moieties (Richly et al., 2005). 
Once modified with poly-ubiquitin, the substrate is competent for recognition by the 
proteasome. However, while a population of proteasomes are in close proximity to the 
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translocon and the membrane bound ubiquitin ligase complex, it has been shown that 
the substrate protein must be released from the ER membrane bound components before 
it can be degraded by the proteasome (Elkabetz et al, 2004). This step has been termed 
dislocation and has been shown to require p97 (Elkabetz et al, 2004). It is unclear 
whether p97 directly removes the substrate from the translocon and membrane bound 
ubiquitin ligase complexes or whether p97 is indirectly part of the process. p97 and 
Cdc48 are also implicated in the next step, presentation to the proteasome. 
Presentation of ERAD substrate to the proteasome 
Once a substrate is poly-ubiquitinated, it must transfer from the ubiquitin ligase 
complex to the proteasome. It was initially postulated that p97 directly accompanied the 
poly-ubiquitinated proteins to the proteasome as p97 immunoprecipitated with the 26 S 
proteasome and also with a poly-ubiquitinated substrate, iKBa (Dai et al., 1998). Lately, 
two methods of transfer have been suggested, firstly, that shuttling factors that bind to 
poly-ubiquitinated proteins at the ligase complex and accompany them to the 
proteasome and secondly that the proteasome has a poly-ubiquitin binding receptor that 
catches poly-ubiquitinated substrates (reviewed by (Madura, 2004)). Research has 
focused on three proteins that can both bind the proteasome and poly-ubiquitin: RpnlO, 
a subunit of the proteasome; and Rad23 and Dsk2 which have also been identified as 
ERAD components downstream of Cdc48-Ufdl-Npl4 (Glickman et al, 1998; 
Medicherla et al., 2004; Saeki et al, 2000) 
RpnlO, Rad23 and Dsk2 at first appeared to have redundant roles with the ability to 
complement each others activity, forming multiple parallel pathways by which poly-
ubiquitinated proteins may be recognised and presented to the proteasome. In yeast, 
individual knockouts of RpnlO, Rad23 and Dsk2 have little effect upon cell viability but 
combinations of double and triple knockouts led to increased sensitivity to cell stress 
(Elsasser et al., 2004; Richly et al., 2005). More detailed work has revealed interesting 
differences between the three. 
When the degradation of cytoplasmic poly-ubiquitinated proteins was examined it was 
found that different proteins have different preferences for Rpn 10, Rad23 and Dsk2 not 
correlated to the E3 responsible for poly-ubiquitination (Verma et al., 2004). Many 
ERAD test substrates degradation has been shown to be dependent upon functional 
Cdc48-Ufdl-Npl4 and this has yielded some important insights into usage of RpnlO, 
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Rad23 and Dsk2 (Taxis et al (2003) JBC, (Huyer et al, 2004), (Gnann et al, 2004), 
(Wang and Chang, 2003), (Doolman et al., 2004)). It was shown by Ravid and 
coworkers, that Cdc48 primarily interacts with ubiquitinated substrates derived from 
inside the ER lumen and ER membrane and not cytosolic substrates that are 
ubiquitinated by the ERAD machinery (Ravid et al., 2006). When the preference of 
ERAD and cytoplasmic substrates for Rad23 and Dsk2 was compared, ERAD substrate 
degradation was shown to be dependent upon functional Ufdl (part of Cdc48-Ufdl-
Npl4) and Rad23 or Dsk2 whereas cytosolic substrate was independent of these three 
proteins (Medicherla EMBO J 2004). This suggested that Dsk2 and Rad23 participate 
downstream in pathways that require Cdc48-Ufdl-Npl4, processing substrates 
specifically from the ER. Possibly facilitating this, direct complexes have been 
demonstrated linking Cdc48 and p97 to Rad23 through an intermediary protein. For 
example: Ufd2 (E4 enzyme) acts as a bridge for poly-ubiquitinated substrates between 
Cdc48-Ufdl-Npl4 and Rad23; PNGase has been shown to form a complex with yeast 
and mammalian Rad23 and Cdc48 and p97; in mammals, Ataxin-3 has been also shown 
to bind to p97 and Rad23 (Doss-Pepe et al., 2003; Li et al., 2005; Richly et al., 2005). 
Another means of discrimination between substrates is by poly-ubiquitin chain length. 
Richly and coworkers found that when presented with a variety of chain lengths, RpnlO 
preferentially bound to chain lengths greater than six ubiquitin moieties whereas Rad23 
and Dsk2 bound to chains less than six (Richly et al., 2005). This supports the idea that 
Rad23 and Dsk2 may collect the majority of ubiquitinated proteins downstream of 
Cdc48-Ufdl-Npl4 as Cdc48-Ufdl-Npl4 has been shown to limit the length of poly-
ubiquitin chains formed through E4, Ufd2 (Richly et al., 2005). Interestingly, Rad23 
and Dsk2 differ slightly in structure, Rad23 has two ubiquitin binding domains whereas 
Dsk2 has only one. This could be reflected in differing affinities for poly-ubiquitin 
(Raasi et al., 2004). 
Some substrates tested weren't received by the proteasome through any of these 
receptors suggesting, that there are other, hitherto uncharacterised receptors (Verma et 
al., 2004). A putative poly-ubiquitin receptor could be S6' (Rpt5 in yeast), a AAA 
ATPase that is a component 19 S regulatory unit of the proteasome which has been 
crosslinked to poly-ubiquitinated proteins but was not shown to be necessary in the 
degradation of many cellular substrates (Lam et al., 2002; Verma et al., 2004). Other 
proteins of similar domain architecture to Rad23 and Dsk2 have been identified as 
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possibly capable of carrying out similar functions including Ddil (in yeast). Among 
proteins that carry capability of interaction with the proteasome and poly-ubiquitin are 
Ubx3 (fission yeast), which appears to have parallel function to RpnlO, and also Ataxin-
3 (in mammals) which while it has been suggested to have proteasomal receptor 
functions, also potentially has deubiquitinating activity (Doss-Pepe et al, 2003; 
Hartmann-Petersen et al., 2004). 
ERAD is likely to occur through a subpopulation of proteasomes bound to the ER 
membrane (Elkabetz et al., 2004). This population of proteasomes may be maintained 
on the ER surface through direct or indirect interactions with Sec61 as the regulatory 
cap of the proteasome has been shown to immunoprecipitate Sec61 and share a common 
binding footprint with the ribosome (Kalies et al., 2005). The proteasome is composed 
of a proteolytic barrel shaped core particle, capped by a regulatory particle at either end. 
The regulatory particles recognise, deubiquitinate and unfold degradation substrates and 
then thread them through to the core particle for proteolysis. They are composed of a 
base, which can recognise lysine 48 linked poly-ubiquitinated substrates and unfold 
tertiary protein structure, and a lid which has deubiquitination activity. The lid and base 
are each large multimeric complexes of proteins and the two are hinged through an 
interaction with RpnlO. The unfolding activity of the base is thought to derive from a 
heterohexamer of AAA+ ATPases (Rptl through to Rpt6) with two non-ATPase 
components of the base (Rpnl and Rpn2) made up of leucine rich repeats that mediate 
protein-protein interactions and can for example bind to Rad23 ubiquitin-like domain. 
The lids function (made up of ten proteins: Rpn3 through to Rpnl2) includes cleavage 
of the poly-ubiquitin chain from substrate proteins. As the substrate protein is threaded 
unfolded into the core particle, peptidase sites contained within four stacked heptameric 
rings cleave the primary sequence multiple times. This processivity generates small 
peptides which may be degraded or displayed on the cell surface by MHC Class 1 
proteins. 
Poly-ubiquitin chain editing functions connected to p97ICdc48 
The previous sections describe how lysine 48 poly-ubiquitin chains may be built and the 
substrate degraded by the proteasome, however recently, other proteins have been 
shown to interact with p97/Cdc48 that may edit or alter the formation of ubiquitin 
chains possibly changing the fate of the substrate. 
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Ufd3 (PLAA in mammals), a protein associated with binding to lysine 29 linked poly-
ubiquitinated chains, has been shown to compete with Ufd2 for binding to Cdc48 
(Ghislain et al, 1996; Rumpf and Jentsch, 2006; Russell and Wilkinson, 2004). 
Intriguingly, when UfdS is deleted from cells, both the amount of free ubiquitin in cell 
lysates and degradation of test substrates is decreased. This phenotype is characteristic 
of deubiquitinating enzymes and is unusual because UfdS has no homology to any 
known deubiquitinating enzymes (Johnson et al., 1995). It was found that in parallel to 
Ufd3 binding, a deubiquitinating enzyme, Otul can also bind to Cdc48 (Rumpf and 
Jentsch, 2006). Otul, Ufd2 and UfdS were all capable of pulling down Cdc48, Ufdl, 
Npl4 and unexpectedly Shpl, the yeast p47 orthologue (Rumpf and Jentsch, 2006). 
Interestingly, it has been shown that a domain of p47 has structural similarity to 
cysteine protease inhibitors and can competitively inhibit Cathepsin L (Soukenik et al., 
2004). As Otul also belongs to a class of cysteine proteases, and can pull down p47, it 
will be interesting to see if p47 can also inhibit this deubiquitinating enzyme also 
(Balakirev et al, 2003). 
In mammals histone deacetylase 6 (HDAC6) also binds to p97, mammalian UfdS 
orthologue, ubiquitin and copurifies with an unidentified deubiquitinating enzyme 
(Boyault et al., 2006; Hook et al., 2002; Seigneurin-Bemy et al., 2001). In vitro, a 
complex of p97, ubiquitin and HDAC6 is modulated by addition of ATP, causing 
HDAC6 and p97 to dissociate from ubiquitin (Boyault et al., 2006). As proteins are 
acetylated at lysine residues, the deactelyase activity of HDAC6 could also possibly 
represent another form of editing but little is currently known about this aspect in the 
context of the UPS. 
Ataxin-3 is a mammalian deubiquitinating enzyme that can interact with poly-
ubiquitinated proteins, the proteasome, mammalian Rad23, CHIP (an E4 enzyme) and 
p97 (Burnett et al., 2003; Doss-Pepe et al., 2003; Jana et al., 2005; Kobayashi et al., 
2002). At the C terminus, there is a stretch of poly-glutamine (which upon expansion 
causes Spinocerebellar Ataxia 3) and a variable C terminal tail both of which are 
reported to interact with p97 (Doss-Pepe et al., 2003)(Section 1.3.1). While it is clear 
that that Ataxin-S participates in ERAD, the role of its deubiquitinating activity within 
the pathway is not well resolved (Zhong and Pittman, 2006). Amongst other hypotheses, 
it has been proposed that Ataxin-3 may deubiquitinate poly-ubiquitinated proteins 
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bound to p97 possibly as an editing function or part of Ataxin-3 interaction with the 
proteasome (Mao et al, 2005). 
1.2.1.3 How p97 and Cdc48 participate in EIRAD 
An underlying theme of the cellular function of p97 is its interaction with many other 
proteins and ubiquitin (Dreveny et al., 2004b). In ERAD, many of the proteins p97 
interacts with contain domains with ubiquitin-like or ubiquitin binding proterties. 
Recently, several key studies have demonstrated that the ERAD pathway is not made up 
of discreet steps and individual spatially distinct interactions. Instead, multiple 
immunoprecipitations suggest that ERAD pathway proteins cluster around the 
translocon, both at the lumenal and cytosolic side of the ER membrane. While this 
hasn't been shown for the Sec61 translocon, there is mounting evidence to suggest that 
Derlinl (and Deri in yeast), Derlin2 and DerlinS translocons associate directly or 
indirectly with lumenal proteins such as EDEM, membrane anchors such as VIMP 
(mammals), Ubx2 (yeast), HERP (mammals), E3 ligases like Hrdl-Hrd3 complex 
(yeast and mammals), DoalO (yeast) and Cdc48/p97 (yeast and mammals). Through 
these proteins others may be recruited, for example, Derlinl can bind PNGase 
(glycanase) which in turn interacts with p97, Gp78 (E3 ligase), Rad23 (shuttling factor) 
and the S4 subunit of the proteasome. This all allows efficient poly-ubiquitination and 
degradation of an ERAD substrate as it emerges from the translocon. 
A non-exhaustive summary of interactions discussed in this section is shown in Figure 
1.4. Whether these multiple interactions represent large multi-protein complexes that 
can be isolated in vitro remains to be seen and it will be interesting to see if any form of 
scaffolding to support a large complex emerges. 
Additionally, the potential complex at the translocon can be modified in response to 
cellular cues. For example, Derlinl and Derlin3 are upregulated in the UPR (Oda et al., 
2006). In mammals Derhnl and Derlin2 have been shown to interact with VIMP, Hrdl-
Hrd3 and p97 (Lilley and Ploegh, 2005; Schulze et al., 2005). This complex also 
interacts with HERP (homocysteine-responsive ER resident protein), a small 
transmembrane protein with a cytoplasmic ubiquitin like domain, which is induced 
during the ER stress response of the UPR (Ma and Hendershot, 2004; Schulze et al., 
2005). It is tempting to speculate that HERP may adapt the translocon complex to deal 
with ER stress effectively. 
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Figure 1.4 A non-exhaustive summary of the interactions in ERAD of p97 and Cdc48 at the cytoplasmic face of the ER membrane 
a. & b. The interactions made by p97 and Cdc48 in the ERAD process In mammals (a.) and S. cerevisiae (b.). Many interactions involve also Ufd1-Npl4 (UN) and so for simplicity Ufd1-Npl4 Is shown bound 
to p97/Cdc48. Often proteins have been renamed In mammals, please see Table 1.1 for a list of proteins and the equivalent yeast orthologues and other aliases. It must be noted that many interactions 
detected are through non-direct means such as yeast two hybrid and immunoprecipltation. (Please see text for references.) 
p97 and Cdc48 have been proposed to fulfil many functions in ERAD including in 
retrotranslocation, dislocation, limitation of poly-ubiquitin chain length, transfer of 
substrates between complexes and chaperone functions. The putative roles in 
retrotranslocation of substrates and dislocation of substrates from the translocon or ER 
membrane are difficult to discriminate between as both, when p97 is experimentally 
compromised, would be expected to lead to accumulation of ERAD substrates on the 
ER surface and in the lumen. Furthermore, retrotranslocation is a highly specialised 
fimction that is unlikely to be adaptable to p97s other functions. The activity in poly-
ubiquitin chain length limitation (in conjunction with Ufd2 E4) could possibly be a 
result of steric hindrance or other proteins bound to p97 (such as Otul deubiquitinating 
enzyme). 
It seems feasible that p97 may act as a transfer factor or ubiquitin dependent protein 
complex disassembler in ERAD. p97 has been reported to have a chaperone-like ability 
to bind unfolded proteins which may help stabilise unfolded substrates as they emerge 
from the translocon (Thoms, 2002). Binding to interacting proteins may allow docking 
of p97 or even provide a scaffold for poly-ubiquitination machinery to access the 
substrate. The ATPase activity of p97 has been shown to be necessary for the release the 
ERAD substrates from the ER surface into the cytosol (Elkabetz et al, 2004; Ye et al, 
2001). This could represent a ubiquitinated protein complex disassembly step. Further 
insight into a more generalised function of p97 may be gleaned from its other cellular 
actions. 
1.2.2 The involvement of p97 and Cdc48 in membrane fusion 
Membrane fusion is essential to the cell not only for vesicular transport but also 
following mitosis when the nuclear envelope (only higher eukaryotes), ER and Golgi 
disassemble at entry to mitosis and must be reformed within the daughter cells. While 
the purpose of this, especially in the case of the Golgi apparatus, isn't clear, the 
mechanism of reassembly has been shown to require p97 (ER, Golgi apparatus, nuclear 
envelope), and Cdc48 (ER) and close homologue NSF (Sec 18 in yeast) (Table 1.2). 
Both p97 and NSF may also maintain the transitional ER during interphase in higher 
eukaryotes. 
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Table 1.2 A list of aliases and orthologues of membrane fusion 
proteins 
Many proteins have several different names between species, and where possible only one name is used during 
discussion. Orthologues are shown on the same line. 
Function Homo Sapiens Sacchromyces cerevisiae 
AAA ATPases p97, VCP 
NSF 
Cdc48 
Seel 8 
AAA ATPase adaptors p47 
VCIP135 
a-SNAP, NAPA 
Shp1 
S a d 7 
SNARE proteins Syntaxin 5, syntaxin 5a Syntax!n 5, Sed5 
Syntaxin 18, stxIB Ufel 
Tethering protein p115,TAP Uso1 
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The adaptor p47 (Shpl in yeast) is required for p97 function in membrane fusion and 
NSF functions in a similar way alongside adaptor, aSNAP. Current evidence suggests 
that p97s role in membrane fusion is independent of its roles in ubiquitin-linked 
degradation pathways as antibodies raised against Ufdl do not halt ER membrane 
fiision and also Golgi cistemae reassembly is not dependent proteasome activity (Hetzer 
et al., 2001; Wang et al., 2004). Despite this, the primary adapter of Cdc48 in 
membrane fusion, Shpl, has increasingly been linked with components of the UPS 
possibly representing a hitherto unidentified role for p47 (Hartmann-Petersen et al., 
2004; Rumpf and Jentsch, 2006; Schuberth et ai, 2004). Additionally, a secondary 
adaptor, VCIP135 (valosin containing protein/p47 complex interacting protein, pl35), a 
deubiquitinating enzyme, is also required for some p97 mediated membrane fusion roles 
in higher eukaryotes. 
The general model for membrane fusion involves two membranes that are brought into 
close proximity by tethering through a membrane bound protein (pI15 mentioned later 
is able to do this). This allows specialised SNARE proteins attached to either membrane 
to interact and form highly stable coiled coil complexes, pulling the membranes close 
and allowing fusion of the lipid bilayer. As the SNARE complex is extraordinarily 
tightly bound, it has been proposed that it must be physically separated to then free the 
SNAREs for further rounds of fusion. SNARE priming has been proposed as one of the 
possible roles for p97 and NSF and may be how they initiate vesicle fusion. 
There are two sorts of membrane fusion in the cell: when a vesicle fuses with a target 
membrane it is referred to as heterotypic membrane fusion and requires two different 
SNARE proteins (designated v- and t- SNARE) whereas when two membranes fuse that 
originate from the same organelle, homotypic fusion, it is mediated by t-SNARE 
proteins only. Heterotypic membrane fusion is considered a function of NSF whereas 
homotypic membrane fusion is primarily thought to be a role of p97. 
The nuclear envelope, ER and Golgi are an interlinked membrane system. The nuclear 
envelope is contiguous with the ER and the Golgi receives vesicles released from ER 
exit sites (the transitional ER). Following mitosis, p97 and Cdc48 have been shown to 
mediate ER biogenesis from a pool of vesicles and additionally in mammals, p97 has 
been shown to function also in Golgi biogenesis, the reformation of the nuclear 
envelope and during interphase, the maintenance of the transitional ER. 
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1.2.2.1 Post-mitotic ER fusion 
At the end of mitosis, the ER exists as an array of vesicles which are reassembled into a 
functional ER through rounds of membrane fusion. As Cdc48 temperature sensitive 
mutants arrest in late mitosis, Latterich and colleagues, proposed that this may be a 
consequence of failed nuclei segregation, a product of failed homotypic fusion of yeast 
nuclear envelope and the contiguous ER membrane. In an assay for ER membrane 
fusion, they showed that Cdc48 temperature sensitive mutant is defective in ER fusion 
(Latterich et al, 1995). Wildtype Cdc48 activity was blocked with anti-Cdc48 
antibodies and addition of purified Cdc48 could rescue ER fusion when Cdc48 was 
mutated. (Latterich et al., 1995). The fusion events of large vesicles observed were 
independent of NSF, but required a SNARE protein Ufel, a homologue of mammalian 
Syntaxin-18. Cross-linking followed by immunoprecipitation showed that Ufel is 
closely associated with Cdc48 at the ER membrane (Patel et al., 1998). This showed 
that Cdc48 functions with t-SNARE Ufel in ER biogenesis in vitro. 
This role for Cdc48/p97 is not restricted to yeast. Using microscopy to assess ER 
network reformation following disruption with mitotic cytosol and then treatment with 
interphase cytosol, Kano and coworkers showed that antibodies to p97, p47, NSF and 
VCIP135 could block reformation (Kano et al., 2005; Uchiyama et al., 2002). When 
microsomally bound proteins were removed by salt washes and cytosol was treated with 
NEM to halt activity of p97 and NSF, addition of p97, p47 and VCIP135 together was 
required to restore reformation activity (Kano et al, 2005). p97 mediated ER fusion 
requires p47 as an adaptor as antibodies raised against p47 caused a moderate inhibition 
of this process (Hetzer et al., 2001). 
Interestingly, the process of reformation appears to have two steps. The first step allows 
fusion of tubules and formation of fine junctions and requires NSF whereas the second 
forms three way junctions and requires p97 and VCIP135 (Roy et al., 2000). Both 
processes could be inhibited by the addition of Syntaxin-18 antibodies and pull down 
assays suggested that Syntaxin-18 binds to p97 through a mutual interaction with p47 
(Roy etal., 2000). 
Thus, in mammals and yeast, ER membrane fusion requires close t-SNARE 
homologues, Syntaxin-18/Ufel and the same ATPase, p97/Cdc48 but in mammals NSF 
is also required to mediate an initial event (Roy et al., 2000). This discrepancy between 
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yeast and mammals maybe a result of differing methods of assessing ER fusion and it 
seems likely that the first NSF dependent event may not have been resolved in the 
indirect ER fusion assays used in the yeast work. Adaptors p47 and VCIP135 are key to 
p97s activity in mammals and further work in yeast may show orthologues of these 
proteins to also be necessary. 
1.2.2.2 Maintenance of the transitional ER 
The transitional ER is an area made up of both smooth and rough ER from which exit 
sites to the Golgi arise and is not prominent in yeast. In mammals, an ATPase 
associated with the transitional ER was identified as p97. Antibodies raised against p97 
were shown to inhibit transitional ER vesicle formation in an in vitro system (Zhang et 
al., 1994; Zhao et al., 1990). It was also shown that the ATP dependent, NEM inhibited 
process of smooth tubule formation can also be inhibited by anti-p97 and anti-Syntaxin 
5 antibodies in another cell free system. This finding may be relevant to the formation 
of exit sites in the smooth ER (Roy et al., 2000). 
1.2.2.3 Post-mltotic reformation of the nuclear envelope 
The ER is continuous with the outer membrane of the nuclear envelope. In mammalian 
cells, the nuclear envelope breaks down at mitosis and reforms around the decondensing 
chromatin surface in a process that requires GTP (hydrolysed by Ran GTPase) and 
ATP. Antibodies against p97 and Ufdl could block nuclear envelope reformation and 
addition of purified p97 and Ufdl were required to restore this activity (Hetzer et al., 
2001). This is consistent with the original identification of Npl4 from mutants that are 
defective in nuclear import and have abnormal nuclear envelopes (DeHoratius and 
Silver, 1996). Intriguingly, it appears that p97-Ufdl-Npl4 is responsible for forming the 
closed nuclear envelope and then another process requiring p47 allows the nuclear 
envelope to expand to full size (Hetzer et al., 2001). 
1.2.2.4 Post-mitotic Golgi fusion 
When the cell enters mitosis, the Golgi as well as the ER are broken into small vesicles 
and then reassembled following mitosis. When this process was chemically mimicked 
by a drug and the components necessary to reform Golgi stacks studied, it was shown 
that both p97 with adapter p47 and NSF with adapter aSNAP (Acharya et al., 1995; 
Kondo et al., 1997 ). NSF possibly allowed larger vesicles to form and p97 was 
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necessary for these larger vesicles to fuse to become cistemae (Acharya et al, 1995). In 
another method of studying this process, mitotic cytosol was used to make Golgi 
fragments which when interphase cytosol was added, reformed these to Golgi cistemae. 
Interestingly, this study showed that reformation of cistemae was dependent upon either 
NSF, aSNAP and pi 15 (a vesicle tethering protein) or p97. NSF and p97 did not have a 
synergistic relationship as expected but instead were interchangeable (Rabouille et al., 
1995). This study also showed that Syntaxin-5 is a t-SNARE that mediates this process 
(Rabouille et al., 1995). These different results may reflect the difficulties of using in 
vitro assays to determine the components of complex cellular processes. 
1.2.2,5 How p97 and Cdc48 participate in membrane fusion 
Both ER and Golgi reformation after mitosis require p97 and p47 and t-SNARE 
proteins: Syntaxin 5 in Golgi reformation and Syntaxin-18 in ER reformation (Hetzer et 
al., 2001; Kondo et al., 1997). It was originally thought that p97 may unravel SNARE 
complexes by applying rotational movement and weakening the interaction within the 
coiled coil (Rabouille et al., 1995; Shorter and Warren, 2002). However, a further 
factor, VCIP135, has been identified to also play a crucial role in membrane 
reformation. VCIP135 has homology to a group of de-ubiquitinating enzymes and is 
able to form a direct complex with p97 (Uchiyama et al., 2002; Wang et al., 2004). To 
salt washed Golgi membranes, only addition of p97, p47 and VCIP135 can cause 
reformation. Additionally, in vivo, antibodies to both VCIP135 and p47 could 
significantly inhibit Golgi and ER reformation. It is thought that VCIP135 may 
modulate the p97-p47-Syntaxin 5 complex. It was shown that p97-p47-VCIP135 can 
bind to Syntaxin 5 and that this complex formation is specifically dissociated when ATP 
is added, liberating p97-VCIP135 complex (Uchiyama et ah, 2002). Furthermore, it has 
been proposed that ubiquitin, acting as a regulatory signal, may be added to an unknown 
protein at disassembly and then removed later by VCIP135 initiating reassembly (Wang 
et al., 2004). The homology of a domain of p47 to cysteine protease inhibitors could 
provide a mechanism for modulation of the deubiquitinating activity of VCIP135 
(Soukenik et al, 2004). 
It has been suggested that instead of acting directly on the SNARE complex, p97 may 
use its activity to remove a SNARE fusion regulator. This regulator would be mono-
ubiquitinated prior to membrane fragmentation (as mutated ubiquitin only halted 
reformation when added at the disassembly stage) and recognised specifically by the 
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p97-p47 complex (as p97-p47 has been shown to preferentially bind to mono-ubiquitin 
over poly-ubiquitin) (Meyer et al, 2002; Wang et al, 2004). p97-p47 complex may 
then act upon the fusion regulator and it would be de-ubiquitinated by VCIP135 
allowing fusion to occur. This model was proposed by Meyer who drew parallels to the 
multi-vesicular body pathway and NSF mediated membrane fusion, both of which use 
ubiquitin or ubiquitin like molecules to regulate fusion and AAA ATPases such as NSF 
and Vps4 (Meyer, 2005). 
This action of p97 is restricted to mitosis through regulation of the location of p47 
through phosphorylation. During interphase, p47 is localised to the nucleus. At the start 
of mitosis, the nuclear envelope is disassembled in mammals and p47 is released to the 
cytosol and phosphorylated, preventing membrane fusion activity. At the end of mitosis, 
p47 is de-phosphorylated triggering its role with p97 in membrane fusion, but as soon as 
the nuclear envelope is reformed, p47 is transported back to the nucleus (reviewed by 
(Uchiyama and Kondo, 2005)). 
1.2.3 Other cellular roles of p97 and Cdc48 
p97 and Cdc48 have been shown to interact with many proteins for which there is no 
clear story describing how p97 and Cdc48 function with these proteins. These include 
BRCAl, Clathrin, SVIP, DUF, TB-RBP, WRN, Emeg-32, Synaptotagmin I and II 
(Boehmelt et al., 2000; Nagahama et al., 2003; Pleasure et al, 1993; Sugita and Sudhof, 
2000; Wu et al, 1999; Yamada et al., 2000). These may be bona fide interactors for 
which a role is yet to be identified or substrates, as has been proposed for 
Synaptotagmin (DeLaBarre et al., 2006). Additionally as some of the interactions are 
detected by non-direct methods such as yeast two hybrid or immunoprecipitation, other 
intermediary proteins may be involved. 
p97 and Cdc48 do, however, have two other functions, mitotic spindle disassembly and 
transcription factor activation, that have yet to be placed into the categories of ERAD or 
membrane fusion (Cao et al., 2003; Dai et al, 1998; Rape and Jentsch, 2004). Both are 
similar as they clearly involve p97 and Cdc48 acting to separate complexes to allow a 
process to proceed. 
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1.2.3.1 Mitotic spindle disassembly 
At the end of mitosis, the microtubules forming the mitotic spindle must be separated to 
allow the cell to return to the interphase morphology. In both Xenopus laevis oocytes 
and yeast cells, p97 and Cdc48 complexed with Ufdl-Npl4 have been shown to interact 
with spindle assembly factors (X. laevis: XMAP215 and TPX2, S. cerevisiae: Asel and 
Cdc5) (Cao et al, 2003). These interactions are thought to cause disassembly of mitotic 
spindles through p97-related sequestering of these factors from the cytosol and 
microtubules or through targeting them for degradation (Cao et al, 2003). However, 
there is no evidence of poly-ubiquitin in the size of proteins co-precipitated with p97 
although p97 could be recruited through other ubiquitinated proteins that are attached or 
a non-ubiquitin requiring interaction. 
1.2.3.2 Transcription factor activation 
The availability of transcription factors to the nucleus must be tightly controlled to 
prevent inappropriate transcription. Two yeast transcription factors, Spt23 and Mga2, 
activate transcription of a gene, OLEl, encoding an ER bound enzyme A9 fatty acid 
desaturase that controls unsaturated fatty acid pools'^ (reviewed by (Rape and Jentsch, 
2004)). These transcription factors exist as inactive precursors bound to the ER and 
possibly may sense the lipid composition of this membrane. The inactive precursors are 
dimerised and activation is triggered by ubiquitination by Rsp5 ligase. This causes 
proteasomal processing of the inactive transcription factor to a shorter variant which 
rapidly redimerises with a full length factor. The active processed transcription factors 
are separated from their precursors by the action of Cdc48-Ufdl-Npl4 complex 
(Hitchcock et al, 2001; Rape et al., 2001). Cdc48-Ufdl-Npl4 is recruited to this 
complex by a mono-ubiquitin tag retained from the initial proteasomal processing step 
(Hitchcock et al, 2001; Rape et al., 2001). Once the shorter form is released, it is then 
able to enter the nucleus and initiate transcription. 
A distant homologue of Spt23 and Mga2 is NF-KB, a transcription factor that is 
maintained in a cytosolic pool by binding to a member of the IKB inhibitor family. 
* Interestingly, HMG-CoA Reductase a key enzyme in the mevalonate pathway controlling amongst others cholesterol 
biosynthesis is resident in the ER membrane and is also degraded through regulated proteolysis although is degraded 
through the full ERAD pathway. 
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Liberation of N F - K B can be triggered by hyperphosphorylation of IKBA leading to 
ubiquitination of iKBa. p97 is able to bind to this form of IicBa and is necessary but not 
sufficient for proteasomal degradation of iKBa (Dai et al, 1998). 
Both processes are often referred to as 'regulated ubiquitin/proteasome-dependent 
processing' or RUP (reviewed by (Rape and Jentsch, 2004)). p97/Cdc48 appears to 
have a role in these processes as a segregase of ubiquitinated proteins from a non-
ubiquitinated partners. 
1.3 The involvement of p97 in disease 
As p97 has so many roles key to a cells survival, its malfunction in vivo, unsurprisingly 
leads to disease. p97 along with other components of the UPS have been found to be 
causative or associated with dementias arising from aggregates of proteins (neuronal 
inclusions). p97s role in transcription factor activation has also linked p97 with cancer. 
1.3.1 Neurodegenerative diseases resulting in dementia 
Neurodegenerative diseases are often caused by cytotoxic aggregates (inclusions) of 
proteins, such as prions, resulting in dementia. Poly-glutamine repeats within proteins 
can also cause inclusions when they expand from lengths of less than 36 residues to 
greater than this (expanded poly-Q). This manifests as a class of autosomal dominant 
inherited neurodegenerative diseases including Huntingtons and Machado-Joseph 
disease (Spinocerebellar Ataxia 3). Many proteins other than expanded poly-Q proteins 
are often found colocalised with neuronal inclusions including transcription factors 
(such as CREB binding proteins) ubiquitin, human Rad23, proteasomes and p97. Some 
appear to be recruited to the inclusion due to their interaction with the expanded poly-Q 
repeat, whereas others may be there as part of the cellular mechanism to disrupt the 
inclusion possibly by degradation through the UPS or refolding with chaperones 
(reviewed by (Michalik and Van Broeckhoven, 2003)). 
Specifically, p97 and also ubiquitin have been shown to colocalise with abnormal neural 
morphology seen in neurodegenerative diseases such as Alzheimers Disease, Machado-
Joseph Disease, Huntingtons Disease, Parkinsons Disease, Creutzfeld-Jacob Disease 
and Motor-Neurone Disease with Dementia, all of which are characterised by 
aggregation of deviant proteins (Hirabayashi et al., 2001; Mizuno et al., 2003) 
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Therefore, it has been suggested that p97 is recruited to these abnormally folded 
proteins via the UPS. Supporting this observation, neuronally differentiated PC 12 cells 
over-expressing an expanded poly-Q of 79 glutamine residues had endogenous p97 
colocalised with expanded poly-Q aggregates whereas this wasn't observed for normal 
length poly-Q repeats (Hirabayashi et al, 2001). 
Whether the cellular strategy of attempted degradation of aggregates is a successful 
means of controlling aggregate formation is unresolved. It has been proposed that 
disassembling large aggregates seeds many smaller ones. In support of this idea, mutant 
forms of p97 Drosophila melanogaster orthologue, Ter94, were shown to be dominant 
suppressors of expanded poly-Q related degeneration (79 and 92 Q) although 
interestingly, no decrease in the aggregate size was apparent (Higashiyama et al, 2002). 
This suggests that p97 is possibly an effector of expanded poly-Q pathogenesis as the 
loss of function Ter94 mutant suppresses disease^. Arguing against p97 as an effector of 
aggregate formation, a Caenorhabditis elegans disease model showed that co-
expression of the organism's p97 homologues partially prevented aggregate formation 
when expanded poly-Q was 40 or 56 residues however, p97 was unable to prevent 
aggregation when the length was increased to 79 residues (Yamanaka et al., 2004). 
The most is known about p97s role in Machado-Joseph disease (Spinocerebellar Ataxia 
3) as it interacts with the causative protein, Ataxin-3, a deubiquitinating protein that 
may play a part in ERAD (see section 1.2.1.2). When Ataxin-3 contains expanded poly-
Q, an ERAD test substrate is stabilised (Doss-Pepe et al., 2003). Ataxin-3 interacts with 
poly-ubiquitinated proteins and also the proteasome, however, these interactions are not 
altered by expansion of the poly-Q repeat and are unlikely to decrease the test substrate 
degradation. Clues as to this effect may be provided by the finding that p97 binds 
specifically to the expanded poly-Q repeat of Ataxin-3, via p97 N domain residues 
although three studies conflict regarding whether the length of the repeat alters the 
binding affinity of p97 to Ataxin-3 (and it is also possible the p97 binding may also be 
mediated by a variable C terminal tail) (Doss-Pepe et al., 2003; Hirabayashi et al, 
2001; Matsumoto et al., 2004). 
' No details of the mutation found or evidence that the said mutation is loss of function are provided. 
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Interestingly, in in vitro binding and release experiments, excess Ataxin-3 cannot 
displace any poly-ubiquitin chains from the ubiquitin binding domain of human Rad23, 
however, when p97 is present, Ataxin-3 can displace poly-ubiquitin chains, leading to 
the suggestion that p97 acts as an uncoupling factor to remove poly-ubiquitinated 
proteins from human Rad23 to Ataxin-3 which acts as a transient proteasomal subunit. 
Alternatively, this could represent a competition experiment in which binding of 
Ataxin-3 to p97 stabilises Ataxin-3 ubiquitin binding domains and concomitantly 
increases the affinity for ubiquitin leading to "transfer". 
Inclusion body myopathy associated with Paget disease of bone and 
frontotemporal dementia (IBMPFD) 
IBMPFD is an autosomal dominant inherited disease caused by six mutations in p97 N 
domain, N-Dl linker and D1 domain as shown by haplotype analysis (Watts et al, 
2004). The etiology is adult onset muscle weakness, early onset Paget disease of the 
bone^ and premature fronto-temporal dementia. 
The functional impact of two of these mutations when transfected into mammalian cells 
was shown to be disruption of normal ERAD processes leading to decreased 
degradation of ERAD substrate CFTR AF508 and increased amounts of punctuate 
inclusions of ubiquitin conjugated proteins including wildtype and mutant p97. These 
inclusions resembled those seen in patients cells and were shown to colocalise with ER 
markers (Weihl et al, 2006). It has been suggested that the p97 mutations seen in 
IBMPFD may result in impaired ubiquitin or adaptor binding, decreased stability or 
disrupt conformational change (Watts et al, 2004; Weihl et al, 2006). 
In conclusion, p97s role in neurodegenerative disease appears to be associated with 
malfunction of the ERAD pathway either through alterations of interactions with 
Ataxin-3 in Machado-Joseph Disease or through disruption of the ERAD pathway by 
direct mutation of p97 as seen in IBMPFD. Similar causative factors are seen in some 
forms of Huntingtons Disease and Parkinsons Disease in which the key mutated 
proteins, Huntingtin and Parkin are either components of the ubiquitin proteasome 
pathway or interact with factors in the pathway. 
® Paget disease of the bone: a disease in which in sufferers, the natural cycle of bone break-down and 
regrowth is altered such that the bone breaks down more easily and regrowth is soft and porous. 
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1.3.2 Werners syndrome 
Werners syndrome is caused by mutations within Werner protein (WRN), a RecQ 
heUcase, involved in unwinding of DNA:DNA and DNA:RNA double helices (Gray et 
al, 1997; Suzuki et al, 1997; Yu et al, 1996). It is a autosomal recessive disorder, 
characterised by premature aging and cancer. Most mutations disrupt the C terminal 
nuclear localisation signal preventing its correct cellular location (Huang et al, 2006). 
p97 has been shown to interact with wildtype WRN in an ATP dependent manner but 
currently there is no link between malfunctioning p97 and the progression of this 
disease (Indig et al, 2004; Partridge et al., 2003). 
1.3.3 p97 and cancer 
Multiple studies have observed statistical correlations between increased p97 expression 
levels in diseased tissues (measured histologically) and worse prognosis in cancers such 
as gastric carcinoma, hepatocellular carcinoma, colorectal carcinomas, prostrate cancer 
and follicular thyroid cancer (Tsujimoto et al, 2004; Yamamoto et al., 2003a; 
Yamamoto et al., 2003b; Yamamoto et al., 2004a; Yamamoto et al., 2005). As with all 
correlative studies however, it is unclear whether p97 is the cause or a consequence of 
the relative aggressiveness of these tumours. 
A mechanism by which p97 could act as a causative agent has been hypothesised. It has 
been suggested that p97s role in N F K B transcription factor regulation through the 
ubiquitin dependent degradation of the inhibitor iKBa may alter the aggressiveness of 
the cancer. High expression levels of p97 may lead to increased free N F K B resulting in 
inhibition of anti-apoptotic pathways (Yamamoto et al., 2004b). In support of this, 
small interfering RNA against p97 led to a decrease in N F K B activation in response to 
growth factor stimulation, resulting in a pro-apoptotic effect (Livingstone et al., 2005). 
Clearly however, as p97 has so many potential roles and interacting proteins (especially 
BRCAl, WRN and Akt kinase (Section 1.6.3)), there are many other potential routes by 
which it would act as a causative agent (Indig et al., 2004; Klein et al, 2005; Zhang et 
al., 2000a). 
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1.4 Discussion of the cellular roles of p97 and Cdc48 
p97 and Cdc48 have been identified as functioning in ERAD, membrane fusion, mitotic 
spindle disassembly and RUP of transcription factors. Prevention of p97s ATPase 
activity in mitotic spindle disassembly leads to cell cycle arrest and is lethal. 
Malfunction of p97 and fellow ERAD proteins in vivo is associated with 
neurodegenerative disease and p97s role in transcription factor regulation has been 
implicated in the progression of several cancers. 
p97 and Cdc48 have been proposed to act as a chaperone, unfoldase, segregase, retro-
translocase amongst many other suggestions. There is currently no uniting view as to 
how p97 can carry out these functions. The action of p97/Cdc48 in the RUP of 
transcription factors may be similar to p97/Cdc48 action in ERAD as both processes 
occur in the cytosol and involve ubiquitination and degradation by the proteasome. p97 
and Cdc48 action in RUP may provide clues to their function in ERAD. It has been 
suggested that p97/Cdc48s action in RUP is linked to the separation of active 
transcription factors from inhibitory binding partners (Rape et al, 2001). This action as 
a segregase is apparently similar to the proposed mechanism of action in mitotic spindle 
disassembly in which p97 and Cdc48 are involved in the removal of spindle assembly 
factors from the mitotic spindle. In line with this idea, it has been recently proposed that 
the action of p97 and Cdc48 in membrane fusion may also involve the separation of t-
SNARE complexes through the removal of a hypothetical inhibitory fusion regulator 
(Meyer, 2005). 
The propensity of p97 and Cdc48 and many of the interacting proteins to bind to 
ubiquitin or ubiquitin-like domains may provide a mechanism by which p97 and Cdc48 
may be recruited to these functions. Indeed, the finding that a de-ubiquitinating enzyme 
(VCIP135) is key to the role of p97 and Cdc48's in membrane fusion may provide a 
link to the recruiting or regulatory factor in this process. 
p97 and Cdc48 have been extensively described as a chaperone, although there is little 
formal evidence for this. An archeal homologue of p97/Cdc48 and NSF, VAT (VCP-
like ATPase of Thermoplasma acidophilum), can unfold penicillinase and ssrA-GFP 
and refold cyclophilin, although the ATPase activity profile of D1 and D2 of VAT is 
more reminiscent of NSF than p97 (Gerega et al., 2005; Golbik et al., 1999) (Section 
6.3.2). Cdc48 has been shown to ameliorate aggregation of heat denatured luciferase 
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and chemically denatured rhodanese but this action occurs in the absence of ATP 
(Thoms, 2002). It is tempting to speculate that in ERAD, p97 and Cdc48 will encounter 
unfolded proteins emerging from the translocon. Any ability to prevent aggregation and 
stabilise these unfolded proteins, may aid p97/Cdc48 in other actions. 
In summary, the role of a disassembler of protein complexes appears to be most likely 
for p97 and it could be speculated that ubiquitin and ubiquitin-like interactions are key 
in the regulation of this process. In this model, p97 is recruited through ubiquitin or 
ubiquitin-like interactions with the N domain. The ATPase catalytic cycle generates 
conformational change in p97 and its interacting proteins, leading to alteration in the 
state of the substrate protein. 
1.5 The biochemistry of p97 
Investigations of the cellular roles of p97 have yielded information about the functional 
gap p97 occupies. To understand more about the action of p97, we must first consider 
the biochemistry of how p97 acts as an ATPase. p97 has been intensely studied both 
structurally and in terms of the catalytic cycle, what follows is a overview of the 
experimental data and the insight they give into the catalytic properties of p97. 
1.5.1 The structure of p97 
To recapitulate, p97 is comprised principally of three domains, an N terminal domain 
that binds many adaptors, and two AAA domains, D1 and D2, with ATPase activity. 
There are flexible linkers between the N and D1 domains and the D1 and D2 domains 
and at the C terminus is an extended unstructured region. Through the D1 AAA domain 
predominantly p97 forms a stable hexamer, resulting in twelve ATPase active sites, six 
each from D1 and D2. 
Crystallographic studies of p97 have shown that the N domain contains a double \|/ 
barrel and a four-stranded P barrel and the D1 and D2 domains are AAA domains each 
with two sub domains: a doubly wound a/p fold and an a-helical domain (Figure 1.5) 
(DeLaBarre and Brunger, 2003, , 2005; Dreveny et al, 2004a; Huyton et al, 2003; 
Zhang et al., 2000b). Within the hexamer, crystal structures show the D1 and D2 
domains are arranged as two stacked rings around a central pore and the N domains are 
positioned coplanar with the D1 domain (Figure 1.1). The ATPase active site of each 
47 
1.5a 1.5b 1.5c CO 
\S9 
Figure 1.5 The structure of p97 AAA ATPase 
a. & b. Side views of the crystal structure of p97 protomer {Huyton et al., 2003). The N domain is shown in pink (light pink; double >|/ barrel; magenta: 4 stranded (3 barrel), the D1 domain is shown in blue 
(a/p domain: light blue; a-helical domain: grey blue) and the D2 domain shown in turquoise and green (a/p domain: turquoise; a-helical domain: light green). The linkers are shown in grey and ADP bound to 
D1 is shown in orange (no nucleotide is bound to the 02 domain). On the left hand side of a. and the right hand side of b. is the central pore when the protomer is assembled as hexamers. 
c. Top view of p97 protomer showing the N and D1 domains (the D2 domain is beneath D1 in this orientation). When assembled as a hexamer, the grey lines indicate the faces that the neighbouring 
protomers contact and the top left hand corner faces into the central pore. The Walker A K251 residue is marked in bright pink and lies close to the p phosphate group of ADP and the Walker B glutamate 
residue is shown in red reaching into the space the y phosphate group would be predicted to lie in. 
AAA domain, is positioned at the interface between each ohgomer (Figures 1.1 and 
1.5). 
The D1 and D2 domains are homologous and, while they show similar structure, they 
differ in some important points. The D1 domain is much more compact than the D2 and 
forms closest inter-protomer contacts, anchoring the hexamer. The D2 in contrast is 
much more flexible and as a consequence crystallographic structures have high 
temperature factors in this domain precluding confident side chains assignment. There 
are additionally some areas of disorder in the D2 domain, particularly the a-helical 
region (Huyton et al, 2003; DeLaBarre and Brunger, 2003,, 2005). 
Furthermore, the crystallographic structures of D1 and D2 appear to have differing 
nucleotide binding properties. All structures have shown D1 bound to ADP and D2 with 
varying nucleotide binding states (empty, ADP, ATP analogue (AMPPNP), transition 
state analogue (ADP-AIF3) (DeLaBarre and Brunger, 2003, , 2005; Huyton et al., 
2003). 
1.5.2 Structural changes in p97 during the ATPase cycle 
In order to understand more about the mechanism of the p97 ATPase cycle and how this 
results in conformational change, multiple structural studies have been carried out on 
p97 bound to different nucleotides using X-ray crystallography, small angle X-ray 
scattering (SAXS) and electron microscopy (EM) (Beuron et al., 2003; Davies et at., 
2005; DeLaBarre and Brunger, 2003,, 2005; Dreveny et al., 2004a; Huyton etal., 2003; 
Rouiller et al., 2000; Rouiller et al., 2002; Zhang et al., 2000b). Crystallographic 
structures have provided the greatest detail whereas the molecular envelopes obtained 
by SAXS and EM have provided valuable information about global conformational 
changes. However, the complimentarity of the techniques and difficulties in resolving 
the exact nucleotide state has led to widely varying results (Figure 1.6). 
The nucleotide binding state 
The interpretation of the nucleotide state of p97 is key to the understanding of the 
structural changes of p97 throughout the ATPase cycle. The atomic resolution of crystal 
structures allows the direct observation of bound nucleotides within the electron density 
obtained. In the case of the D1 domain, ADP is unambiguously assigned as binding to 
the D1 domain. However, in D2, as the electron density is less ordered than Dl, the 
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Figure 1.6 Comparison of the different structures obtained for p97 
The structures obtained by EiVI, SAXS and crystallography are compared varied significantly in the D1 and D2 domain pores (open and closed) and the position of the N domain (Beuron et al., 2003; 
DeLaBarre and Brunger, 2005; Huyton et al., 2003; Rouiller et al., 2000; Rouiller et al., 2002). The low resolution structures determined in the presence of excess nucleotide are assigned as the most similar 
to the crystal structure with these nucleotide present in the D2 domain. (Figure adapted from (Pye et al., 2006).) 
assignment of nucleotide state here is more problematic hindering the exact 
quantification of the occupancy of nucleotides. This was demonstrated in the stmctures 
of p97 D2 domain bound to ADP-AIF3. Initial results suggested that ADP-AIF3 was 
bound to all D2 active sites but upon inclusion of some higher resolution data, it was 
revealed that there was incomplete occupancy of the D2 ring with AIF3 (DeLaBane and 
Brunger, 2003,, 2005). Of the three adjoining protomers in the assymetric unit, one had 
full occupancy of AIF3, the next had partial occupancy of AIF3 and the final one had no 
AIF3 (DeLaBarre and Brunger, 2005). Full occupancy of AMPPNP and ADP was 
observed, although different space groups may prevent a similar effect being revealed 
(DeLaBarre and Brunger, 2005). 
The lower resolution of EM prevents the nucleotide state of p97 samples from being 
directly observed. This is circumvented by incubating samples with saturating quantities 
of nucleotide (typically 5 mM nucleotide with lower than 10 |iM p97) (Beuron et al, 
2003; Rouiller et al., 2002). The assumption is made that all available sites are saturated 
with nucleotide. While this is unsatisfactory in terms of providing a detailed mechanism 
of conformational change throughout the ATPase cycle, it does in the absence of 
knowledge of the dissociation constants of various nucleotides, give a valuable guide of 
how motions may be correlated to nucleotide state. 
Davies and co-workers overcame the non-atomic resolution of SAXS models by using 
high performance liquid chromatography (HPLC) analysis of nucleotides released from 
denatured proteins (Davies et al., 2005). Native p97, with no exogenous nucleotide 
added, showed that ADP was nevertheless present and could be removed by treating the 
proteins sample with apyrase (an enzyme that degrades ATP and ADP to AMP). 
Adding saturating quantities of ADP or AMPPNP respectively doubled the ADP peak 
or led to an equal mixture of AMPPNP and ADP (Davies et al., 2005). While they 
didn't prove the locations of the bound nucleotides, this information could be loosely 
interpreted as D1 binding ADP throughout (except when subjected to an apyrase digest 
to remove pre-bound ADP) and D2 binding AMPPNP and extra ADP. All in all, the 
SAXS data shows the best characterisation of the nucleotides state of all low resolution 
studies. To aid discussion, this interpretation of the nucleotide binding locations under 
saturating conditions of added nucleotides (D1 invariantly bound to ADP, D2 bound to 
added nucleotide) will be also assumed for EM structures. 
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Comparison of structures throughout the ATPase cycle 
There is little consensus between structures of p97 as determined by different 
techniques (reviewed by (Pye et al., 2006)). Crystallographic structures vary only 
within the range of the resolution limit, all showing the N domain coplanar with D1 and 
no real alteration of the central pore size except small openings in D2 (Figure 1.5). This 
may be due to limitation of movement of the flexible molecule through crystal packing 
contacts. It is especially difficult to compare the four crystal structures there are two 
different space groups and crystallisation conditions. They have been interpreted as two 
groups of conformation, pre-activated (D2 empty and bound to ATP analogue 
AMPPNP) and activated (D2 bound to transition state analogue ADP-AIF3 and ADP). 
Between these two states there were small alterations in the position of the N, D1 a and 
D2 a/p domains and order-disorder transitions in the D1-D2 linker and D2 a domain 
(DeLaBarre and Brunger, 2005). 
The most variation of p97 conformation is observed in EM and SAXS structures 
possibly resulting from the lack of constraint of the molecules compared to those 
sampled by crystallography (Figure 1.5). The greatest changes in different nucleotide 
states are seen in the position of the N domain with respect to D1 and the central pore 
size. The differences between two groups EM structures is marked, one group always 
sees N domains above the plane of D1 whereas the other doesn't observe them (due to 
flexibility) except in ADP-AIF3 structures (Beuron et al., 2003; Rouiller et al., 2002). 
This may have possibly led to difficulties for the latter group in assigning the correct 
orientation of the reconstruction as the obvious asymmetry generated by the N domain 
is not present (Rouiller et al., 2002). They also differ in assignment of open and closed 
D1 and D2 pores and the architecture of the interface between D1 and D2. Beuron and 
coworkers observe cavities whereas Rouiller and coworkers observe protusions (Beuron 
et al., 2003; Rouiller et al., 2002). Other structural data does not specifically agree with 
either model. The SAXS data is striking as not only does it show opening and closing of 
the pores but also large positional changes in the N domain from coplanar with D1 (in 
empty, ADP-AIF3 and ADP) and below the plane of D1 in AMPPNP (Davies et al., 
2005). 
The lack of agreement between structures is not only a consequence of the different 
methods employed, but also possibly a result of different sources of p97, image 
refinement protocols and buffer conditions. We can conclude from the structures that 
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the main areas of movement throughout the ATPase cycle, are the internal pore and the 
N domains (Figure 1.5). There may also be movement in the D2 a-helical domain as 
this goes through order and disorder transitions in crystal structures (DeLaBarre and 
Brunger, 2005). Interestingly, the N and D2 domain have been shown to be regions of 
p97 through which some adaptors (such as p47, Ufdl, Ufd2 and Ufd3) and putative 
substrate proteins (such as Synaptotagmin 1) bind to (DeLaBarre et al, 2006; Dreveny 
et al., 2004a; Richly et al., 2005; Rumpf and Jentsch, 2006). 
Conformational changes of p97-p47 complex throughout the ATPase 
cycle 
In vivo, p97 functions with a multitude of adaptor proteins of which the best 
characterized is p47 which binds to p97 through a UBX domain (Bruderer et al., 2004; 
Dreveny et al., 2004a). Three molecules of full length p47 bind to p97 and are thought 
to target p97 to membrane fusion functions and possibly is also involved in the UPS in 
yeast (Beuron et al., 2006). An EM study of p97-p47 complex in the presence of 
AMPPNP or ADP showed a remarkable rearrangement of p47. In the AMPPNP state, 
the majority of p47 is placed above the N domains but in the presence of ADP there is a 
conformational change to a three membered propeller (Beuron et al., 2006). This 
demonstrates dramatically how nucleotide dependent movement of the N domain can be 
transmitted to the bound p47 molecule and result in large reconfiguration of the adaptor 
and presumably any bound substrates. 
1.5.3 The catalytic mechanism of ATP hydrolysis in p97 AAA ATPase 
The global changes of p97 hexamer structure are a result of differential nucleotide 
occupancy of the twelve ATPase active sites contained in the hexamer. Each nucleotide 
binding site is contacted by conserved motifs whose residues act together to bind ATP, 
catalyse a precise mechanism of ATP hydrolysis and possibly coordinate the twelve 
individual active sites. 
1.5.3.1 Conserved motifs 
p97, like other AAA ATPases, contains conserved sequences within the AAA domain 
key to nucleotide binding, hydrolysis of ATP and coordination of the AAA rings and 
the motions of N, D1 and D2 domains. The Walker A and B motifs are crucial for ATP 
binding and hydrolysis respectively and sensor 1, conserved arginine fingers in the SRH 
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and the Hnker motif are thought to contact the nucleotide and may be involved in 
catalysis and the relay of the nucleotide state to the rest of the protein (Summarised in 
Figure 1.7). 
Walker A 
The Walker A motif is part of a loop, often referred to as the P loop, which stabilises the 
nucleotide. The highly conserved residues of the Walker A motif (GxxxxGKT, x - any 
residue) have differing roles. In p97, the conserved threonine (Thr 252, Thr 525) forms 
ionic interactions with the p and y phosphate groups of ATP and lysine (Lys 251, Lys 
524) is thought to form a salt bridge with Mg^^ (Figure 1.8). Just outside the Walker A 
motif, a leucine (Leu 253, Leu 526) contributes to a hydrophobic binding pocket around 
the adenine base (Zhang et al, 2001). Mutation of the lysine residue to alanine or 
threonine is proposed to lead to greatly reduced binding affinity of the nucleotide. This 
has been shown for other AAA proteins, and for D2 in p97, but there is currently no 
direct evidence for this in D1 (Wang et al, 2003b). 
Walker B 
The Walker B motif (hhhhDExx, h = hydrophobic residue), is positioned near the y 
phosphate of ATP. The glutamic acid residue is proposed to activate a water molecule 
to allow nucleophilic attack of the phosphodiester linkage between the P and y 
phosphate groups of ATP (Figure 1.8). In p97, as well as in the wider AAA family, 
mutation of these residues (E305, E578), even conservatively to glutamine, decreases 
ATPase activity (Song et al., 2003; Ye etal, 2003). 
Sensors 1 and 2 
Sensors 1 and 2 have been proposed to sense the nucleotide state of the binding pocket. 
Sensor 1, a conserved polar residue (Asparagine, Serine, Threonine, Histidine) within 
the AAA minimum consensus, is positioned to contact the y phosphate. This residue is 
asparagine in p97 but no mutational analysis has yet confirmed its role, although this 
work has been completed in other AAA+ proteins. Some AAA ATPases also contain a 
sensor 2 arginine residue which performs a very similar role, however this residue is not 
conserved in p97. 
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Figure 1.7 The conserved motifs of p97 AAA ATPase 
a. The key motifs within p97 and other AAA ATPases. X represents any residue and h represents a hydrophobic residue. 
b. A domain map with motifs marked on. The N, D1 and 02 domains are shown in light grey and comparatively unstructured regions in darker grey. The motifs are shown as follows D1 Walker A (green • ), 
D2 Walker A (blue • ), D1 Walker B (tangerine • ), D2 Walker B (yellow ), D1 SRH (dark orange • ), D2 SRH (pink • ). 
c. An annotation of the amino acid sequence of p97. Domains and motifs are marked using the scheme described for b except the linker residues which are shown in purple ( • ) . 
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Figure 1.8 The nucleotide binding site of p97 D1 domain 
a. Cartoon of the D1 active site bound to ADP as determined by Zhang and co-worl<ers (Zhang et a/., 2000). The N-D1 linl<er passes close to the adenine ring (cyan backbone), the Walker A motif wraps 
under the phosphate groups (pink backbone) and the Walker B motif (yellow backbone) is remote from the nucleotide, projecting its residue towards the area the y phosphate residue is expected to be 
positioned. 
b. A diagram showing the potential interactions between ADP and p97 D1 domain (Figure constructed using LIGPLOT). Lysine 251 is not shown in close contact with ADP as it is predicted to interact instead 
with Mg * which is not present in any of the structures of p97. 
Arginine fingers 
Within the AAA+ superfamily, four arginine residues are conserved amongst the 
families named positions 1-4. Position 1 is conserved throughout all families, positions 
2 and 4 only in the classical AAA family and position 3 in all except the AAA family 
(reviewed by (Ogura et al, 2004)). These residues have been implicated in ATP binding 
and hydrolysis and also in mediating longer range movement. It has been widely shown 
by mutational analysis that positions 1 and 2 are essential for ATP hydrolysis in the 
AAA family, except in NSF in which they appear to take a nucleotide sensing role 
(Ogura et al, 2004). As the arginine residues are 'trans elements', protruding into the 
active site of the neighbouring protomer, they may provide a route for communication 
between the protomers, possibly allowing coordination of the ATPase cycle. 
These positions in the p97 D1 domain (R362, R359) have been shown in crystal 
structures to protrude into the neighbouring protomers active site and are predicted to 
contact the y phosphate (Zhang et al, 2000b). Although the difficulty in positioning 
side chains in the more flexible D2 domain may lead to misleading predictions of the 
arginine orientation, ATPase assays of mutations of these arginine residues, suggest 
similar roles for the analogous D2 residues (R638, R635) (DeLaBarre and Brunger, 
2003, , 2005; Huyton et al, 2003; Wang et al., 2005) (Section 1.6.2). Structural data 
does appear to suggest in the case of D1 that R359 and R362 are flexible and 
interchangeable and is supported to some extent by ATPase activity assays of single or 
double mutants in Dl. In contrast to Dl , in D2, the presence of both arginine residues is 
critical for detectable ATPase activity (Wang et al, 2005). 
Linker motif 
Between the domains of many AAA+ proteins is a flexible linker. In the case of Hspl04 
the linker between the two AAA+ domains is elongated and propeller like, possibly 
playing a direct role in the disaggregating properties of the protein, in many other 
proteins (including p97) though, this is a short sequence (Reviewed by (Lee et al., 
2004)). An alignment of linker sequences between N and Dl domains shows 
conservation of a pair of glycine residues (Gly-Gly) in p97-like AAA+ ATPases (such 
as NSF) and in Clp-like AAA+ ATPases there is a hydrophobic-glycine motif (Smith et 
al., 2004). These patterns are repeated in the D1-D2 linker sequence (Smith et al., 
2004). It has been proposed that the conserved glycines in the linker may act as point 
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through which the domains may be hinged. As the linker passes close to the nucleotide 
binding pockets, another alternative role for this conserved motif is that it may provide a 
route for conformational change to be propagated or for communication between 
domains. Currently, other than computational analysis, there is no experimental 
evidence to confirm these ideas. 
1.5.3.2 The nucleotide binding site 
The structural studies of p97 during the ATPase cycle provide snapshots of the structure 
of p97 at different nucleotide binding states. The D1 AAA domain has been determined 
at 2.9 A resolution and so gives the clearest model of the binding pocket bound to ADP 
(Figure 1.8) (Zhang et al, 2000b). The nucleotide binding chamber is composed of two 
regions, a polar, charged section, interacting with the ribose ring and triphosphate chain, 
and a hydrophobic section that sandwiches the adenine base. The polar and electiostatic 
residues stabilising the triphosphate chain and ribose sugar are contributed by the highly 
conserved P-loop (containing the Walker A motif), Walker B motif and AAA minimum 
consensus sequence (or SRH). The adenine ring is sandwiched between two 
hydrophobic residues (p97 Dl: Leu 253 and He 380) and also contacts the linker region 
amongst others. 
The role of Mg 2+ 
When ATP is free in solution, it binds Mg^^ ions with reasonably high affinity 
(dissociation constants in the range 10 to 100 )j.M) (Tanner et al., 2002; Wilson and 
Chin, 1991). The binding site lies between the |3 and y phosphate oxygens and binds 
with a 1:1 stoichiometry. This binding interaction is favourable for Mg-ATPases as the 
Mg^ "^  positive charge is thought to stabilise the developing negative charge on the y 
phosphate leaving group. Hence, nucleotide binding pocket also contains residues 
capable of coordinating Mg^^-ATP, although, Mg^^ has not been observed bound to 
p97. The structure of NSF D2 domain, a close homologue of p97 Dl has Mg^ ^ bound by 
residues Thr 550, three water molecules (one coordinated by Asp 603) and the p and y 
phosphate oxygens corresponding to Thr 252 and Asp 304 in p97 Dl (Yu et al., 1998). 
These residues are all members of the highly conserved Walker A and Walker B motifs 
and form a polar environment for the Mg^ ^ ion. The presence of the Mg^' in the binding 
site and interaction with the p and y phosphate groups may bias the location of double 
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bonds and leading to patches in the resonance structure vulnerable to attack by an 
activated water molecule and also would stabilise the y phosphate leaving group. 
Whether p97 binds Mg^^-ATP together or sequentially remains unresolved. Song and 
coworkers when testing the effect of differing concentrations of Mg^^ on the activity of 
p97, showed that at concentrations of Mg^^ where all ATP present is of the Mg-ATP 
form (by calculations based upon the reported dissociation constants), the activity was 
half optimal, and the concentration of Mg^ "^  had to be increased to over six times that of 
ATP for optimal activity (Song et al, 2003). This could be evidence that p97 requires 
Mg^ "^  to fully saturate its binding sites before ATP may bind or equally could be a more 
general salt effect. 
In summary, the Walker A motif functions in the mechanism of ATP hydrolysis to form 
stabilising interactions with the p and y phosphate groups; a highly conserved threonine 
forms hydrogen bonds while a conserved lysine positions a Mg^ "^  ion so that it is also 
coordinated by the p and y phosphate oxygens. 
1.5.3.3 ATP hydrolysis mechanism 
Chemical energy is encapsulated in the "high energy bonds" bridging the P and y 
phosphate groups of ATP. The hydrolysis of this bond has a Gibbs free energy change 
of approximately -50 kJ.mol"' and is hence highly exergonic. Spontaneous hydrolysis of 
ATP in aqueous solution is prevented by an unusually large activation energy. 
There are two basic mechanisms proposed for enzyme catalysed ATP hydrolysis, 
termed associative and dissociative mechanisms (Figure 1.9) (Maegley et al., 1996; 
Streckenbach et al., 1980). Both mechanisms proceed via a penta-coordinate phosphoryl 
transition state resulting from nucleophilic attack by an ordered water molecule. The 
associative mechanism is so named because it describes an activated attacking water 
molecule binding to the y-phosphorus atom whilst the ADP leaving group remains 
bound (Figure 1.9a). This bonding intense situation leads to two of the oxygen atoms of 
the y-phosphoryl group developing negative charge. The dissociative mechanism in 
contrast depends upon a weak binding of a well placed water molecule and an almost 
total cleavage of the phosphate bond to the ADP leaving group (Figure 1.9b). As charge 
accumulates on the P-y bridging oxygen, and hence is not dense around the phosphorous 
atom, two y-phosphoryl oxygens participate in double bonds. 
59 
1.9a 
H O 
b + "O-P-OR' 
/ I 
R -O 
H O 
O—P—OR' / , \ 
R - O o . 
H+ 
J . 
O 
RO-P -O" 
- 6 
OR' 
1.9b 
I o 
b + "O-P-OR' 
/ • 
I " O 
H O 
/ o -
OR' 
O 
RO-P -O" OR' 
Figure 1.9 Associative and dissociative mechanisms of ATP hydrolysis 
a. The associative mechanism of ATP hydrolysis. The incoming nucleophile bonds with the phosphate group and there is little cleavage of the ADP product In the transition state. The transition state 
therefore carries three negative charges as all bonds are single. (H-O-R represents a water molecule and R' represents ADP) 
b. The dissociative mechanism of ATP hydrolysis. There is little bond formation between the incoming nucleophile but bond cleavage of the ADP product. The transition state carries a single negative charge 
and two double bonds to the non-bridging oxygens. 
(Both figures adapted from (Admiraal and Herschlag, 1995)) 
There is Httle data or discussion to suggest that either is correct in AAA+ proteins and 
as a result, the mechanism is almost always assumed to be an associative one (Ogura 
and Wilkinson, 2001). Therefore, the assigned role of a conserved Walker B glutamic 
acid is to act as a general base to activate an ordered water molecule such that it may 
perform a nucleophilic attack. Mutation of this residue to glutamine has been shown to 
reduce enzymatic turnover over twenty fold. However, pKa calculations performed by 
Maegley and colleagues with respect to a similar enzymatic mechanism have suggested 
that full deprotonation of the water molecule (activation) is similarly unlikely for both 
residues but do suggest that the mutation may decrease the strength of hydrogen 
bonding with the water molecule (Maegley et al, 1996). Two other reasons offered for 
the effect of this mutation are that glutamic acid gives better positioning of the water 
molecule or that glutamic acid is more effective at stabilising the developing positive 
charge. In general, either mechanism is difficult to prove conclusively without labelling 
experiments. 
1.6 Biochemical evidence for tl ie action of p97 
Much evidence of the action of p97 has been derived from biochemical assays 
comparing the effects of mutations in the Walker A, Walker B and SRH motifs to 
reduce nucleotide binding or hydrolysis in D1 or D2. As a result of much interest in 
p97, some results are conflicting and there have been many potential mechanisms 
proposed. This section will outline the data independently of the mechanisms suggested 
to highlight trends of information. Enzymatic mechanisms proposed for p97 and those 
of other AAA+ ATPases will be reviewed as part of the discussion (Section 6.3). 
1.6.1 The homologous D1 and D2 domains have different biochemical 
properties 
The D1 and D2 are homologous, sharing 40 % sequence identity and Walker A, Walker 
B and SRH motifs are highly conserved. Despite this, there is wide ranging evidence 
suggesting that they are not structurally or enzymatically equals. 
The flexibility of D1 and D2 
p97 forms a highly stable hexamer that is only experimentally disassembled by 6 M 
Urea (Wang et al., 2003a). To understand the nature of hexamerisation, Wang and 
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coworkers disassembled p97 and observed rates of reassembly. They found that 
addition of nucleotide enhanced the rate of reassembly suggesting that nucleotide 
binding to the active sites positioned at the oligomer interface may aid stabilisation of 
the hexamer. Using mutants of the Walker A motif to reduce nucleotide binding in D1 
or D2 individually, they showed that the enhanced rate was due to nucleotide binding to 
D1 (Wang et al, 2003a). This is in agreement with crystallographic structures that show 
that the D1 domain interface has tighter packing interactions compared to the D2 
domain interface (DeLaBarre and Brunger, 2003,, 2005; Huyton et al., 2003). 
The D2 domain, while homologous to the Dl, shows looser packing of the quaternary 
structure crystallographically (DeLaBarre and Brunger, 2003, , 2005; Huyton et al, 
2003). This prediction was shown experimentally through trypsin digests which showed 
an accumulation of a stable fragment the same size as N and D1 domains (Wang et al., 
2003b). This suggests that the D2 domain compared to the N and Dl domains is more 
vulnerable to trypsin digestion and therefore may have a more open conformation or 
looser structure (Wang et al., 2003b). 
The different nucleotide binding properties of D1 and D2 
All crystal structures of p97 show ADP invariantly bound to the Dl domain and D2 
empty or containing the added nucleotide, leading to the suggestion of the ".. .Dl 
domain of p97A^CP irreversibly binding ADP..." (Quotation taken from (DeLaBarre 
and Brunger, 2003)). The presence of ADP in untreated p97 was also observed 
experimentally through urea denaturation of p97 and analysis of the released nucleotide 
by HPLC (Davies et al., 2005). As the location of ADP in p97 crystal structures is in 
Dl, it is likely but not proven that this is where ADP is pre-bound. (This result however 
is controversial as Wang and coworkers performed a similar assay although with 
apparently lower amounts of p97 and observed no ADP pre-bound (Wang et al., 
2003b)) The assertion that ADP binding to Dl is irreversible was challenged by the 
observation that treatment with apyrase was able to decrease the observed ADP upon 
denaturation from p97 to close to zero (Davies et al., 2005). This confirms that 
equilibrium exists between ADP bound to Dl and free ADP. 
The prediction that D2 is empty unless nucleotide is added is less disputed. Addition of 
ADP or AMPPNP to p97 (with ADP pre-bound) lead to HPLC peak sizes representing a 
doubling of the amount of nucleotide bound, presumably from binding sites contributed 
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by D2 (Davies et al, 2005). In another study, nucleotide induced increases in 
tryptophan fluorescence were shown to result from tryptophan residues in the D2 
domain and were abrogated by D2 Walker A nucleotide binding mutants (Wang et al., 
2003b). A further study observed binding of ADP to untreated p97 (with ADP pre-
bound) by isothermal titration calorimetry (ITC) and showed that a further six sites per 
hexamer were available for binding, suggesting that this may represent ADP binding to 
D2 (DeLaBarre and Brunger, 2003). 
In summary, the weight of evidence suggests that D1 in most preparations of p97 has 
ADP bound to the D1 domain and D2 is empty until nucleotides are added. This is 
consistent with crystallographic structures (DeLaBarre and Brunger, 2003, , 2005; 
Dreveny et al., 2004a; Huyton et al., 2003). This also agrees with some interpretations 
of profiles of p97s ATPase activity. 
The differential ATPase activity of D1 and D2 domains 
The first measurements of the ATPase activity of p97 revealed that p97 had low activity 
when compared to ATPases such as the mitochondrial F, ATPase (Egerton and 
Samelson, 1994; Peters etal., 1990). 
To understand the relative roles of D1 and D2 in the ATPase cycle. Song and coworkers 
measured the activity of p97 when mutated in the Walker A and Walker B (to reduce 
nucleotide binding and hydrolysis respectively) in the D1 and D2 domains (Song et al., 
2003). This showed that when the D1 was mutated in either motif, there was little 
alteration in activity whereas when D2 was mutated in either motif there was a large 
decrease in activity (Song et al., 2003). This leads to the conclusion that D2 contributes 
the bulk of the ATPase activity and this activity isn't dependent on ADP bound to D1 
(as the D1 Walker A mutant had close to wildtype activity). 
However, these results weren't supported by another study which used similar 
mutations but different buffers and activity measurements (Ye et al., 2003). This instead 
suggested that the activity of D1 and D2 were mutually dependent as any mutation of 
D1 or D2 (with the exception of Walker B in Dl) decreased the activity dramatically 
(Ye et al., 2003). It was concluded that ATP binding in Dl was required to induce 
hydrolysis in D2 and ADP binding in D2 is required for hydrolysis in Dl (Ye et al., 
2003). A third study, using the same mutations as Ye and coworkers, showed different 
results. ATPase activity was undetectable in Dl Walker A and D2 Walker B mutants 
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but present for D1 Walker B and D2 Walker A mutants (DeLaBarre et al, 2006). 
Unfortunately, the authors present little discussion of these results with respect to the 
ATPase mechanism of p97. 
Both groups of studies lead to very differing views of p97s action. The first, when 
supported by the data outlined in previous sections, suggests that D1 may be important 
for hexamerisation and the D2 for ATPase activity (Song et al, 2003). The second two 
suggest that D1 and D2 may cooperate to hydrolyse ATP (ie. D1 and D2 hydrolyse ATP 
alternately) (DeLaBarre et al., 2006; Ye et al., 2003). While there is less experimental 
data to support this than the first, molecular dynamics simulations suggest that p97 may 
do so (Beuron et al., 2003). This would also explain why the necessary residues for 
ATP hydrolysis in D1 are well conserved. 
1.6.2 Cooperation around AAA rings and between AAA rings 
Two possible mechanisms of cooperativity have been proposed for p97 between D1 and 
D2 (referred to here as inter-domain cooperativity) and also around the D1 or D2 ring 
(referred to here as intra-domain cooperativity). Early ATPase activity studies when 
fitted to a cooperative equation showed a Hill coefficient for p97 of 1.2-1.5 and 2.5 for 
Cdc48, indicating a low level of inter-domain or intra-domain positive cooperativity 
(DeLaBarre et al., 2006; Frohlich et al., 1995; Song et al, 2003). 
Inter-domain cooperativity 
It is thought that the linker between D1 and D2 may provide a route for communication 
between domains as it contacts the D2 nucleotide binding site and contains a conserved 
gly-gly motif also observed in the N-Dl linker and other AAA ATPases (Smith et al., 
2004) (Section 1.5.3.1). Currently, though there is no structure-function analysis of 
these residues to confirm this role or inter-domain cooperativity. 
Intra-domain cooperativity 
As the nucleotide binding sites of p97 are at the interface between the protomers, one 
way the active sites in D1 or D2 may be coordinated is through two arginine fingers 
protruding from one protomer into the active site of the neighbouring protomer. These 
arginine fingers are predicted to contact the y-phosphate of the bound ATP molecule 
and may stabihse binding or aid hydrolysis (Ogura et al., 2004). 
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In the D2 domain, DeLaBarre and Brunger report that these residues point inwards 
towards the nucleotide of the same protomer in AMPPNP bound state (DeLaBarre and 
Brunger, 2005). To test the roles of these two arginines, they were mutated to lysine 
(conservative) and alanine (neutral). Mutation of each individually in D2 led to low or 
undetectable ATPase activity (DeLaBarre et al, 2006; Wang et al., 2005). This was 
shown to not be a consequence of reduced nucleotide binding as similar binding 
properties in D2 were demonstrated by tryptophan fluorescence and measurement of the 
KM value (DeLaBarre et al, 2006; Wang et al., 2005). 
To probe whether there is coordination of hydrolysis around the protomer, hybrid 
hexamers of wild type and mutant p97 were assembled by two different methods. 
Firstly, wildtype p97 was disassembled by high concentrations of urea and then 
reassembled into hexamers with increasing amounts of D2 Walker A mutant (K524T, 
deficient in nucleotide binding and activity) while maintaining a constant amount of 
wildtype p97. If activity remained the same, it would be suggestive that all D2 domains 
are independent, however, it lead to up to 50% decrease in activity suggestive of some 
form of communication between the two (Wang et al., 2003a). To test the role of the 
arginine fingers in D2 hydrolysis, a second method was used to create hybrid hexamers 
of K524T and R635A or R638A (arginine fingers) by co-expression of the two mutants 
together (Wang et al., 2005). All of these mutations have been individually shown to 
decrease ATPase activity to almost undetectable levels. Mixed hexamers showed an 
ATPase activity 10 % of wildtype presumably resulting from the contribution of Arg 
635 or Arg 638 from K524T protomers to the functional binding site of R625A or 
R638A protomers allowing hydrolysis (Wang et al., 2005). 
While these experiments do not control the actual ratios of p97 mutants in the hybrid 
hexamers, they do show that the D2 domains are not independent of each other and that 
it is likely the D2 arginines do contribute to the neighbouring binding site, despite the 
predictions made from interpretation of side chains in the low resolution DeLaBarre and 
Brunger structures (DeLaBarre and Brunger, 2005). 
The nucleotide occupancy of D2 
Intriguingly, there is evidence to suggest binding or hydrolysis may not occur in a 
concerted fashion in the D2 domain. As discussed previously, the crystal structure of 
ADP-AIF3 bound to D2 suggests that in the asymmetric unit of three neighbouring 
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protomers, there is only full occupancy of AIF3 in one protomer, partial occupancy in 
another and no AIF3 in the final (DeLaBarre and Brunger, 2005). As ADP-AIF3 is a 
transition state analogue, this appears reminiscent of a binding change model (or 
sometimes called sequential) of hydrolysis (reviewed by (Pye et al, 2006)). A similar 
pattern is not observed for other nucleotides. Furthermore, this partial occupancy was so 
subtle that it wasn't reported when the structure was first published but only came to 
light after inclusion of higher resolution data (DeLaBarre and Brunger, 2003). Other 
data that supports the unequal occupancy seen in the crystal structure was provided by 
Zalk and colleagues who measured the binding stoichiometry of a photo-activated 
crosslinking ATP molecule (Bz-ATP) to p97 purified from brain tissue (Zalk and 
Shoshan-Barmatz, 2003). They observed a stoichiometry of 2.23 molecules of Bz-ATP 
per p97 hexamer, however, the covalent modification of p97 with the probe may 
prevent fall saturation of the binding sites. Alternatively, as this is the only experiment 
with endogenous p97 and the starting state has not been characterised, binding could be 
in D1 or D2 and other nucleotides may also be bound. 
The incomplete occupancy of the D2 ring is reminiscent of the stoichiometry of ATP 
binding to hydrolysis deficient ClpX AAA+ ATPase, observed to be around three ATP 
molecules per ClpX hexamer (Hersch et al., 2005). 
1.6.3 The effects of external modification on p97 activity 
As p97 has been demonstrated to have relatively low activity for an ATPase, it has been 
postulated that its activity is modulated by external factors including interacting proteins 
and chemical modification. As p97 is suggested to make up about 1 % of all cytosolic 
proteins, this would give a mechanism by which ATP may not be consumed in large 
quantities unproductively. 
Modification of activity by interacting proteins 
It has been proposed that adaptors may affect the properties of p97 although only three 
of the identified binding partners have been tested. The UBX domain containing protein 
and major adaptor, p47, can decrease p97s activity significantly in a dose dependent 
manner (Meyer et al., 1998). This affect did not result alone from the region of p47 that 
binds to p97 (Bruderer et al., 2004). Although the oligomerisation state of p97-p47 
complex was not observed during the ATPase assay, it seems unlikely that this 
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inhibition was a result of disassembly of the hexamer as p97-p47 complex is observed 
as a p97 hexamer bound to a p47 trimer by EM (Beuron et al, 2006). The other major 
adaptor Ufdl-Npl4, does not show any impact on p97s activity (Bruderer et al., 2004). 
The complex formation was not observed in assay conditions although it is likely that 
complex formation is not dependent upon nucleotide state of p97 (Pye, personal 
communication). Interestingly, despite the highly stable hexamer contacts in p97, the 
orthologue of p97 in Arabidopsis thaliana, AtCdc48, was shown to be disassembled by 
binding to interacting protein, plant UBX domain-containing protein 1 (PUXl). 
Disassembly of the hexamer, abrogated ATPase activity in an allosteric manner 
(Rancour et al, 2004). No orthologues of PUXl have been identified in mammals or 
yeast. 
Synaptotagmin 1 has been shown to interact with p97 and was shown in a study 
searching for potential substrates of p97 to enhance the ATPase activity fourfold 
(DeLaBarre et al., 2006; Ruden et al., 2000; Sugita and Sudhof, 2000). Whether 
Synaptotagmin l i s a true substrate for p97 remains to be proven but regardless is the 
first report of a p97 binding protein that stimulates ATPase activity. 
Phosphorylation 
p97 has been shown to be phosphorylated in response to T cell activation at two 
tyrosine residues in the C terminal extension, an unstructured region proceeding the D2 
domain (Egerton et al., 1992). Comparison of ATPase activities of tyrosine 
phosphorylated and non-phosphorylated p97 suggest that this modification is unlikely to 
affect ATPase activity (Egerton and Samelson, 1994). Phosphorylated p97 may instead 
have altered cellular localisation. Phosphorylated p97 was shown to localise to the 
nucleus in late G1 and shown to have decreased association with the transitional ER and 
t-SNARE Syntaxin-5 (Lavoie et al., 2000; Madeo et al., 1998). 
Linked to the apparent role in cancer, p97 can also be phosphorylated at serine residues 
but the impact on ATPase activity has not been tested. DNA damage stimulates 
phosphorylation at Ser 784 by phosphatidylinositol-3 kinase-related kinases (PIKK) and 
p97s accumulation at sites of double strand breaks (Livingstone et al., 2005). p97 is also 
able to interact with and be phosphorylated by activated Akt at Ser 352, Ser 746 and Ser 
748 (Klein et al., 2005; Vandermoere et al., 2006). Activation of Akt (and the assumed 
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phosphorylation of p97) decreased the amount of poly-ubiquitinated proteins co-
precipitated with p97 (Klein et al., 2005). 
In summary, there is evidence that p97 is phosphorylated at six sites in response to cell 
cycle and DNA damage cues. Phosphorylation has been shown to not alter the ATPase 
activity of p97 in two cases but does instead alter its cellular localisation, possibly 
through modulating interactions with p97 binding proteins or by revealing localisation 
motifs (Madeo e( al, 1998). 
Oxidation 
Oxidative stress has been implicated in several diseases including cancer and 
neurodegenerative disease. Oxidative stress modifies proteins leading to ER stress and 
ultimately cell death. Treating p97 with oxidising agents revealed that Cys 69, Cys 77 
and Cys 522 were modified (Noguchi et al, 2005). The Cys 522 residue is part of the 
D2 active site and so modification was proposed to affect ATPase activity. Treating 
ATPase assay mixtures with increasing amounts of oxidising agent led to inliibition of 
ATPase activity, however, there was only limited reversal of this effect by treatment 
with reducing agent, dithiothreitol (DTT) (Noguchi et al., 2005). Additionally, absence 
of some helpful controls, suggest that in addition to specific inhibition tlirough 
modification of Cys 522, there may be some non-specific chemical inhibition resulting 
from the treatment. 
Interestingly, modification of cystine residues with N-ethylmaleimide (NEM) has been 
widely exploited in functional assays to halt the activity of p97 (and related AAA 
ATPase NSF). This has been shown to inhibit p97 ATPase activity presumably through 
a similar mechanism (Song et al., 2003). 
1.7 Summary 
p97 forms a stable hexamer of two stacked toroids of D1 and D2 AAA ATPase domains 
with N domains protruding from outer edge of the D1 domain. Structural studies have 
shown that different nucleotides can alter the conformation of p97 and bound adaptors 
(Beuron et al., 2006). There is some contention over the nature of these changes but 
they seem to focus particularly in the N domain position and the D1 and D2 central 
pores (reviewed by (Pye et al., 2006)). The activity of p97 may be modified by some 
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adaptors, for example ATPase activity of p97 can be decreased by binding of p47 and 
PUXl and also oxidation of a cysteine residue in D2 (Meyer et al, 1998; Noguchi et 
al., 2005; Rancour et al., 2004). The roles of multiple phosphorylation sites on p97 are 
currently not linked to modification of p97s enzymatic activity. 
Enzymatic characterisations of the ATPase activity of p97 and other AAA+ ATPases 
have relied upon site-directed mutagenesis of highly conserved motifs. Mutation of the 
Walker A lysine residue reduces nucleotide binding and mutation of the Walker B 
glutamic acid residue reduces the hydrolysis of ATP. Furthermore, ATP hydrolysis may 
also be reduced by mutation of arginine fingers. The D1 and D2 domains are 
homologous but appear to be structurally and enzymatically non-equivalent. The D1 
domain has been shown to produce the majority of hexamer contacts and is tightly 
packed. The D2 domain, in contrast, is flexible and loosely packed. ADP is likely to be 
bound tightly to the D1 domain in some p97 preparations but not others and the D2 
domain appears to bind to added nucleotides readily. There is some evidence to suggest 
that the D1 and D2 domains may cooperate to hydrolyse ATP and nucleotide binding in 
the D2 ring may not be equal to all sites but both these points remain highly 
controversial. 
1.8 Aims 
The aims of this study are to understand further the ATPase mechanism of p97. As p97 
has twelve active sites there are multiple mechanisms by which these sites may bind and 
hydrolyse ATP. The active sites may be coordinated by cooperative mechanisms or be 
independent. Some active sites may be redundant while others contribute greatly to ATP 
hydrolysis. To gain insight into the nucleotide binding properties of the D1 and D2, 
dissociation constants of ADP and ATP to D1 and D2 domains are determined. Key to 
this study are mutations in the Walker A motifs to reduce or knockout nucleotide 
binding properties in the D1 or D2 domains allowing study of the D1 and D2 domains 
individually (Section 1.5.3.1). Initially, recombinant p97 and mutants are biochemically 
characterised (Chapter 3) and then a range of biophysical techniques are used to 
determine the ADP and ATP binding properties of p97 (Chapters 4 and 5). These results 
are discussed in Chapter 6 with respect to other studies and a mechanism for p97s action 
is proposed. 
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Chapter 2 
Materials and Methods 
2.1 Solutions and buffers 
2.1.1 Bacterial growth 
LB Broth 1% (w/v) Bactotryptone, 1% (w/v) NaCl, 0.5% (w/v) Bactoyeast Extract 
oQp 20 mM Glucose, lOpM MgCL, 2.5 (oM KCl, 2% (w/v) Bactotryptone, 0.05% 
(w/v) NaCl, 0.05%0 (w/v) Bactoyeast Extract 
LB-Agar LB broth, 2% (w/v) agar 
Hyper Broth Purchased from AthenaES (Baltimore, MD) 
2.1.2 Electrophoresis buffers and gels 
Agarose Gel 0.8-2 % Agarose in Agarose Gel Running Buffer 
Agarose Gel Running Buffer (TAE) 40 mM Tris-Acetate, 1 mM EDTA 
Agarose Gel Loading Buffer (6 X) 0.25% (v/v) Bromophenol Blue, 40% (w/v) Sucrose 
Agarose gels 
Denaturing poly-acrylamide gels 
Resolving Gel 
15 % (v/v) Acrylamide Mix (Amresco), 25 % Resolving 
Buffer, 0.1% (w/v) SDS, 0.1% (w/v) Ammonium 
Persulphate (APS), 0.04% (v/v) N,N,N',N'-
tetramethylethylenediamine (TEMED) 
Stacking Gel 
4% (v/v) Acrylamide mix, 25 % Stacking Gel Buffer, 0.1% 
(w/v) SDS 0.1% APS, 0.04% (v/v) TEMED 
Resolving Buffer (4 X) 1.5 M Tris (pH 8.8) 
Stacking buffer (4 X) 0.5 M Tris (pH 6.8) 
Running buffer (10 X) 250 mM Tris Base, 2 M Glycine, 0.4 % (w/v) SDS 
Loading buffer (2 X) 100 mM Tris HCl (pH6.8), 200 mM P-mercaptoethanol, 4% (w/v) SDS, 0.2% (v/v) Bromophenol Blue, 20 % 
Glycerol 
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Non-denaturing gels 
Non-denaturing Gel 10 % (v/v) Acrylamide Mix (Amresco), 25 % Resolving Buffer, 0.1% APS, 0.04% TEMED 
Running Buffer (10 X) 250 mM Tris Base, 2 M Glycine 
Loading Buffer (2 X) 100 mM Tris HCl (pH6.8), 0.2% (v/v) Bromophenol Blue, 20 % Glycerol 
2.1.3 Purification and protein buffers 
Purification buffers 
Ni Column Buffer A 25 mM HEPES (pH 8), 500 mM KCl, 10 mM p-
mercaptoethanol 
Ni""^  Column Buffer B 25 mM HEPES (pH8), 500 mM KCl, 200 mM Imidazole, 10 
mM P-mercaptoethanol 
Song Activity Buffer 50 mM Tris HCl (pH 8), 20 mM MgClz, 1 mM EDTA 
Removai of pre-bound nucleotide buffers 
Apyrase Buffer 25 mM HEPES (pH 7.1), 150 mM Sodium Acetate, 5 mM MgClz, 2 mM DTT 
pH 9 Dialysis Buffer 50 mM Tris HCl (pH 9), 20 mM MgCL 
2.2 Bacterial strains and plasmlds 
Bacterial Strain Source Genotype 
XL 1-Blue 
Rosetta™ Cells 
Stratagene RecAl endAl gyrA96 thi-1 hsdR17 supE44 relAl lac[FcproAB laclqZDMlS TnlO (TetR)] electrocompetent 
Novagen F- dcm ompT lisdSB(rB'SB') gal, A,(DE3) pRARE(Cam'^) 
Plasmid Source Antibiotic Resistance 
Affinity tag 
position Protease cleavage site 
pET22-d Novagen Ampicillin C terminal None 
pTrcHisB Invitrogen Ampicillin N terminal MCS-1 
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2.3 p97 constructs and DNA manipulation 
Genotype Affinity Tag Plasmid Source 
Wildtype C terminal Hisg pET22-d Dr. Trevor Huyton 
Wildtype N terminal Hise pTrcHisB Dr. Hisao Kondo 
K251A N terminal Hise pTrcHisB Dr. Hisao Kondo 
K524A N terminal Hisg pTrcHisB Dr. Hisao Kondo 
K251A, K524A N terminal Hisg pTrcHisB Dr. Hisao Kondo 
E305Q N tenninal Hise pTrcHisB Dr. Hisao Kondo 
E57GQ N terminal Hiss pTrcHisB Dr. Hisao Kondo 
E305Q, E578Q N temiinal Hisg pTrcHisB Dr. Hisao Kondo 
R359K, R635K N terminal Hisg pTrcHisB Louise Briggs 
R359A, R635A N terminal His^ pTrcHisB Louise Briggs 
G480A, G481A N temiinal Hisg pTrcHisB Louise Briggs 
2.3.1 Site-directed mutagenesis 
The pTrcHisB wildtype p97 construct was used to produce site directed mutant clones 
(G480A, G481A; R359K, R635K; R359A, R635A). Reaction amounts and cycling 
parameters based upon the Quikchange® method (Stratagene) as outlined below. 
Component Volume (pL) Cycle Temperature Time 
10 X Pfu Turbo buffer 5 1 9 5 ^ : 1 min 
100 mM dNTP mix 5 16-18 9 5 ^ : 45 sec 
25 ng/(j,L fwd primer 5 5 5 ^ : 1 min 
25 ng/jjL rev primer 5 6 8 ^ : 2 min/kb 
20-50 ng template plasmid X 
Pfu Turbo polymerase 1 
ddHoO to 50 i^L 
The samples were digested following PGR with Dpnl, removing parental plasmid. The 
efficacy of this digestion was analysed by 0.8 % agarose gel electrophoresis. The 
mutated strands were transformed into electrocompetent XL 1-Blue cells and cells 
resuspended in 500 \iL SOC media and incubated with shaking at 37 °C for 1 hour. 
Selection for transformed cells was achieved by plating cells on LB agar plates 
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containing 100 |j.g/mL ampicillin. Mutated plasmid was isolated from colonies grown 
and sequenced across mutated region. 
2.3.2 Preparation of electrocompetent cells 
Electroporation was the sole method of transformation of E. coli used. XL 1-Blue or 
Rosetta^'^ cells were grown in LB broth containing 20 |ig/mL tetracycline at 37°C with 
shaking, and at mid log phase (ODgoo = 0.4-0.6) cells were pelleted (4000 rpm, 15 min 
at 4 °C). Cells were washed with ddH^O and again with 10 % (v/v) glycerol by 
repelleting and resuspension. The cells were finally washed again with 10% (v/v) 
glycerol, flash frozen in liquid nitrogen and stored at -80 °C in 50 |j,L aliquots for future 
use. 
2.3.3 Transformation by electroporation 
To prepare for transformation, cells were mixed with plasmid sample (typically 1 |a.L of 
plasmid dissolved in ddH20) and incubated on ice. A 0.1 cm gap cuvette (Biorad) was 
also chilled. Cells were transferred to the cuvette and transformed using a Biorad Gene 
Pulsar (settings 1.67 kV, 25 |iF, 200 Q). Following electroporation, cells were 
immediately resuspended in 0.5 mL SOC broth and incubated with shaking at 37 °C for 
an hour before being plated on LB agar containing 100 p.g/mL ampicillin and grown 
overnight at 37 °C. 
2.3.4 Isolation of plasmid DNA 
Routine isolation of plasmid DNA from bacteria harvested from LB media was carried 
out using a modified alkaline lysis method (Bimboim and Doly, 1979). Small quantities 
of DNA were prepared from 10 mL overnight cultures of bacteria in LB-ampicillin (100 
|j,g/mL) broth. DNA was prepared using the QIAprep Miniprep protocol (Qiagen). 
Larger scale preparations of DNA were obtained from 100 mL LB ampicillin cultures 
using the QIAfilter Maxi kit (Qiagen). All kits were used according to the 
manufacturers instructions. All DNA preparations were resuspended in ddHzO 
following purification to aid sequencing. 
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2.3.5 Quantification of plasmid DNA 
The concentration of DNA was determined by spectrometry from 1:100 dilutions of 
plasmid DNA where 1 AU at 260 nm corresponded to 50 ng/^L double stranded DNA. 
2.3.6 Agarose gel electrophoresis 
Agarose gels, typically 0.8 % (w/v) in TAE buffer were prepared by heating in a 
microwave for 4 min. 50 ng/mL ethidium bromide solution was added and gels set in 
mould. Gels were run in TAE buffer and DNA visualised by a UV transilluminator, or 
Gene Genius (Syngene) 
2.4 Protein preparation 
2.4.1 Protein expression 
Expression constructs were transformed into electrocompetent Rosetta™ cells as 
described previously. Glycerol stocks of the transformation were used to inoculate a 
starter culture of 100 mL LB broth with 100 pg/mL ampicillin and incubated overnight 
with shaking at 37 °C. Typically, 0.8 L of Hyper Broth (containing 100 pg/mL 
ampicillin) was inoculated with 10 mL starter culture and grown at 37 °C with shaking 
to an ODeoo of 0.5-0.6. 1 mM IPTG was added and growth continued for a further 3 
hours. Cells were harvested by centrifugation at 4000 rpm for 10 min. In general, 
batches of 12 L of cells were expressed, so parameters that follow are for this volume. 
2.4.2 Affinity column protein purification 
Harvested cells were resuspended in 75 mL Ni^^ column buffer A and a protease 
cocktail was added (0.1 mM PMSF, 100 |ig/mL Leupeptin, 100 ^ig/mL Pepstatin 100 
P-g/mL Aprotinin 100 pg/mL Anti pain 100 pg/mL Benzamidine). Cells were lysed by 
sonication for at 40 % amplitude for 10 min with 10 min resting time interspersed. 
Cellular debris was removed by centrifugation at 18 000 rpm for 30 min. 
The crude soluble protein extract was loaded onto a three tandem Hi Trap affinity 
columns (Amersham Biosciences) charged with Ni^^ and equilibrated with Ni^ ' column 
buffer A. Unbound protein was washed out with 10 column volumes of Ni^ ^ column 
buffer A and loosely bound protein was eliminated with a 15 column volume step of 20 
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% column buffer B. A gradient of Ni^ "^  column buffer B to 80% over 25 column 
volumes eluted p97 in a peak at approximately 70 % buffer B. 
2.4.3 Size exclusion chromatography 
Where protein samples were to be used several days after purification (for example after 
treatment to remove pre-bound ADP), an additional gel filtration step was employed to 
remove microaggregates of p97. p97 samples were concentrated to less than 3 mL, 
loaded onto a pre-equilibrated Superdex 200 column (Amersham Biosciences) 
(flowrate 0.5 mL/min). p97 eluted as two overlapping peaks, the first was determined to 
be micro-aggregates by electron microscopy and the second was p97 hexamers. Both 
peaks had identical profiles by SDS-PAGE and generally, an insignificant amount of 
impurities were eluted later. 
2.4.4 Protein buffer exchange 
Buffer exchange from Ni^^ affinity column buffer B to Song activity buffer was 
performed using either of two methods, dialysis or exchange over a desalting column. 
Dialysis 
Purified protein was sealed into a section of dialysis tubing with a molecular weight cut 
off of 12-14 kDa. The bag was then suspended in 1 L of 1 X Song activity buffer and 
incubated for at least 2 hours at 4 °C with stirring. Buffer was exchanged for fresh 
buffer and the incubation repeated. 
Desalting column 
Purified protein was concentrated to less than 5 mL and loaded onto a 26/10 desalting 
column (total volume 55 mL, void volume 20 mL) (Amersham Biosciences), 
equilibrated with 100 mL Song activity buffer. A further 100 mL of Song activity buffer 
was washed through the column, and protein eluted at approximately 20 mL, well 
separated from salt and imidazole peaks. 
2.4.5 Denaturing poly-acrylamide gel electrophoresis 
Denaturing poly-acrylamide gel electrophoresis (SDS-PAGE) was used to check the 
purity of samples. Gels were made according to the recipe specified in section 2.1.2. 
75 
Protein samples (20 |_iL) were denatured by heating to 90 °C in loading buffer (10 |iL) 
and up to 20 piL was loaded onto a 12 % Tris-glycine poly-acrylamide gel. The gel was 
typically run at 50 A for 75 min, stained with Coomassie stain and destained in water 
and methanol. 
2.4.6 Non-denaturing poly-acrylamide gel electrophoresis 
To determine the oligomeric state of protein preparations, non-denaturing gels were 
used. All equipment was washed thoroughly with water to remove traces of SDS. Gels 
made according to the specifications of section 2.1.2. 20 |iL of samples mixed with 
loading buffer (2:1 mix) and loaded in parallel to molecular weight standards, selected 
for a similar pi to p97 (Thyroglobulin (670 kDa), Ferritin (470 kDa) and Albumin (66 
kDa)). The gel tank was placed on a tray of ice and the gel run at 20 A for 120 min. The 
gels were stained and destained similarly to SDS PAGE. 
2.4.7 Quantification of protein concentration 
Protein concentration was determined by measuring the absorbance at 280 nm of a 
protein sample diluted in a ratio of 1:3 protein to 6 M guanidinium hydrochloride, 0.02 
M phosphate buffer (pH 6.5). Three readings were taken of a dilution that gave 
absorbance at 280 nm between 0.2 and 1 AU. The concentration was calculated from 
with an estimated extinction coefficient (in guanidinium hydrochloride) of 34990 M" 
^cm'\ The concentration of protein solutions was increased where necessary using a 
centrifugal concentrating device (Amicon Ultra, Molecular weight cut-off 30 kDa, 
Millipore). 
2.4.8 Quantification of nucleotide concentration 
The concentration of nucleotides, dissolved in Song activity buffer, was quantified by 
absorbance at 259 nm. The concentration was calculated from three readings of a 
dilution that gave absorbance at 259 nm of between 0.2 and 1 AU using the extinction 
coefficient of adenine (15400 M"'cm"'). 
2.4.9 Removal of pre-bound ADP 
Pre-bound nucleotide was removed by dialysis against apyrase from potato 
(Grade VII, Sigma Aldrich). Two methods of apyrase dialysis were used throughout this 
study, the first covering the results of Chapter 3, 4 and 5 (sections 5.1-5.5) and the 
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second for the final results section 5.6. This latter method was the most effective and 
gave the most reproducible results (Section 3.5.4). 
The first method sealed around 3 mL of protein in a low molecular weight cut-off 
dialysis bag and dialysed against 100 mL of apyrase buffer containing 50 U of apyrase. 
The second method reversed this, and instead protein samples were diluted to between 1 
and 5 (around 100 mL) in apyrase buffer and 50 U apyrase was sealed in a low 
molecular weight cut-off dialysis bag. In both cases, the apyrase was dialysed against 
p97 for 8 hours at room temperature and 16 hours at 4 °C. Following dialysis, the 
protein sample was concentrated to less than 3 mL and any aggregates removed by size 
exclusion chromtography. 
2.5 Protein assays 
2.5.1 Quantification of pre-bound nucleotide 
This method uses heat to precipitate protein samples, allowing protein to be separated 
from pre-bound nucleotide by centrifugation. The concentration of nucleotide was then 
determined by absorbance at 259 nm. Briefly, the concentration of p97 was adjusted to 
between 75 and 100 p,M and three aliquots of 75 pL p97 were heated at 100 °C for 20 
min. The precipitated protein was removed by centrifugation at 13 000 rpm for 20 min 
and a defined volume of supernatant was decanted (typically 50 |iL) and diluted with 
100 pL Milli Q in a fresh tube. The absorbance at 259 nm was measured twice per 
sample (2 x 60 fj,L) compared to a buffer blank. The concentration of adenine nucleotide 
was calculated as described in section 2.4.8 and scaled for dilution. The amount of 
nucleotide released was expressed as a ratio of nucleotide:p97 protomer. 
2.5.2 HPLC analysis of the pre-bound nucleotide species 
Unlabelled nucleotides bound to p97 were analysed in a similar manner. Excess 
nucleotide was removed by diluting the sample 100 fold and concentrating to 100 fJ.M. 
The sample was precipitated with 2.5 pL 10 % perchloric acid (pH < 2) to stop the 
reaction. The pH was adjusted to approximately pH 4 with 1.75 pL 4 M Sodium Acetate 
(pH 5.1) and the sample was centrifuged for 20 min. Typically, 20 pL of sample was 
loaded onto a Whatman Partisil SAX (Strong anion exchange) (Bead size: 10 pm. Bore: 
4.6 mm. Length: 25 mL) and eluted isocratically with 0.6 M Ammonium Phosphate (pH 
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4), 25 % Methanol at a flow rate of 1.5 mL/min. Detection of nucleotide was by 
absorbance at 260 nm and eluted peaks were compared to controls of ADP and ATP. 
2.5.3 Colorimetric ATPase activity assay 
Inorganic phosphate (Pi) release was measured colorimetrically by quantifying phospho-
molybdate complexes dyed by malachite green (Cogan et al, 1999; Song et al, 2003). 
Briefly a 1 mL reaction mixture was assembled containing 3 mM ATP and 1 X Song 
activity buffer equilibrated at 37 °C and 1 pM p97 was added to start the reaction. At 
time-points 0, 5, 10, 15, 20, 30 min, 100 |j.L was removed and mixed with 900 |aL 
colour reagents (6.02 mM Ammonium Molybdate, 451.5 mM H2SO4, 0.056 % 
Polyvinyl Alcohol, 121 pM Malachite Green). Colouration was developed over 19 min 
and then the reaction stabihsed with 100 |iL 3.4 % Citric Acid. Absorbance at 600 nm 
was then measured. 
Absorbance readings were plotted against time and the linear portion of the data 
(normally between 0 and 20 min) was fitted to a straight line with zero intercept. The 
gradient (abs/min) was converted to moles Pi released, through a standard curve with 
known Pi concentrations, and factored for dilution and concentration to give nmol Pi 
released/nmol p97 protomer.min. 
2.5.4 Fluorescence detection of ATPase activity 
Hydrolysis of MANT-ATP over a time course of 120 min was measured by HPLC. 
Aliquots of reaction mixture (50 |iL) were removed throughout the time course and 
precipitated with 2.5 10 % perchloric acid (pH < 2) to stop the reaction. The pH was 
adjusted to approximately 4 with 1.75 |j,L 4 M Sodium Acetate (pH 5.1) and the sample 
flash frozen by placing immediately on dry ice. Prior to analysis by HPLC, the samples 
were defrosted and centrifuged at 13000 rpm for 1 min to pellet the precipitate. 
Typically, 20 |iL were loaded onto a Whatman Partisil SAX (Bead size: 10 |am. Bore: 
4.6 mm, Length: 25 mL) and eluted isocratically with 0.6 M Ammonium Phosphate (pH 
4), 25 % Methanol at a flow rate of 1.5 mL/min. MANT-nucleotide was detected with a 
Hitachi F-1050 fluorescence detector (excitation 366 nm, emission 440 nm) and peaks 
monitored with a Hewlett Packard 3 3 90A integrator. 
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2.5.5 Fluorescence anisotropy 
A basic overview of fluorescence anisotropy theory 
The technique exploits the differential rate of tumbling in solution of free ligand 
compared to ligand bound to a large protein. Plane polarised light is used to excite a 
population of fluorophores in a similar orientation with respect to the polarisation and 
the resulting emission is detected in planes parallel and perpendicular to excitation. 
Large molecules such as proteins, tumble slowly in solution compared to small 
molecules as described by the approximation: 
0 = 
2 0 0 0 n s 
(1) 
where (f) is the rotational correlation time (or the reciprocal of the rate constant for the 
randomisation of the orientation of the molecule by Brownian motion) and Mr is the 
molecular mass. As the fluorescence time scale (delay between excitation and emission) 
is less than 100 ns and so similar to the timescale of molecular tumbling, it is possible to 
measure the proportion of ligand binding to protein (slow tumbling) compared to the 
amount of free ligand (fast tumbling). Free fluorescent ligand tumbles fast in solution so 
in the time lapse between excitation and emission of a photon, the molecule is much 
more likely to have tumbled out of the vertical plane of excitation (parallel) and into the 
horizontal plane, perpendicular to the plane of excitation. This results in a larger 
intensity of emitted photons in the horizontal plane (perpendicular) compared to the 
vertical plane (parallel). When compared to a small fluorescent ligand, the fluorescent 
ligand-protein population rotates much slower and so it is less likely to have tumbled 
into the plane horizontal plane following excitation and hence fewer counts are recorded 
as parallel compared to perpendicular. The anisotropy is defined as the ratio of the 
difference in intensity of light collected in the parallel and perpendicular planes and the 
total expected light to be collected in all planes (denominator of equation (2))'. This is 
' The total expected light to be collected in all planes is defined as parallel (x axis) plus perpendicular (y 
axis) plus perpendicular in the third plane (z axis). The fluorescence intensity of the z axis is not easily 
measurable but as both the y and z axis are a 9 0 ° rotation from the x axis, they theoretically have the 
same intensity and hence the expression vertical plus 2 X horizontal. 
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described in equation (2) in which Aniso is the anisotropy, Inty is the intensity of the 
parallel light and Intn the intensity of the perpendicular light. 
. Iniv - Intn 
Ant so = 
I n t y 4- 2Inttj 
(2) 
Practically, as the anisotropy value increases, the slower the rate of rotation of an 
increasing fraction of fluorescent molecules, resulting from an increase in the apparent 
molecular weight of the fluorescent molecules. 
Fluorescent ligands 
Equilibrium studies were carried out using fluorescent labelled nucleotides (Invitrogen) 
selected for a high extinction coefficient (and hence large fluorescent signal) and good 
photo-stability and fluorescence in physiologically relevant buffers (Tris pH 7). The 
fluorophore, 6-((4,4-difluoro-5.7-dimethvl-4-bora-3 a,4a-diaza-s-indacene-3 -
P.ropionyl)amino)hexanoic acid (BODIPY®), is attached to the nucleotide by a long 
flexible linker which links to the nucleotide at positions 2 or 3 of the ribose ring (there 
is isomerisation between these positions). Both BODIPY ADP and BODIPY AMPPNP 
(Molecular Probes, Invitrogen) were used for binding studies under the following 
fluorimeter settings: BODIPY ADP- Excitation 595 nm, slit width 3 nm, Emission 620 
nm slit width 10 nm; BODIPY AMPPNP- Excitation 504 nm, slit width 2 nm, Emission 
514 nm, slit width 5 nm; both with an integration time of 5 s. 
Kinetic studies of binding and hydrolysis studies were carried out with N-
Methvlanthranilovl (MANT) nucleotides (a kind gift from Dr. J. Eccleston, NIMR, 
London). There is a shorter linker between the MANT group and the nucleotide than the 
BODIPY labelled nucleotides but the attachment is able to isomerise between the 2' and 
3' positions on the ribose in common with the BODIPY labelled nucleotides. MANT 
nucleotides were chosen because the excitation wavelength is suitable for fluorescence 
resonance energy transfer experiments between tryptophan and the fluorophore. 
Fluorescence anisotropy binding experiments 
All equilibrium binding experiments were carried out in a FluoroMax-3 (Horiba Jobin 
Yvon) at 25 °C. Typically, a fixed amount (and in practice a fixed concentration) of 
ligand labelled with a fluorophore is placed in a glass cuvette. This concentration is 
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ideally in the concentration range of the dissociation constant to be determined. In all 
experiments described, the concentration of fluorescent ligand is 50 nM. An anisotropy 
reading is taken of ligand alone and then small volumes of concentrated protein are 
titrated into the cuvette, mixing thoroughly. Equilibrium is usually achieved rapidly (< 1 
second) and three to five readings are taken per titration point. The readings are 
averaged and plotted against total protein concentration. A limitation of this 
experimental setup is that as the protein concentration increases, random scattering of 
light also increases, thus, so does anisotropy linearly. Once the scattering effect is 
characterised for a specific system, this can be subtracted to correct results for this. 
Competition experiments between BODIPY-ADP and unlabelled nucleotides were 
carried out in two ways. The linear regression approach required that a succession of 
titrations were carried out at different fixed concentrations of ADP. To achieve this for 
each individual titration point, a fresh mixture in the cuvette of BODIPY-ADP, ADP 
and p97 was made up so that as the concentration of protein was increased, the added 
ADP was decreased to compensate for the increasing pre-bound ADP. The 
displacement experiments were more simple to perform, 50 nM of BODIPY-ADP was 
saturated with a fixed concentration of p97 (100 nM wildtype p97 and 450 nM K524A 
p97) and unlabelled nucleotide was then progressively added to displace the BODIPY-
ADP. 
Data was fitted to equations using Grafit (v. 5) (Erithacus Software) which are detailed 
in sections 2.6.1 and 7.1. 
Fluorescence anisotropy kinetic experiments 
p97 and MANT-ATP were rapidly mixed and fluorescence anisotropy measurements 
were taken over a short timescale at 25 °C using a Hi-Tech SF-61 DX2 stopped-flow 
instrument (TgK Scientific). Excitation was through a monochromator at 366 nm, and 
emission was viewed through a Schott KV 399 cut-off filter. Concentrations quoted are 
those after mixing and are therefore half of those in the syringes. Typically, 5 |aM 
MANT-ATP was mixed with 5 p.M p97 (protomer) and the parallel and perpendicular 
fluorescence intensity were recorded over 1 s to 1000 s timescale. Anisotropy and total 
fluorescence intensity were calculated from equation (2). 
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2.5.6 Isothermal titration calorimetry 
Binding affinity, stoichiometry, enthalpy changes and entropy changes were measured 
by isothermal titration calorimetry (ITC). ITC utilises the energy released or consumed 
upon binding of a ligand as a direct measure of the reaction progression. Each titration 
point in a binding reaction gives rises to a change in temperature of the reaction cell 
leading to an alteration in the energy required by the calorimeter to maintain the 
temperature of the reaction cell equal to a reference cell^ (Further details shown in 
section 7.3). 
p97 and unlabelled nucleotides were prepared in identical buffer solution and loaded 
into the cell and injection syringe respectively of a Microcal VP ITC microcalorimeter 
(Microcal) equilibrated at 25 °C. Typically, 1.7 mL of 100 jaM p97 and 300 |_iL of 1 
mM nucleotide were used. A titration generally consisted of 30 injections of 10 pL of 
ligand with each injection spaced apart. After completion of the titration, the baseline 
was adjusted to remove artefacts and peaks were integrated using Origin software to 
give [ical/mol 
To control for ligand solvation energy, ligand was injected into buffer alone and the 
resulting integrated peaks subtracted from the experimental data. 
2.6 Analysis of experimental data 
Fitting the experimental data to equations describing various mechanistic situations is a 
well-accepted method of diagnosing modes of enzymatic action. Should the data fit 
closely to the equation then it can be suggested that this equation fully describes the 
ligand binding situation and enzymatic parameters required derived from this fit. 
Obviously, there are many potential pitfalls in this method of hypothesis testing as 
^ This energy is referred to as DP (standing tor d Power) and with the units pcal/s. 
^ To avoid conflision, all discussion of measurements made with this equipment uses the non-SI unit of 
the calorie (cal) as measure of energy rather than the Joule (J). Calories are the output of the equipment 
and custom analysis and are the convention within this technique. For reference, 1 cal is equal to 
4.18400 J. 
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many data sets can be fitted to inappropriate equations, so each step must be thoroughly 
reasoned. 
2.6.1 Fluorescence anisotropy equilibrium binding experiments 
The equilibrium dissociation constant {K^ of ligand binding to protein was determined 
by non-linear fitting of anisotropy data to equations describing the binding of ligand (I) 
to protein (P). 
P L ^ P-HL 
(3) 
The concentration of protein bound {PL) was calculated from the assumption that 
anisotropy (Aniso) varies linearly with the concentration bound ([PZ]). 
[FL\ = 
j4. m 4^. ? 7. z s j 
(4) 
\Ltot\ represents total ligand concentration, which in every experiment is 50 nM 
BODIPY-ADP. Grafit was then used for non-linear fitting of binding data to three 
equations: 1 site binding (5), 1 site tight binding (6), 1 site competition (7). The linear 
regression method interpreted the line of best fit according to equation (8) (Cheng and 
Prusoff, 1973). The derivations are covered in section 7.1 and shown below are the final 
expressions used for fitting. 
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[Pl\= 
^ — [Ptot] 
C= [Ptot][Ltot] (6) 
[PL] —b — \ /6^ — 4c 
2 
b = —A jD — [^tot]^d^ rr ] rp 1 [^tot\ [^tot\ 
' = of] [Z'w] 
(7) 
APP.Kal = KJL ( 1 + 
Where {Ptot\ is total protein concentration and [Itot\ is the total inhibitor concentration 
(the competing unlabelled nucleotide) and Kdi and Kdi are the equilibrium dissociation 
constants of ligand and inhibitor respectively. 
1 site binding equations were applied to lower affinity data (K251A and K251A-K524A 
datasets) and the 1 site tight binding equation applied to high affinity datasets (wildtype 
and K524A datasets). The 1 site binding equations make the assumption that the total 
protein concentration is equal for the free protein concentration and so is only 
appropriate for lower affinity binding measurements, as at higher affinities (nominally 
Kd < 100 nM) this assumption breaks down at the concentrations necessary these 
experiments. The 1 site tight fit doesn't require this assumption but does not fit low 
affinity data well especially at saturation. The 1 site competition equation allows the 
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consideration of two ligands competing for one site. This equation assumes that the total 
ligand concentration is equal to the free ligand concentration"^. 
Data was fitted by the Marquadt-Levenburg method over 20 iterations and the standard 
error was less than 10 % of the fitted parameter. 
2.6.2 Fitting isothermal titration calorimetry data 
Raw ITC data was analysed using Origin?® (OriginLab coiporation) with a Microcal 
LLC ITC add in. A baseline was fitted to the raw data to define the regions on the 
profile that represent changes in heat resulting from each titration point (rather than 
artefacts from bubbles etc.). The peaks were automatically integrated and converted to 
kcal/mole ligand and plotted against the molar ratio of ligand to protein. 
Data was fitted to one site, two site and one site competition binding equations, which 
are outlined in detail in Section 7.3 (Sigurskjold, 2000; Wiseman et al, 1989). As the 
equations used were complex, they are not reproduced here (Section 7.3). Non-linear 
curve fitting was by the Levenburg-Marquardt algorithm and fitting iterations halted 
when the reduced chi-squared value no longer decreased. Where necessary, when the fit 
converged upon inappropriate minima, individual stoichiometry, association constant 
and enthalpy values were constrained to approximations until the fit had taken the 
desired route. These values were then allowed to vary at freely as possible. When fitting 
low affinity binding data, the stoichiometry was poorly constrained and regularly fixed 
at 1 (as it could vary widely with minimum impact upon other results. 
When differentiating between which equation to fit data to, fits were evaluated for the 
lowest error for individual parameters and the lowest overall reduced chi squared. Those 
fits with an error larger than the individual parameter were discarded. The mean of the 
parameters achieved from several raw data sets (>3) and the standard deviation of this 
were used to define the final parameter and its likely error. 
An exact calculation is available although non-trivial to program as it is based on a cubic function 
(Wang, 1995) 
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2.6.3 Fitting of stopped flow data 
Stopped flow fluorescence intensity data in parallel and perpendicular planes was 
collected and the total fluorescence intensity and anisotropy data calculated from 
equation (2). Typically, data from five individual repetitions of data was averaged. 
Anisotropy and total fluorescence intensity data were fitted to models using Berkeley 
Madonna (v.8.0.1) to fit to differential equations describing rates of change of reaction 
components. Fitting to both total fluorescence intensity and anisotropy simultaneously 
allowed the increase in total fluorescence intensity upon binding to be factored into 
anisotropy measurements. 
Three models were used for fitting and are shown in detail in section 7.2. The one site 
model describes ligand binding reversibly to a single type of site on p97 associated with 
a single fluorescence increase and defines the association and dissociation rate constants 
(ki and k_i respectively). 
P + L ^ PL 
A-i 
(9) 
The two site model describes ligand binding to two different sites on p97 each with an 
individual fluorescence increase and association / dissociation rate constants (site 1: k, 
and k-i and site 2: kz and k.;) 
p + 2 L ^ P L ^ 4 - L ^ PLf 
k-i k-s 
2 . T p r l2 p + 2L ^ PL- + L ^ PL. 
fc-i 9 (10) 
The one site, two state model describes ligand binding to p97 in one type of site with an 
associated fluorescence increase and then undergoing a transformation leading to a 
second fluorescence increase. The two fluorescence states are assigned different rate 
constants (state 1: k; and k_i and state 2; kz and k.2). 
k. kn . 
P + L ^ P L ' ^ PL^ 
k-t k-2 (11) 
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Chapter 3 
Purification and Characterisation of 
Recombinant p97 and IVIutants 
3.1 Introduction 
p97 was first identified in 1987 and the initial characterisations that established p97 as a 
hexameric ATPase of low activity were carried out on p97 purified from animal organs, 
xenopus oocytes and mammalian cell culture (Egerton and Samelson, 1994; Koller and 
Brownstein, 1987; Meyer et al., 1998; Peters et al., 1992). Recombinant p97 was first 
expressed in 1992 in mammalian cells and purified by epitope tags (Egerton et al., 
1992). In the proceeding years, most biochemical characterisation studies were carried 
out with recombinant p97 expressed in E. coli and purified with a Hise affinity 
purification tag and it is this method of production of p97 that is also used in this work. 
Recombinant p97 expression in E. coli produces low yields but gives protein that is a 
soluble, stable hexamer and purifies simply in several steps to give protein of good 
purity. This chapter describes the optimisation of expression and purification, the 
characterisation of wild type p97 activity and the determination and manipulation of 
ligand starting state. As many mutations of p97 are used in subsequent assays these are 
also similarly characterised. 
3.2 Recombinant p97 constructs 
Recombinant p97 used throughout this study was produced using expression constructs 
originally generated by Dr. H. Kondo and purification methodologies established by Dr. 
T. Huyton and Dr. A. Shaw (Figure 3.1a). Mutations were made where necessary to 
wildtype constructs by the QuikChange® technique (Section 2.3.1). 
To separate the properties of the D1 and D2 rings, mutations were made in the 
conserved Walker A and B motifs, the second region of homology (SRH) and the Dl-
D2 linker to remove the functionality of these motifs (Figure 3.1b). These mutations 
were designed to alter nucleotide binding (Walker A), ATPase activity (Walker B and 
SRH) and connectivity between protomers (also SRH) and between D1 and D2 (D1-D2 
linker). These mutations, with the exception of the D1-D2 linker mutation, have been 
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3.1a 3.1b 
!ATG 6xHis - EK MCS 
_L J_ 
EroR. V 
pTrcHisB(p97-rat) 
5.21 kb 
•J- p^ iii 
N Domain D1 Domain 
I I I I 
D2 Domain 
Wildtype • 
Walker A mutants 
K251A • 
K524A • 
K251A-K524A • 
Walker B mutants 
E305Q • 
E578Q • 
E305Q-E578Q • 
SRH mutants 
R359K-R635K • 
R359A-R635A • 
D1-D2 linker 
G480A-G481A • 
• I 
C terminal 
extension 
Figure 3.1 Expression constructs of full length p97 and mutants used in this study 
a. A map of p97 expression plasmid pTrcHisB(p97-rat). The genetic sequence of Rattus norvegicus p97 (residues 2-806) was inserted between a BamHI and Hind III restriction sites in the multiple cloning 
site by Dr. H. Kondo. (Graphic of plasmid adapted from www.invitrogen.com) 
b. The mutations of the p97 insert to pTrcHisB(p97-rat). All contiguous expressed regions are shown in gray ( • ) and regions of interest highlighted: Hise purification tag (purple • ), folded domains (light 
gray • ), D1 Walker A (green • ), D2 Walker A (blue • ), D1 Walker B (tangerine a ), D2 Walker B (yellow ), D1 SRH (dark orange • ), 02 SRH (pink • ), D1-D2 linker (cyan • ). 
used widely in other structure-function studies of p97 and AAA proteins and their 
effects are well characterised (Section 1.5.3.1) (reviewed by (Ogura and Wilkinson, 
2001). The chief caveat of this strategy is that the mutations may not only affect the 
desired features but also have other effects. This has been bom in mind throughout this 
study, however, fortunately, most mutations have affected p97 as anticipated. 
The Walker A motif 
A role of the Walker A motif is to provide favourable binding interactions with the 
nucleotide. The structure of the D1 domain shows that the conserved lysine in the 
Walker A (K251) is positioned to coordinate Mg^ "^  which interacts with the p and y 
phosphate groups of ATP and this interaction is also predicted for the equivalent residue 
in D2 (K524) (Zhang et al, 2000). Substitution of the conserved lysine of this motif for 
alanine or threonine is well known to decrease binding of nucleotide sufficiently to 
effectively halt ATPase activity in that site (Song et al, 2003; Wang et al., 2003b; Ye et 
al, 2003). Three variants of p97 were produced mutated in D1 (K251A), D2 (K524A) 
and both D1 and D2 (K251A-K524A). 
The Walker B motif 
The proposed role of the Walker B motif is to stabilise and activate a water molecule to 
perform the nucleophilic attack of the y phosphate of ATP. The glutamic acid residues 
(E305, E578) in the motif were conservatively mutated to glutamine and also to alanine 
to attempt to halt all ATPase activity as suggested by previous studies (Song et al., 
2003; Ye et al., 2003). The Dl, D2 and both D1 and D2 domains were mutated to give: 
E305Q, E578Q and E305Q-E578Q. 
The second region of homology 
The SRH contains two arginine residues, position 1 which is conserved in all AAA+ 
protein families (p97: Dl R362, D2 R638) and position 2 which is found only in the 
AAA family (p97: Dl R359, D2 R635) (reviewed by (Ogura et al., 2004)). The arginine 
residues have been proposed to contribute to the ATPase activity by protruding into the 
neighbouring protomers active site and contacting the y-phosphate of ATP bound to that 
site and may also provide a means of inter-protomer communication (Wang et al., 
2005). As it has previously been shown that mutation of position 2 in p97 decreases the 
ATPase activity markedly but does not have a significant effect upon D2 nucleotide 
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binding, these residues were mutated to alanine and lysine in D1 and D2 with the aim of 
creating p97 variant with these properties and also disrupted inter-protomer 
communication. 
The D1-D2 linker 
Between N and D1 and between D1 and D2 are flexible linkers that are predicted to be 
unstructured but appear to be positioned close to the respective nucleotide binding 
pocket. A conserved pair of glycine residues has been proposed to act as a pivotal point 
through which conformational change and nucleotide binding information may be 
transmitted (Smith et al, 2004). To test this hypothesis and uncouple the D1 and D2, 
both glycine residues in the D1-D2 linker were mutated to alanine to give G480A-
G481A 
3.3 Recombinant p97 expression and purification 
Production of p97 was by a variation of the existing protocol established by Dr. T. 
Huyton and Dr. A. Shaw (Huyton et al, 2003; Zhang et al., 2000). A plasmid 
containing the cloned p97 coding sequence with an N terminal Hise affinity purification 
tag was transformed into E. coli expression host cells. Purification was by a single step 
of separation of p97 from host proteins using Hise tag binding to a Ni^ ^ chelated resin 
(Section 2.4). Wliile the methodology to express and purify p97 had been optimised in 
detail previously to provide protein of sufficient purity for crystallisation, it was 
necessary to adjust several aspects of the procedure to increase yields. 
p97 was expressed within Rosetta host cells which were originally chosen for their 
category 1 classification and rare codon expression features'. Overnight cultures were 
grown from glycerol stocks and inoculated into 2 L flasks containing 800 mL broth. LB 
growth media was substituted with Hyper broth due to the higher pellet weight of cells 
grown in enriched Hyper media. Growth was carried out at 37 °C with 225 rpm shaking 
giving a doubling time of around 45 min. Once an OD^oo of 0.5-0.6 AU was reached, 
expression was induced with IPTG and the cells were grown for a further 3.5 hr. Cells 
' p97 contains five arginine residues using the rarest arginine codon in E. coli, AGG (ref website: 
http://molbiol.ru/eng/scripts/01 11.html; http://www.kazusa.or.ip/codon/"). 
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were then harvested by centrifugation and lysed by vigorous sonication and the cell 
lysate was separated from debris by centrifugation. The cell lysate was loaded onto a 
column previously equilibrated in Ni^^ affinity column buffer A and the unbound and 
non-specifically bound lysate washed away with Ni^ "^  affinity column buffer A and 20% 
Ni^ "^  affinity column buffer B washes (Sections 2.1.3 and 2.4.2). In earlier methods, p97 
was eluted from the column in a single peak using a short gradient of Ni"^ affinity 
column buffer B containing imidazole. However, as large volumes of viscous cell lysate 
(normally greater than 50 mL) were routinely purified, the short purification procedure 
favoured by previous workers (typically spanning a maximum of 15 column volumes) 
was inappropriate. Instead, the column was washed in over 25 column volumes to 
remove the bulk of E. coli host proteins. Elution was over a shallower gradient of 25 
column volumes with the concentration of imidazole reduced to 60 % of the previous 
method allowing more weakly bound impurities to be eluted prior to p97. This resulted 
in p97 eluting in two peaks, the first at 35 % Ni^ "^  affinity column buffer B which also 
contained many lower molecular weight contaminants and the second at 65 % Ni^ "^  
affinity column buffer B which contained p97 of greater purity (Figure 3.2a). As in 
general, assays were more reproducible with very fresh protein, these modifications 
allowed large amounts of p97 to be prepared in short periods of time without 
compromising purity. 
The p97 was concentrated using a high molecular weight cut-off concentrator to further 
remove impurities by size exclusion. The typical purity was judged by SDS PAGE to be 
95 % (Figure 3.2b). Commonly, gels of purified p97 show that several contaminating 
low molecular weight bands. They have been identified previously as degradation 
products by mass spectrometry and have not been removed by gel filtration or anion 
exchange by other experimenters. This suggests that degraded p97 protomers may be 
incorporated within the hexameric unit. Addition of protease inhibitors during cell lysis 
has not significantly altered the amounts of degradation products suggesting that 
protease digestion may occur during expression. Mutated p97 was expressed and 
purified by the same methods and differed only in yields and minor degradation 
products (Figure 3.3c). 
Following buffer exchange to activity buffer the concentration was measured from 
absorption at 280 nm of denatured protein. Fresh protein produced by this method was 
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Figure 3.2 The purification of recombinant p97 
a. Elution profile of p97 HiSe affinity purification. The protein is detected by absorbance at 280 nm (left hand axis and blue line) as the percentage of elution buffer B is increased (right hand axis, green line). 
The x-axis shows the mL of buffer flowing through the column (black numbers) and fractions are annotated on the x-axis in red. 
b. SDS PAGE of fractions from the purification of p97. p97 elutes in majority in the 3rd peak (surrounding fraction 46) but, due to overlap of the 2nd and 3rd peaks, only fractions above 46 were pooled. The 
molecular weight marker is IVIark12 (Invitrogen) and the full list of molecular weights of the ladder in kDa is:200, 116.3, 97.4, 66.3, 55.4, 36.5, 31, 21.5, 14.4, 6. 
0. Fluorescence anisotropy titration of BODIPY AMPPNP binding to N (red) and C (green) terminal His6 tagged p97. The location of the tag has little effect upon BODIPY AMPPNP binding. 
shown to be active, hexameric and lacking insoluble aggregates by EM and native gels 
(Sections 3.4.1). 
To check whether the purification tag altered p97s properties, the binding of a 
fluorescent ATP analogue (BODIPY-AMPPNP) to p97 tagged at the N or C terminus 
was measured by fluorescence anisotropy. When each preparation was titrated into a 50 
nM solution of BODIPY-AMPPNP, super-imposable binding curves were generated 
suggesting that the presence of the tag or its position does not generate binding artefacts 
(Figure 3.2c). As a consequence, removal of the tag by protease digestion was not 
included in the purification protocol. 
3.4 Characterisation of recombinant p97 
Several studies have carried out preliminary characterisations of p97 from varying 
sources. To benchmark my preparations against each other and those of other 
experimenters the following characteristics were assessed: oligomeric state, ATPase 
activity and the starting nucleotide binding state of p97. 
Many mutations used in this study have been designed to affect the ATPase activity and 
nucleotide binding properties of p97. While these mutations are of highly conserved 
residues in p97 and other AAA proteins, several studies have disputed the effects of 
these mutations with respect to nucleotide binding state and ATPase activity. 
Additionally, there is evidence that although the oligomeric state of p97 is very stable, it 
may be altered by mutation (DeLaBarre et al, 2006; Wang et al., 2003a). Therefore, it 
was important that the basic characterisation of the mutants was also repeated. 
3.4.1 The oligomeric state of p97 
p97, unlike some AAA proteins, has been shown to be a stable hexamer which has only 
been chemically dissociated in 6 M urea (Wang et al., 2003a). Several mutations 
however have been shown to affect the hexamerisation of p97. When p97 is mutated to 
remove ADP binding in Dl, the rate of hexamer reassembly following chemical 
dissassembly is decreased (Wang et al, 2003a). The same mutation has also been 
reported to produce a non-hexameric population of p97 (DeLaBarre et al, 2006). 
Additionally when both of the SRH arginine residues in Dl are mutated simultaneously 
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to glutamic acid which carries an opposite charge (R359E-R362E), p97 is unable to 
form hexamers (Wang et al., 2005). 
The oligomerisation state of wildtype p97 preparations was first assessed with native 
PAGE and showed a single band between ferritin (470 kDa) and thyroglobulin (670 
kDa) molecular weight standards, consistent with six p97 protomers (Figure 3.3a). 
When the same sample was viewed by electron microscopy, this showed hexameric 
particles further confirming that p97 is formed as a hexamer (Figure 3.3b). 
As several mutations investigated alter the nucleotide binding properties and also the 
arginine fingers connecting protomers, the oligomeric state of these mutants was also 
assessed by poly-acrylamide electrophoresis. The purification and quality of protein 
prepared of all mutants was similar and native PAGE showed all to be hexameric 
(Figure 3.3c and d). It was therefore concluded that all preparations gave p97 which is 
in a majority of hexameric form. 
3.4.2 The ATPase activity of p97 
Several studies have carried out preliminary characterisations of p97's activity. 
(DeLaBarre et al, 2006; Frohlich et al, 1995; Meyer et al, 1998; Peters et al, 1990; 
Song et al, 2003; Ye et aL, 2003). They show that p97 has an activity of between 5 and 
94 p.mol/mg/hr (equivalent to 0.13 and 2.52 s ')^ which is considered relatively inactive 
when compared to a hydrolysis rate of 100 s"' for the F,Fo ATPase (reviewed by (Senior 
et al., 2000)). An ATPase activity assay was used to benchmark the ATPase activity of 
different p97 preparations and test hypotheses concerning the mechanism of action of 
p97. 
The ATPase assay used is based upon the published method of Cogan and coworkers 
adapted for p97 by Song et al (Cogan et al., 1999; Song et al., 2003). This assay was 
chosen because it had been used previously to carry out the most systematic 
investigation of the properties of p97 and, therefore, would allow direct comparison of 
^ 1 mg of p97 is approximately 0.01 jxmol, so for comparison, a calculated turnover rate from these 
numbers would be between 0.13 and 2.52 s"'. 
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Figure 3.3 Recombinant p97 forms a stable hexamer 
a. A non-denaturing gel of p97 and three molecular weight standards: albumin (which forms multiple oligomeric states, a monomer Is 66 kDa), ferritin (the dominant band is 470 kDa and thyroglobulin (the 
higher band is 670 kDa and the lower band may represent some limited degradation of the standard). p97 runs predominantly as a hexamer although a tiny fraction is observed as higher molecular weight 
aggregates, 
b. Selected particles from two electron micrographs of p97. The sample was negatively stained and electron microscopy kindly carried out by Dr. Fabienne Beuron. Particles shown are top and bottom 
views clearly showing the hexameric structure surrounding the central pore. 
c. SDS PAGE comparing the purification of wildtype p97 with Walker A mutants. Lane 1 shows wildtype p97 and lanes 2-4 show the Walker A mutants (2: K251A; 3: K524A; 4: K251A-K524A). The 
molecular weight marker is Mark12™ as before. The purification of all other mutants yielded protein of similar purity. 
d. Native PAGE comparing the hexameric state of wildtype p97 and Walker A mutants. Lanes are labelled as c. The purification of all other mutants yielded protein that was similarly hexameric. 
my results with previous work. The assay is colorimetric and detects levels of inorganic 
phosphate (Pi) by the absorbance of phospho-molybdate complexes dyed with malachite 
green. 1 p.M p97 was equilibrated in Song activity buffer to 37 °C and 3 mM ATP 
rapidly mixed in to start the reaction. Aliquots of the reaction mixture were removed at 
5 min intervals (including time zero) over a 30 min time-course and mixed with colour 
reagents. Each colour reaction was halted after 20 min by raising the pH to give stable 
coloration and the absorbance at 600 nm taken. The absorbance measurements were 
compared against a standard curve to convert to P, concentration and the linear portion 
of the time-course (rate of increase in absorbance with time) was used to calculate a 
specific activity (Figure 3.4a). 
The activity of wildtype p97, expressed as nmols phosphate released per nmol p97 per 
min, was calculated to be 5.4 min ' (SD = 0.7, n = 9) (Figure 3.4b). Whilst this is 
relatively low activity, this figure is in the same range as specific activities estimated in 
previous studies of p97 (Table 3.1). The differences observed could be accounted for by 
differences in p97 source, partial degradation, buffer, method of reading activity and 
temperature of experiment. 
A note about buffers 
The ATPase assay also allowed me to test the buffer p97 is routinely added to prior to 
crystallisation studies. This buffer contained a high concentration of KCl (150 mM), a 
relatively low concentration of MgCli (2 mM) with respect to the concentration of ATP 
and a pH of 7.4. p97 in this buffer showed httle activity. Some studies have suggested 
that Mg^^-ATP is crucial for some ATPase activity, indeed, some experimenters start 
ATPase activity studies by adding Mg^^ to a mixture of enzyme and ATP (Davies et al, 
2005). It has been shown that monovalent cations such as and Na^ can compete with 
Mg^ "^  for binding to ATP (Tanner et al., 2002). Therefore, it seems possible that a 
relatively high concentration of KCl would prevent Mg^^-ATP binding to p97 and lead 
to inactivity in these conditions. Instead, the buffer used by Song and coworkers is used 
in this study because p97 is stable and active in this buffer, it contains a large 
concentration of Mg^^ (20 mM) preventing this becoming a limiting factor in binding 
and hydrolysis experiments and as p97 has already been investigated in some detail in 
it, allowing this work to be compared to other work in the field directly (Song et al., 
2003). 
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Figure 3.4 The ATPase activity of p97 and mutants 
a. Progression of ATP hydrolysis by wildtype p97 over 30 min as measured by the increased in absorbance of malachite green dyed phospho-molybdate complexes. Absorbance increases linearly with time 
until colour reagents become saturated. A straight line with an intercept of zero is fitted and the gradient (abs/min) is adjusted for volume, concentration and factored for the amount of phosphate necessary 
for 1 absorbance unit to give specific activity in nmol phosphate released / nmol p97 protomer.min 
b. Comparison of specific activity of wildtype p97 compared to Walker A and B mutants. Mutation of the D2 domain (either Wall<er A or B) leads to a larger decrease in activity than mutation of D1. 
c. Specific activity of p97 mutations were designed to decrease the ATPase activity of p97 to zero: Walker B motif was mutated to glutamine, the SRH position 2 was mutated individually to lysine and 
alanine and the D1-D2 linker was mutated at conserved glycine positions (G480A-G481A). 
Table 3.1 The ATPase activity of wildtype p97 compared to activities 
determined by other studies 
Source Organism Activity (nmol/mg/hr) Reference 
Recombinant Rattus norvegicus 3.2 This study 
Recombinant Unknown 31.2 (Song et al, 2003) 
Endogenous (oocyte) Xenopus laevis 5 (Peters etai, 1990) 
Endogenous (liver) Rattus norvegicus 18 (Meyer ef a/., 1998) 
Recombinant Unknown 25 (Ye gf a/., 2003) 
Endogenous Cdc48 Sacchromyces cerevisiae 93.6 (Frohlich e? a/., 1995) 
As the activity of p97 has been previously widely expressed in (jmol/mg/hr, these units are used for comparison here. 
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3.4.3 The ATPase activity of p97 mutants 
Each p97 protomer has two active sites, D1 and D2, both of which are theoretically 
competent at binding and hydrolysing ATP as the necessary residues are conserved in 
each active site. In order to gain insight into the mechanism of p97, two groups have 
akeady mutated key residues in the Walker A and B motifs (Walker A; K251, K524; 
Walker B: E305, E578). This gave two very different profiles of how p97 acts. 
One group showed that mutation of D1 (K251T or E305Q) had little effect upon overall 
activity, whereas mutation of D2 (K524T or E578Q) had a large effect (Song et al, 
2003). This led them to conclude D2 carries out the bulk of the ATPase activity in p97 
whereas 1)1 is relatively inert (Section 1.6.1). A second group showed that mutation of 
D2 (K524A or E578Q) and also D1 Walker A (K251A) reduces p97's activity 
dramatically, whereas D1 Walker B (E305Q) mutation only decreases the activity by 50 
% (Ye et al., 2003). This led them to conclude that the two domains act in an 
interdependent manner with hydrolysis in D2 requiring nucleotide binding in D1 and 
hydrolysis in D1 requires nucleotide binding and hydrolysis in D2. The two results 
differ specifically with respect to the effect of the Walker A mutations used, which were 
of the same amino acid position (K251 and K524) but to different residues (Ala and 
Thr) and so it was suggested that this difference was the cause of the discrepancy 
between the results but other reasons could include buffer conditions and method of 
ATPase assay (colorimetric vs. radioactive). 
Using colorimetric ATPase activity assay of the first group and the mutations of the 
second group (K251A, K524A, E305Q, E578Q) I repeated this characterisation of the 
mutants (Figure 3.4b). Mutation of D2 in both Walker A and B motifs had a large effect 
upon ATPase activity whereas mutation of D1 had a lesser effect within the same class. 
These results parallel those of Song and coworkers suggesting that the mutations alone 
do not account for the reported discrepancy. This evidence also lends weight to their 
hypothesis that the D2 domain contributes to major activity of p97 although this 
conclusion requires the assumption that the mutations have identical effects in D1 and 
D2. While D1 and D2 are homologous and the Walker A and B motifs are very well 
conserved, D1 and D2 do show different structural properties especially as D2 is much 
more flexible than D1 (Section 1.6.1) (Huyton et al., 2003; Wang et al., 2003b). It is 
possible that these mutations may have differing impacts, for example, the effects of 
mutations in D1 may be compensated for by other residues in a way not seen in D2. 
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Mutations to eliminate ATPase activity 
One aim of this characterisation is to identify mutations that can reduce ATPase activity 
to a very low level. Such a mutant would allow ATP binding experiments to be carried 
out over the necessary timeframe. Interestingly, the double Walker B mutant, widely 
suggested to remove all ATPase activity from p97, showed just under 10 % of the 
activity of wildtype p97 (Figure 3.4b). As over a longer time frame this low level of 
activity results in a significant turnover of ATP, other mutations were designed to 
attempt to reduce the ATPase activity further. The SRH has been suggested to remove 
the ATPase activity of other AAA ATPases so this was mutated in both domains at 
position 2 to lysine and alanine (R359K-R635K, R359A-R635A) (Ogura et al, 2004; 
Wang et al, 2005). Both mutations led to a decrease in ATPase activity comparable to 
the Walker B mutant, showing that while these mutations significantly reduce activity, 
they do not completely eliminate it (Figure 3.4c). 
Conformational change in the D1-D2 linker has been proposed to be the main route of 
communication between the D1 and D2 domains and could be key to the coordination 
of ATPase activity of the hexamer. The conserved pair of linker glycine residues was 
mutated to alanine to test whether this affected ATPase activity. ATPase activity was 
again significantly reduced but not to zero, consistent with the proposed role of these 
residues (Figure 3.4c). 
In conclusion, these results suggest that the discrepancy between published results for 
Walker A and B mutations is not a consequence of variation in substitution (Walker A: 
Threonine/Alanine; Walker B: Glutamine/Alanine) as previously suggested (Ye et al., 
2003). Additionally, these results show the greatest similarity to those of Song and 
coworkers, agreeing that D2 appears to contribute greater ATPase activity than D1 
(Song et al., 2003). No mutations tested succeeded in reducing the ATPase activity to 
less than 5 % of wildtype. This could be due to a contaminating ATPase, too 
conservative mutations or a consequence of compensation for mutations by other side-
chains. 
3.5 Testing the nucleotide starting state of p97 
Prior to carrying out binding studies of nucleotides it is important to confirm whether 
any ligand scavenged from the expression host is already bound to the protein. Every 
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crystal structure of p97 has shown ADP bound to the D1 domain (DeLaBane and 
Brunger, 2003, , 2005; Dreveny et al, 2004; Huyton et al, 2003; Zhang et al, 2000). 
Several biochemical studies have also investigated whether ADP is bound to p97 
following purification (pre-bound), HPLC analysis of heat denatured p97 showed that 
ADP was pre-bound to samples used for SAXS studies although another group showed 
in a similar assay that no ADP was bound to their preparations (Davies et al, 2005; 
Wang et al, 2003b). 
3.5.1 Nucleotide pre-bound to wildtype p97 
hi order to indicate whether any nucleotides are likely to be pre-bound to p97, wildtype 
p97 was denatured by heat, the precipitated protein pelleted by centrifugation and the 
supernatant, (carrying any ligand released by the unfolded protein) scanned for 
absorption maxima. Controls showed that this treatment did not decrease the absorption 
of adenine based nucleotides. The supernatant had an absorption maximum at 259 nm, 
characteristic of adenine based nucleotides (Figure 3.5a). This maximum also correlated 
with a shoulder of the 280 nm peak on the absorption profile of non-denatured p97 
suggesting that an adenine nucleotide may indeed be bound to p97. Using the extinction 
coefficient of adenine nucleotides (15400 M"'cm"'), the amount of nucleotide released 
was compared to the amount of p97 boiled. Typically a ratio of 0.9 mol nucleotide to 1 
mol p97 protomer was achieved (SD = 0.18). If both D1 and D2 had nucleotide bound, 
this ratio would be 2:1, so this result is consistent with just D1 binding to nucleotide 
(Figure 3.5b). 
This is consistent with the findings of Davies and co-workers, who also observed ADP 
in preparations of p97 not previously treated with nucleoddes (Davies et al., 2005). 
Interestingly, Wang and colleagues were unable to identify nucleotide pre-bound to any 
p97 preparations by boiling the protein and analysis by HPLC (Wang et al., 2003b). 
This could be a consequence of the concentration and detection wavelength used by 
them (2.5 p,M, 254 nm) as this concentration of nucleotide even at the absorption 
maxima of 259 nm would only be expected to give an absorbance of 0.0385 AU, a 
reading not significantly above the baseline noise of their profiles. It remains possible 
that different constructs, purification procedures and buffers could have led to these 
discrepancies between results. 
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Figure 3.5 Recombinant p97 has ADP pre-bound 
a. The absorbance profile of p97 when heat-denatured. As a control, ADP was similarly treated and the characteristic absorption maximum at 260 nm is shown (grey line). The supernatant of heat denatured 
p97 also shows a similar maximum (black line). 
b. The amount of nucleotide released when wildtype p97, Walker A mutants, Walker B mutants are heat denatured. The amount of nucleotide is expressed as mol nucleotide released per mol p97 protomer. 
This shows that only the Walker A mutant in D1 reduces the amount of ADP released showing that ADP binds to D1. 
0. Examples of HPLC profiles of nucleotide released from acid denatured p97. Controls showed that ADP elutes at 3 min and ATP elutes at 4.5 min. The top profile shows ADP released E305Q p97 and the 
bottom profile shows ADP released (although in lower amounts) from K251A p97. The initial accompanying peaks are the solvent front and the later peaks a consequence of column degradation as they 
were observed in controls. 
3.5.2 Nucleotide pre-bound to p97 mutants 
To confirm the location of the nucleotide and also characterise the binding mutants 
further, the heat denaturation experiment was repeated with the Walker A mutants. 
Mutation of the D2 ring gave amounts of released nucleotide similar to wildtype 
whereas mutation of D1 led to a large decrease in nucleotide (Figure 3.5b). This 
confirms that the nucleotide is bound to the D1 domain and suggests that the D1 domain 
has high affinity for nucleotide whereas the D2 has comparatively lower affinity for 
nucleotide (Figure 3.5b). Walker B mutants in D1 or D2 showed had similar amount of 
nucleotide pre-bound as wildtype showing that these mutations do not affect binding in 
Dl . 
3.5.3 The identity of pre-bound nucleotide 
It is likely that the identity of the nucleotide is ADP as ATPase assays suggest that both 
domains can hydrolyse ATP to some extent and crystal structures and HPLC analysis 
shows that ADP is bound to wildtype in the absence of exogenous nucleotide (Davies et 
al, 2005; DeLaBarre and Brunger, 2003, , 2005; Dreveny et al, 2004; Huyton et al, 
2003; Zhang et al., 2000). Because the absorption maximum of adenine based 
nucleotides is unchanged by the number of phosphate molecules attached to adenine, 
the heat denaturation experiments don't identify whether ADP or ATP is bound to 
wildtype p97. Additionally, p97 mutants have not been characterised in this respect and 
may contain different nucleotides to wildtype. 
In collaboration with John Ecclestone and colleagues, I determined the identity of the 
nucleotides released by using HPLC separation of ATP and ADP followed by detection 
at 260 nm. Acid denatured p97 was passed through a strong anion exchange column 
(flowrate 1.5 mL/min) from which ADP eluted following the solvent front and before 
and distinctly from ATP (ADP:3 min; ATP: 4.5 min). Denatured wildtype p97 and all 
mutants tested showed release of ADP from the Dl domain however, the magnitude of 
the ADP peak was significantly lower for p97 carrying the Dl Walker A mutant, 
corresponding to the observed lower ratio of ADP;p97 shown by heat denaturation 
experiments (Figure 3.5c). Interestingly, this confirms that while Walker B mutations 
may reduce the rate of hydrolysis, they do not abolish hydrolysis in D1 as ADP is found 
here. 
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3.5.4 Adjusting the nucleotide starting state 
As ADP is found pre-bound to the D1 domain but not to the D2 domain, it can be 
predicted that D1 has high affinity for ADP. When p97 was dialysed against a 1 L 
volume of buffer, no decrease in the amount of nucleotide released from heat 
denaturation experiments was observed. To carry out binding studies of p97 without 
competing pre-bound ADP it was necessary to devise a method to remove the ADP 
without denaturing and refolding p97. Two methods based upon dialysis were 
developed, one using buffer pH to destabilise nucleotide binding interactions and the 
second exploiting an enzyme that degrades ATP and ADP. 
Dialysis trials using multiple exchanges of dialysis buffer at pH's of 7, 8, 9 revealed that 
increasing the pH, increased the efficiency of ADP removal from p97 with pH 9 optimal 
amongst those tested (pH 5 and 6 were also tested but led to precipitation of the protein) 
(Figure 3.6a). Twelve exchanges of buffer (each dialysis for at least 1 hr) were 
necessary to extract the majority of ADP making this a labour and reagent intensive 
method which proved impractical (Figure 3.6b). 
The second method was based on one developed by Davies and coworkers who used 
apyrase to digest ATP and ADP to AMP for which p97 has low affinity (Davies et al, 
2005). For the majority of experiments detailed here, apyrase treatment was carried out 
by dialysis of several mL of concentrated p97 (typically greater than 100 p.M) against 
buffer containing apyrase. This generally reduced the amount of ADP in p97 but had 
variable results and was difficult to control. More lately, the dialysis was altered to 
make ADP release more efficient. Concentrated p97 was diluted 100 fold to less than 2 
I^ M and a dialysis bag containing apyrase was floated in this to digest released ADP 
(Figure 3.6c). The lower concentration favoured dissociation of ADP aiding 
accessibility of ADP to apyrase. Unfortunately, this modification to the apyrase digest 
protocol was only made in time to be applied to the results presented section 5.6. The 
apyrase enzyme is reported to have optimal activity at room temperature conditions, an 
unfavourable condition for p97 leading to small aggregates of p97 hexamers (as seen by 
EM courtesy of Fabienne Beuron) (Figure 3.7a). These aggregates were routinely 
removed by gel filtration. It must be noted therefore, that samples treated to remove 
ADP were older and hence showed less reproducibility and lower activity than others. 
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Figure 3.6 Removal of pre-bound ADP from the D1 domain 
a. A screen of the effectiveness of dialysis at different pH upon ADP release. Samples of p97 were dialysed under identical conditions (50 mM Tris HCI, 20 mM MgCIs) and the amount of ADP remaining 
assayed by heat denaturation, each data point represents three repetitions ( • filled circles). To control for pH effects upon the absorbance of ADP, 30 pM ADP was made up in the same buffer and heated 
in parallel with protein samples (O open circles). As is shown, the pH's used do not alter the absorbance of ADP but increase of the pH does enhance the rate of ADP release. 
b. The release of ADP from p97 with extensive dialysis against buffer. Each dialysis was of 1 L for at least 1 hr at 10 °C. At intervals, aliquots of p97 were removed and heat denatured to release ADP pre-
bound. This shows that dialysis against pH 9 buffer (O open circles) compared to pH 8 Song activity buffer ( • filled circles), increases the rate of ADP release in dialysis over a short regime of buffer 
exchange, however following greater than 6 exchanges, the pH of the buffer has a negligible effect. 
c. Timecourse of apyrase treatment of p97. A dialysis bag containing apyrase was dialysed against 100 mL of 2 pIVI p97 at room temperature. Samples were taken, concentrated, buffer exchanged to activity 
buffer and heat denatured. As is shown, the majority of ADP is removed from p97 after 24 hours of dialysis. 
Similar to p97 D1 mutants, apyrase treated p97 still formed stable hexamers as judged 
by EM and native PAGE (Figure 3.7). This is consistent with published results showing 
that nucleotide bound to D1 may increase the rate of hexamer assembly but is not 
necessary for hexamer formation or maintenance (Wang et al, 2003a). 
3.6 Summary 
This chapter describes the purification and characterisation of p97 with respect to 
oligomeric state, ATPase activity and starting nucleotide binding state and is 
summarised below: 
• Recombinant p97 and mutants in this study are purified by affinity 
chromatography yielding protein that is; 
o a stable hexamer 
o has ATPase activity 
o unaffected by the presence of the affinity tag 
• Analysis of the ATPase activity of wildtype p97, compared to mutants designed 
to have defects in nucleotide binding and hydrolysis, suggests that the D2 
domain contributes greater activity than D1 in line with a previous study. 
No mutations have been shown to decrease ATPase activity to insignificant 
levels. 
• ADP is pre-bound to the D1 domain of wildtype and p97 mutants. ADP may be 
removed by treatment with apyrase. 
• p97 treated to remove ADP retains a hexameric structure. 
These results provide the foundation for the rest of the work, determining the binding 
properties of ADP and ATP to p97. 
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Figure 3.7 The hexameric structure of p97 is not altered by removal of pre-bound ADP from the D1 domain 
a. Negative stain electron micrograph of apyrase treated p97 (Courtesy Dr Fabienne Beuron). Note how the p97 hexamers are clustered in groups. 
b. Non-denaturing gel of apyrase treated p97. Comparison with untreated p97 shows that confirms that the treated p97 retains a hexameric state despite loss of ADP. 
Chapter 4 
The Characterisation of ADP Binding to p97 
4.1 Introduction 
As shown in the previous chapter, recombinant wildtype p97 has ADP pre-bound to the 
D1 domain but not to the D2 domain. This is in hne with pubhshed findings of high 
resolution structures of p97 which all show ADP bound to the D1 domain (DeLaBarre 
and Brunger, 2003, , 2005; Dreveny et al, 2004; Huyton et al, 2003; Zhang et al., 
2000). There is also evidence suggesting that the D2 domain may also bind to ADP. A 
low resolution crystal structure of p97 shows ADP bound to both the D1 and D2 
domains (DeLaBarre and Brunger, 2005). In vitro binding experiments showed when 
samples of p97 were characterised by HPLC analysis prior to small angle x-ray 
scattering (SAXS), ADP was already bound to p97 samples. When extra ADP was 
added and the excess removed, the area of the HPLC peak for ADP doubled, implying 
that a second set of site could be saturated with ADP (Davies et al., 2005). A second 
study observed nucleotide binding induced tryptophan fluorescence increases in the D2 
domain. Upon addition of ADP to wildtype p97 there was an increase in tryptophan 
fluorescence, however, when the D2 domain was mutated at the Walker A motif 
(K524T) there was no increase in fluorescence (an effect that wasn't found when the D1 
domain carried the analogous mutation (K251T) (Wang et al, 2003). 
As the D1 domain appears to have higher affinity for ADP than D2, the balance 
between these respective affinities may hold the key to the differential activities of the 
two domains. To investigate ADP binding to p97 further, two complementary 
equilibrium techniques were used to measure the affinity of ADP binding: fluorescence 
anisotropy and isothermal titration calorimetry (ITC). In common with the analysis of 
pre-bound ADP, the decrease in binding affinity induced by Walker A mutations was 
exploited to probe the location of binding. 
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4.2 Measurement of ADP binding by fluorescence anisotropy 
equilibrium binding experiments 
4.2.1 A brief introduction to fluorescence anisotropy binding experiments 
This method exploits the similarity of timescale of macromolecular tumbling and 
fluorescence relaxation (<100 ns). Polarised light is used to selectively excite 
fluorescent molecules of similar orientations (in this case, a fluorophore connected to a 
nucleotide) and the emitted light is collected in the same plane as excitation (parallel) 
and also in a perpendicular plane. Small molecules tumble fast in the time lapse 
between excitation and emission thus leading to a similar amount of fluorescence 
emitted in both collection planes as they randomise quickly. Larger molecules like 
proteins tumble comparatively slower and so more fluorescence is collected in the plane 
of excitation (parallel) compared to a perpendicular plane. Anisotropy is a ratio 
measurement, calculated by dividing the difference between the fluorescence intensity 
collected in the parallel and perpendicular planes by the total fluorescence intensity. 
Because of this, anisotropy can be assumed to be independent from overall changes in 
fluorescence intensity (this is discussed further in Chapter 5). As the size of the 
fluorescent molecule dictates the rate of tumbling, a fluorescent molecule the size of 
p97 hexamer has an experimental anisotropy reading of around 0.3 whereas a small 
molecule such as a fluorescent nucleotide has an experimental anisotropy of around 
0.03. When a fluorescent nucleotide is mixed with p97, there is an increase in 
anisotropy. This increase can be assumed to be directly proportional to the amount of 
fluorescent nucleotide bound and tumbling at the same rate as p97. (A more complete 
explanation of the technique is given in 2.5.5) 
Fluorescent anisotropy binding experiments are here carried out with a small fixed 
concentration (50 nM) of fluorescent nucleotide, BODIPY-ADP, into which increasing 
concentrations of p97 are titrated until all fluorescent nucleotide is bound to p97 (Figure 
4.1a). All experiments were performed at a constant temperature of 25 °C. It is 
important to note that this experimental set up has an excess of p97 and so all binding 
sites on p97 are not saturated. This means that only the highest affinity site is detected. 
4.2.2 BODIPY-ADP binding to wlldtype p97 
To observe wildtype p97 binding to BODIPY-ADP, p97 was titrated into 50 nM 
BODIPY-ADP up to a concentration of 10 |iM. Equilibrium was reached rapidly after 
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Figure 4.1 Fluorescence anisotropy measurements of BODIPY-ADP binding to p97 
a. The structure of BODIPY-ADP, The BODIPY fluorophore is attached via a flexible linker to the 2' and 3' position of ribose (there is isomerisation between these positions). (Taken from www.probes.com) 
b. Wildtype p97 binding to BODIPY-ADP, Wildtype p97 was titrated into 50 nM BODIPY-ADP (red dots). Anisotropy readings were fitted to the one site tight binding model. 
c. Walker A mutants of p97 binding to BODIPY-ADP. Conditions were as b. K251A (green dots) and K251A-K524A (teal dots) anisotropy data were converted to [Bound] and fitted to one site binding 
equations and K524A (blue dots) was fitted to the one site tight binding equation. The anisotropy data is plotted on the same graph to demonstrate the similarity between wildtype and K524A and between 
K251Aand K251A-K524A, 
mixing (less than 1 min) as identified by stable anisotropy readings in this timescale. 
Three readings were averaged per titration point and the each titration was repeated 
three times (using two different preparations of p97). The binding data showed a high 
affinity interaction between BODIPY-ADP and wildtype p97 with apparent saturation 
reached at 1 )LIM p97 and thereafter a low level of linear deviation due to scatter (Figure 
4.1b). Fitting this data to the one site tight binding equation gives an apparent 
dissociation constant (App. Ka) of 16 nM (Section 7.1.2). This could potentially 
represent binding to D1 or D2 or a composite of both. In addition, if BODIPY-ADP 
binds to Dl, the ADP pre-bound to this domain could act as a competing ligand. 
4.2.3 The location of BODIPY-ADP binding 
To test whether BODIPY-ADP binds to the Dl or D2 domains, Walker A mutants were 
employed to selectively reduce the affinity of nucleotide binding to either Dl or D2 
active sites, using titrations of identical form to section 4.2.2. Results were fitted to 
single site binding equations to give apparent dissociation constants (Sections 7.1.1 and 
7.1.2). As ADP is pre-bound to wildtype and K524A, any BODIPY-ADP binding to Dl 
will be in competition with pre-bound ADP. This effect is reduced for those mutated in 
Dl (K251A and K251A-K524A) as there is little ADP pre-bound to the Dl domain. A 
consequence of this difference is that the binding curves and results from the fits may 
only be compared qualitatively (Table 4.1). 
Mutation of the D2 domain, K524A, had little effect upon BODIPY-ADP binding, 
producing a profile similar to wildtype (Wildtype p97 App. IQ = 16 nM; K524A App. 
Kd = 16 nM) (Figure 4.1.c). However, when the Dl domain was mutated (K251A), the 
apparent dissociation constant of BODIPY-ADP was increased significantly (K251A 
App. Kd = 503 nM). Mutating both the Dl and D2 domains (K251A-K524A) similarly 
increases the apparent dissociation constant (K251A-K524A App. Kd = 413 nM) 
(Figure 4.1.c). 
This data suggests that BODIPY-ADP binds solely to the Dl domain as mutation of the 
D2 domain has little effect on the apparent dissociation constant. There are though other 
possible experimental reasons for this finding. It is possible that the D2 mutation 
K524A doesn't affect nucleotide binding. This would be contrary to published results as 
an increase in tryptophan fluorescence induced by ADP and ATP binding was abolished 
by K524T (Wang et al., 2003). Furthermore, in quasi-equilibrium binding experiments, 
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Table 4.1 Fitting results from fluorescence anisotropy experiments of 
BODIPY-ADP binding to p97 
Sections 4.2.2 and 4.2.3 
Results from fits to wildtype p97 and Walker A mutants binding to 50 nM BODIPY-ADP. 
p97 variant Equation Reduced Chf App. Kd (fiM) StdEr 
Wildtype Tight fit equation 3.6x10-^ 0.0162 0.0010 
K524A Tight fit equation 3.3x10'^ 0.0163 0.0014 
K251A One site equation 4.9x10'^ 0.5034 0.0125 
K251A-K524A One site equation 2.8x10'^ 0.4135 0.0067 
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K524A mutation halved the amount of nucleotide bound to p97 when compared to 
wildtype (Ye et al., 2003). There is a possibility that the BODIPY moiety prevents ADP 
from accessing the D2 active site. Examination of the crystal structure of this domain 
suggests this is unlikely, especially as the D2 domain has a more flexible structure than 
the D1 domain. 
In conclusion, the high affinity binding site for BODIPY-ADP is likely to be located in 
the D1 active site alone and mutation of this active site (IC251A) decreases the affinity 
of binding to this site. This is consistent with heat denaturation experiments suggesting 
that D1 has much higher affinity than D2 for ADP and also in agreement with the 
crystal structures showing ADP bound to the D1 domain (Section 3.5.2) (DeLaBarre 
and Brunger, 2003, , 2005; Dreveny et al, 2004; Huyton et al., 2003; Zhang et al, 
2000). A likely reason for the single site binding observed is the limitation that titrations 
of excess protein favour detection of highest affinity binding site and so do not exclude 
the possibility of BODIPY-ADP binding to D2 albeit with much lower affinity. 
Importantly, this experiment allows the assumption to be made that BODIPY-ADP 
binds to one site alone and hence qualifies the choice of fitting binding data to one site 
models. 
4.2.4 Determination of the dissociation constants of BODIPY-ADP and 
ADP to the D1 domain 
As wildtype p97 has ADP pre-bound, binding of BODIPY-ADP must be analysed as a 
competition between two ligands. Two different methods were used to calculate the 
dissociation constants of BODIPY-ADP and ADP. A conventional linear regression 
approach was taken and data was also fitted to a single site competition model 
developed specifically for this study. 
By linear regression 
Initial wildtype p97-BODIPY-ADP titrations were conducted with p97 with pre-bound 
ADP. As a consequence, the concentration of ADP increased concomitantly with 
protein concentration. This led to two competing ligands for p97 present (ADP and 
BODIPY-ADP). To determine the dissociation constants of both ADP and BODIPY-
ADP, four different constant ADP concentrations (1 |iM, 5 |j.M, 10 pM, 20 piM) were 
used. 
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To achieve this, the amount of ADP bound to p97 was determined by heat denaturation 
and extra ADP was added to adjust to the fixed ADP concentration for each protein 
concentration point. For each titration point, a blank reading was taken of buffer, 
supplementary ADP and BODIPY-ADP, then p97 was added and the mix allowed to 
reach equilibrium over 5 min before anisotropy readings were taken. 
At 1 p.M ADP, the binding data produced overlaid perfectly with data from the initial 
wildtype p97 titration where the amount of ADP varied with p97 concentration (Figure 
4.2a). It is therefore reasonable to assume that in this concentration range, the amount of 
ADP present in the system does not affect BODIPY-ADP binding and implies that 
BODIPY-ADP has comparatively higher affinity for p97 than ADP. 
Greater concentrations of ADP (5 |iM, 10 p.M and 20 p.M ADP) caused a decrease in the 
apparent affinity of BODIPY-ADP as the effects of competition increased (Figure 
4.2.b). The apparent dissociation constants were plotted against concentration of ADP 
and linear regressed (Figure 4.2.c and Table 4.2). At zero concentration of ADP, the 
linear regression predicts the dissociation constant of BODIPY-ADP (Section 7.1.4). 
The dissociation constant of BODIPY-ADP was determined to be 30 nM, very similar 
to the apparent dissociation constant measured when the concentration of ADP was 
allowed to vary. Substitution of the dissociation constant of BODIPY-ADP into the 
equation describing the gradient of the linear regression gives the dissociation constant 
of ADP,1.4 laM. 
By single site competition model 
The dissociation constants of ADP and BODIPY-ADP can be also be determined using 
a one site competition model developed for this study (Section 7.1.3). This model 
allows the known concentrations of ADP in the system to also be factored into the 
analysis giving the dissociation constant of ADP as well as the dissociation constant of 
BODIPY-ADP. This model was used for a more complete analysis of data from 
wildtype and K524A binding to BODIPY-ADP as ADP is pre-bound to these 
preparations of protein. Additionally, it was used to analyse displacement experiments 
in which ADP was titrated into 50 nM BODIPY-ADP already saturated with wildtype 
orK524Ap97. 
Fitting wildtype p97 binding to BODIPY-ADP to the 1 site competidon equation led to 
the dissociation constant of ADP being poorly constrained. Presumably, at these 
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Figure 4.2 BODIPY-ADP competition with ADP for binding to wildtype p97 D1 domain (linear regression approach) 
a. Superimpositiion of BODIPY-ADP binding curves generated when ADP concentration was adjusted to be constant at 1 (red) and when ADP concentration was allowed to vary with p97 concentration 
(black). 
b. Wildtype p97 binding to BODIPY-ADP at constant ADP concentrations (1 [jM top left hand side (LHS), 5 fiM top right hand side (RHS), 10 jiM bottom LHS and 20 pM bottom RHS). The apparent 
dissociation constants are defined as the concentration of p97 at half maximal capacity. The concentration of BODIPY-ADP was 50 nM. 
0. Apparent dissociation constants plotted against concentration of competing ADP. Linear regression was used to determine the gradient (21) and intercept (30 nM) (correlation coefficient = 0.999). 
Tables 4.2 Determination of the dissociation constants of BODIPY-ADP 
and ADP 
Section 4.2.4 Linear Regression Method 
Wildtype p97 was titrated into 50 nM BODIPY ADP while the concentration of ADP was maintained at a constant 
concentration. The apparent dissociation constant was extracted from the resulting binding profiles from the half 
maximal saturation. These values were plotted against the concentration of ADP and the intercept gradient used to 
calculate the dissociation constants of ADP and BODIPY ADP. 
[ADP] (nM) Equation Reduced Chi^ Capacity Std Er App. K<j (nM) Std Er 
1 One site 1x10^ &3098 0.0054 0.0049 0.0029 
5 One site 9x10^ 0.3111 0.0065 0.1261 0.0092 
10 One site 1x10^ 03309 &0078 0.2497 0.0149 
20 One site 1x10^ 0.3149 0.0054 0.4384 0.0232 
Results of Linear 
Regression 
B-ADP Kj (nM) 
(y intercept) Gradient ADP Kd (nM) 
Correlation 
Coefficient 
30 21 1.4 0.999 
Section 4.2.4 One site competition model 
Wildtype p97 and K524A p97 were titrated into 50 nM BODIPY ADP in binding experiments and in displacement 
experiments unlabelled ADP was titrated into 50 nM BODIPY ADP saturated with protein. Both models were fitted to a 
competition model and where necessary the dissociation constant fixed to constrain the fits. 
Wildtype 
Experiment Reduced Chi^ ADP Kd (nM) Std Er B-ADP Kd (nM) Std Er 
Binding 3.6x10'^ 1.000 (Fixed as constant) 0.0163 0.0029 
Displacement 7.9x10'^ 0.684 0.2711 0.0396 0.018 
K524A 
Experiment Reduced Chi^ ADP Kd (fiM) StdEr B-ADP Kd (nM) StdEr 
Binding 3.3x10'^ 0.803 0.310 0.016 0.0006 
Displacement 8.1x10"^ 0.336 0.033 0.016 (Fixed as constant) 
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concentrations, the presence of ADP had little effect upon the binding of BODIPY-
ADP. This is consistent with the findings of section 4.2.4 where addition of 1 p.M of 
ADP to the titration had little effect upon the apparent dissociation constant. To 
constrain the fit, the dissociation constant of ADP was fixed at 1 and the 
dissociation constant of BODIPY-ADP was calculated to be 16 nM (Figure 4.3a). 
Displacement of BODIPY-ADP from wildtype p97 by titration of competing ADP 
produced better constrained fits. Both the dissociation constant of ADP and BODIPY-
ADP were fitted as variables and gave dissociation constants of 684 nM and 40 nM 
respectively (Figure 4.3b, Table 4.2). 
K524A binding to BODIPY-ADP was also well constrained and both dissociation 
constants also fitted as variables with values similar to those achieved for wildtype p97 
(ADP Kd = 803 nM; BODIPY-ADP K<i = 16 nM) (Figure 4.3c). However, in order to fit 
the displacement experiment, the dissociation constant of BODIPY-ADP was fixed at 
16 nM, giving the dissociation constant of ADP as 336 nM (Figure 4.3d, Table 4.2). 
Overall, the dissociation constants gained from wildtype one site competition fits are 
within the error of those achieved from linear regression methods and considerably less 
experimentally complex to perform. K524A fits indicate that this mutation in the D2 
domain does not significantly alter the properties of the D1 domain. 
4.2.5 Summary of fluorescence anisotropy experiments 
In summary, these results show that BODIPY-ADP binds to the D1 domain of p97 
preferentially because mutation of D1 results in greatly increased dissociation constant 
of BODIPY-ADP (Table 4.1). Mutation of D2 suggests that there is neghgible binding 
of BODIPY-ADP to the D2 domain under these experimental conditions. The 
dissociation constant of BODIPY-ADP is calculated to be 16 nM to wildtype p97 and a 
similar value when D2 is mutated. 
Competition and displacement experiments have shown that unlabelled ADP binds to 
D1 domain with lower affinity than BODIPY-ADP. Dissociation constants of ADP to 
wildtype p97 are estimated to lie between 684 nM (calculated from a one site 
competition model) and 1.4 fxM (calculated from linear regression analysis) (Table 4.2). 
The linear regression analysis is limited by the number of points on the graph (4) and 
the increasing effects of error in the calculation apparent dissociation constant as the 
concentration of ADP increases. The displacement data has many more points (> 30) 
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Figure 4.3 Fitting wildtype and K524A binding to BODIPY-ADP with ADP as a competitor using the one site competition equation 
a. Wildtype p97 with pre-bound ADP binding to BODIPY ADP. The concentration of ADP is calculated as 0.9 * [p97] and Kd of ADP is fixed at 1 pIVI 
b. The displacement of BODIPY-ADP from wildtype p97 by ADP. 150 nM p97 was used to saturate 50 nM BODIPY-ADP. Both Kd ADP and Kd BODIPY ADP TR are fitted as variables. 
c. K524A p97 with pre-bound ADP binding to BODIPY-ADP. The concentration of ADP is calculated as 0.9 x [p97]. Both Kd ADP and Kd BODIPY ADP TR are fitted as variables. 
d. The displacement of BODIPY-ADP from wildtype p97 by ADP. 400 nM p97 was used to saturate 50 nM BODIPY-ADP and the Kd of BODIPY ADP TR is fixed at 16 nM in fits 
but is limited by assumption that the x-axis represents the concentration of unbound 
ADP (whereas more precisely it is the total concentration of ADP). It seems likely that 
the true value lies between the two values at around 1 |iM. One site competition analysis 
of K524A calculates that the dissociation constant of ADP to K524A p97 to 336 nM 
and 803 nM from binding and displacement respectively (Table 4.2). As the fit to the 
K524A binding titration is well constrained, the estimate of the dissociation constant of 
803 nM is judged to be the most accurate 
It is always a concern when using mutations for structure-function studies that artefacts 
may be introduced. The finding that the dissociation constants of ADP and BODIPY-
ADP to K524A are very similar to wildtype clearly shows that this mutation in D2 does 
not alter the ADP binding properties of Dl. 
Unfortunately, although fluorescence anisotropy has given clear results for Dl, as the 
experimental set up does not saturate all of p97's ADP binding sites, measurements of 
D2 binding to ADP must be made by a different technique. Additionally, the fluorescent 
BODIPY moiety appears to increase the dissociation constant of ADP by up to 100 
times. This could be due to entropic benefit of the hydrophobic fluorophore packing 
against the protein surface and may perturb the system unduly. In order to study D2 
binding of ADP and deduce other parameters such as stoichiometry, enthalpy and 
entropy, I continued equilibrium binding experiments using ITC. 
4.3 Measurement of ADP binding to p97 by ITC 
4.3.1 A brief introduction to ITC experiments 
The binding of a ligand to a macromolecule is driven by changes in enthalpy and 
entropy giving a favourable Gibbs free energy (AG). The enthalpy change that 
accompanies the majority of binding events either raises the temperature of a reaction in 
an exothermic event or decreases the temperature in the case of an endothermic event. 
ITC detects minute heat changes released by a binding reaction. Protein-ligand binding 
experiments are performed as automated titrations of ligand into a reaction cell 
containing protein. Each injection of ligand leads to perturbation in temperature of the 
reaction cell and as a result, an alteration in the amount of energy required to maintain 
the reaction cell at the same temperature as a reference cell. Once the reaction cell 
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reaches equilibrium and the temperature is equal to that of the reference cell, the energy 
required returns to the energy level prior to the injection of ligand. The calorimeter 
records the changes in energy over time (power) to give a plot of |j.cal.s"' (W or J.s"') 
against titration time. Each injection of ligand is observed as a peak in power and 
integration of each peak, adjusting for concentrations and injection volumes, gives a 
value of energy released per mole of injectant (cal.mole"' or J.mole"'). When this is 
plotted against the molar ratio of ligand to protein, a sigmoidal binding curve is 
observed if the correct concentrations and injection volumes for the affinity of 
interaction are used. The point of inflection gives the stoichiometry of binding, the 
affinity of binding is proportional to the gradient of the sigmoid and information about 
the enthalpy is related to the magnitude of energy released per mole of injectant. 
Binding models allow stoichiometry («), enthalpy (AH), entropy (AS) and equilibrium 
association constants (Ka) of binding reactions directly from one dataset (An 
introduction to ITC is given in (Wiseman et al, 1989)). 
This technique was chosen as it allows saturation of all binding sites. The extent of 
binding is detected by temperature changes of the reaction cell so no fluorescently 
tagged ligands are required that may introduce artefacts. Each ITC experiment required 
around 20 mg of protein, typically produced from bacteria grown in 8 L of broth. In 
total, the data described in this section required over 40 ITC experiments to determine 
the values presented here. 
Initial ITC experiments probing ADP binding to p97 showed that there are two types of 
ADP binding sites: a high affinity site that is saturated early in the titration and a low 
affinity site that begins to saturate at higher concentrations of ligand. While the first site 
forms a sigmoidal curve, the second site is seen as a diagonal increase of the tail of the 
sigmoid that has no clear beginning or end. The concentration of the protein was 
increased from 10 |iM to 100 |iM to improve the curvature of the second event. It was, 
however, impractical to increase the concentration to the levels necessary to give a 
sigmoidal curve of the lower affinity site due to viscosity and aggregation of p97 at high 
concentrations and difficulties producing very large quantities of p97 in a low 
expression system. The high affinity site, shown to be Dl, is discussed first followed by 
the low affinity site, D2. 
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4.3.2 The ADP binding properties of the D1 domain 
Binding of ADP to untreated recombinant p97 in an ITC experiment revealed a high 
affinity binding site and a lower affinity site that is poorly resolved due to experimental 
constraints (Figure 4.4.a) (The lower affinity site is discussed further in Section 4.3.3). 
As fluorescence anisotropy experiments and heat denaturation experiments showed that 
D1 has the highest affinity for ADP, the high affinity site is assigned as Dl. When 1)1 is 
mutated to K251A, the high affinity site is replaced by a low affinity one further 
confirming this (Section 4.3.3). 
The data fi-om nine experiments were fitted to a two site binding model and the 
parameters obtained for the high affinity sites were averaged (Table 4.3 ) (Section 
7.3.2). The average dissociation constant of ADP to Dl was 1.1 p,M (SD = 0.8), similar 
to calculations made by fluorescence anisotropy experiments. The enthalpy change was 
-9200 cal.mole"' (SD = 3500) and entropy change was -5 cal.mole ' (SD = 12).' 
Heat denaturation experiments suggested that the majority but not all Dl active sites are 
occupied with ADP (unoccupied Dl sites: 0.1, SD = 0.18, n = 26) (Section 3.5.1). The 
stoichiometry of the high affinity site was determined by ITC to be an average of 0.2 
(SD = 0.05, n = 9) molecules of ADP per p97 protomer. (For comparison, if Dl had no 
pre-bound ADP, the stoichiometry would be 1 molecule ADP per p97 protomer and, if 
both Dl and D2 had high affinity for ADP the stoichiometry would be 2 molecules of 
ADP per p97 protomer.) This stoichiometry could represent the proportion of D1 sites 
that no longer have ADP due to dissociation throughout purification and buffer 
exchange processes (i.e. 20 % of Dl sites are empty before ITC and are filled during the 
experiment, 80 % have ADP already bound and therefore do not bind additional ADP). 
The stoichiometry of 0.2 is close to one Dl site per hexamer (one site per hexamer 
would be calculated to give a stoichiometry of 0.167 per protomer) and it could be 
speculated that it is unoccupied in a mechanistically relevant maimer. If one D1 site free 
per hexamer is part of the mechanism of p97 ATP hydrolysis then it would be expected 
that binding of ADP to this final site is different from binding of ADP to the other five 
' The small error of enthalpy compared to entropy is a consequence of the direct measurement of enthalpy 
change and indirect calculation of entropy change from the enthalpy and equilibrium constant (the 
entropy change is therefore subject to the errors associated with both these processes). 
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Figure 4.4 ITC binding of ADP to wildtype and K251A p97 
a. ITC titration of ADP binding to wildtype p97. The top pane shows the raw ITC data and the bottom pane shows the integrated ITC peaks 
b. An example of the integrated ITC data from two samples of p97 binding to ADP, one is untreated and the other apyrase digested. As the number of vacant sites is increased by apyrase digest, p97 
saturates at higher molar ratios. Both curves are fitted to the two site binding equation. 
c. The dissociation constant of ADP does not alter as the number of available D1 sites Increase. The number of available sites was increased by apyrase treatment, but the dissociation constants remained 
within the error of non-apyrase treated p97. 
d. ITC titration of K251A p97 binding to ADP fitted to a one site binding equation. (The jagged raw data profile Is a consequence different injection volumes.) 
Tables 4.3 Fitting results from ITC binding experiments of ADP 
binding to the high affinity site of p97 
Sections 4.3.2 Titration of ADP Into p97 with ADP pre-bound to D1 (high affinity site) 
ADP was titrated into wildtype p97 and the profiles fitted to a two site binding model. The data presented here are the 
results of the high affinity site 
n + / - K„(M-') + / - K j (nM) AH (cal.mol"') 
+ / - AS 
(cal.mor') Chi^ 
0.23 0.007 580000 76000 1.7 -10900 700 -10 700 
0.22 0.004 860000 150000 1.2 -16500 500 -28 14500 
0.20 <1018 1200000 660000 0.8 -4800 100 12 1700 
0.23 0.040 970000 120000 1.0 -9100 100 -3 1000 
0.27 0.020 370000 180000 2.7 -5300 400 -13 4000 
0.24 0.005 940000 150000 1.1 -9800 200 -6 1000 
0.21 0.012 1600000 1100000 0.6 -11200 200 -9 39200 
0.20 0.007 3100000 470000 0.3 -6800 300 7 6900 
0 4 8 0.004 4300000 1200000 0.2 3900 600 1 17080 
Mean 0.21 1550000 1.1 -9200 -5 
Std Dev 0.05 1300000 0.8 3500 12 
Section 4.3.3 Titration of ADP into apyrase digested p97 (high affinity site) 
ADP was titrated into apyrase treated wildtype p97 and the profiles fitted to a two site binding model. The data 
presented here are the results of the high affinity site. 
n +/- K. ( M ' ) + / - K j (nM) AH (cal.mor') 
+/ -
AS 
(cal.mor') Chi^ 
0,23 0.003 1710000 1360000 0.6 -13100 200 -15 16100 
0.37 0.010 2099000 1237000 0.5 -13100 200 1 30200 
0.52 0 a 0 8 1575000 328700 0.6 -7700 100 21 15600 
0.53 0.016 2970000 108000 0.3 -10100 300 -4 22300 
0.67 0.029 946000 476000 1.1 4900 100 4 9400 
0.76 0.013 2360000 855000 0.4 -9600 100 -3 25300 
0.81 0.012 1491000 370000 0.7 -7500 100 3 25000 
Mean 0.56 1880000 0.6 -9700 -2 
Std Dev 0.21 660000 0.2 2600 7 
Average of all parameters obtained for ADP pre-bound in D1 and apyrase digested p97 
Mean 1692000 &86 -9400 -4 
Std Dev 1054000 0.63 3100 10 
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sites (i.e. the sites in D1 may have different microscopic dissociation constants) or 
negatively cooperative binding may exist in Dl. 
To investigate this possibility, wildtype p97 was treated with apyrase to remove 
differing amounts of ADP from the Dl domain and the same ITC experiment carried 
out (Figure 4.4b). At different amounts of free Dl sites (stoichiometrics ranging from 
0.2 to 0.8), the dissociation constant did not vary significantly from the values already 
determined (0.6 pM, SD = 0.2, n = 7) and the enthalpy and entropy were also similar 
(AH = -9700 cal.mole ', SD = 2600; AS = -2 cal.mole"', SD = 7) (Figure 4.4c and Table 
4.3). Unfortunately, the apyrase digest did not completely remove all pre-bound ADP so 
ADP binding to p97 with no pre-bound ADP cannot be measured. Although, as there is 
no downward trend in dissociation constant, it can be postulated that the dissociation 
constant would be the same if all Dl active sites are vacant. 
In conclusion, the total stoichiometry of high affinity ADP binding to Dl is close to 1 
molecule of ADP per p97 protomer. The average dissociation constant of ADP (0.9 |iM) 
is very similar to that observed by fluorescence anisotropy and the binding properties of 
each Dl active site are likely to be equivalent. 
4.3.3 The ADP binding properties of the D2 domain 
All titrations of wildtype p97 binding to ADP show a high affinity site followed by a 
low affinity tail. The low affinity tail has little sigmoidal character resulting in poor 
resolution of the properties of the interaction. As the equilibrium association constant is 
determined from the gradient of the binding curve, this parameter has more confidence 
than the stoichiometry. All wildtype p97 data was fitted to a two site model. (The first 
high affinity site has already been discussed in the previous section.) To fit the low 
affinity second site it was necessary to fix the stoichiometry of ADP binding to the D2 
domain at 1 molecule of ADP per protomer. The assumption that all D2 sites can be 
fully occupied with ADP is valid as the crystal structure of p97 with ADP bound to Dl 
and D2 implied that there is full occupancy of ADP in the D2 domain (DeLaBarre and 
Brunger, 2005). It must be noted though that the ITC data presented here is consistent 
with a wide range of stoichiometrics. 
Averaging the results from 11 fits, the dissociation constant of ADP binding to D2 was 
a mean of 86 pM (SD = 51), much higher than that of the Dl domain (Table 4.4). The 
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Tables 4.4 Fitting results from ITC binding experiments of ADP 
binding to the low affinity site of p97 
Section 4.3.3 Titration of ADP to wildtype p97 (low affinity site) 
ITC isotherms of wildtype p97 were fitted to a two site binding model and the results from the low affinity sites collected 
in this tables (the results from the high affinity sites are shown on table 4.2). 
n + / - Ka (M-') + / - K, (nM) AH (cal.mor') + / -
AS 
(cal.mo]"') Chi^  
1.0 0.0 33400 25000 30 -4600 1000 0 30300 
1.0 0.0 9000 1200 111 -7500 400 -7 15600 
1.0 0.0 27700 %wo 36 -9300 1300 
-11 22300 
1.0 0.0 18300 9W0 55 -5600 1200 1 25300 
1.0 0.0 8200 2100 122 -6000 600 -2 25000 
0.9 0.1 10900 1400 92 -5700 1200 -1 700 
1.0 0.0 21400 3200 47 -4300 200 6 14500 
0.8 0.1 8500 700 118 -9200 1400 -13 1700 
1.0 0.0 5200 500 192 300 -13 4000 
1.0 0.0 16300 1300 61 -4600 100 4 1000 
Mean 1.0 
Std Dev 0.1 
15900 
9300 
86 
51 
-6500 
2000 
-4 
7 
Section 4.3.3 Titration of ADP to K251A p97 (low affinity site) 
ITC isotherms of K251A p97 binding to ADP. Data was fitted to a one site binding model and the results from all the fits 
collected in this table. 
+ / - K, (M-') +/- Kd(nM) AH (cal.mol"') + / -
AS 
(cal.mor') Chi' 
1.7 
1.6 
1.7 
0.050 
0.020 
0.020 
12100 
37800 
36100 
1200 
3100 
2400 
83.0 
27.0 
2 8 0 
-11700 
-8900 
-8800 
600 
200 
20 
-20 
-9 
-9 
11800 
15700 
10900 
Mean 1.7 
Std Dev 0.1 
28700 
14400 
46 
32 
-9800 
1600 
-13 
7 
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enthalpy change associated with D2 binding ADP was -6500 cal.mole"' (SD = 2000) 
and the entropy change was similar to D1 (AS = -4 cal.mole'', SD = 7). 
ADP binding to K251A p97 
Further estimates of the affinity of ADP to D2 were achieved by measuring ADP 
binding to the K251A mutant which has lowered affinity for ADP in D1 (Figure 4.4d) 
(Sections 3.5.2 and 4.2.3). To boost the curvature of the profile, the protein 
concentration was increased to 300 |iM. 
Data was fitted to a one site binding equation as the data did not sufficiently constrain 
the two site model (Table 4.4) (Section 7.3.1). The dissociation constant determined by 
the fits, 46 |a,M (SD = 32, n = 3), is a composite of ADP binding to mutated D1 and 
wildtype D2. The observed stoichiometry was close to 1.7 moles ADP per p97 protomer 
(SD = 0.07, n = 3). If all D1 and D2 domains were completely empty and then filled to 
full capacity, the total stoichiometiy would be expected to be 2 molecules of ADP per 
protomer. It seems likely that the observed stoichiometry of 1.7 may therefore be a 
consequence of some sites in D1 already containing ADP. This is supported by heat 
denaturation and HPLC experiments showing residual ADP in K251A p97 (Section 
3.5.2) and is consistent with the crystal structure of p97 which shows the D1 and D2 
domains fully occupied with ADP (DeLaBarre and Brunger, 2005). 
4.3.4 Summary of ITC binding experiments of ADP 
This data estimates the dissociation constant of ADP to D1 to be 0.9 ^M, confirming 
predictions from fluorescence anisotropy work. It also shows that D2 can also bind 
ADP concurrently with D1 albeit at a much lower affinity (46 - 86 range). This 
supports data from crystal structures showing ADP bound to both D1 and D2. In 
conjunction with fluorescence anisotropy data, this work confirms that mutation of D1 
K251A does not eradicate ADP binding to D1 but instead reduces the affinity. 
Binding to both domains is driven by a large exothermic enthalpy change and a small 
entropy change and so is likely to be associated predominantly with hydrogen bond 
formation and conformational change rather than hydrophobic interactions (reviewed by 
(Thomson and Ladbury, 2004)). 
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4.4 Summary of ADP binding to p97 
The binding of ADP to p97 has been assessed by two different methods, fluorescence 
anisotropy and ITC and is summarised on Table 4.5. 
ADP binding to D1 was high affinity and gave similar results by both methods. 
• ITC binding experiments to D1 exploited a small number of vacant D1 sites 
previously identified by heat denaturation experiments. Filling these remaining 
sites is likely to lead to full occupancy of the D1 domain and an overall 
stoichiometry of the high affinity site of 1 molecule of ADP per p97 protomer. 
• Fluorescence anisotropy estimated the dissociation constant of ADP to be 
between 0.68 fxM and 1.4 pM and ITC confirmed these results giving an overall 
average dissociation of 0.86 p-M. As the dissociation constant did not alter 
significantly upon increasing the number of vacant D1 sites by apyrase digest, it 
is unlikely that binding of ADP to D1 is cooperative. 
• Spontaneous binding of ADP to D1 is driven predominantly by a strong 
enthalpic component (average AH = -9400 cal.mole"') and a weak entropic 
component (-TAS = 1200 K.cal.mole"'), suggesting that the formation of 
hydrogen bonds and electrostatic interactions rather than hydrophobic 
interactions stabilise binding. Unfortunately, it wasn't possible to compare the 
enthalpies of ADP binding to wildtype and K251A D1 domains as the data for 
K251A fitted best to a one site equation (preventing separation of the data from 
D1 and D2). 
Binding of ADP to D2 was more difficult to measure as it was of lower affinity and, 
consequentially, not measured by fluorescence anisotropy and poorly resolved by 
ITC. To overcome this, two approaches were taken, firstly, the results of fits from 
many ITC experiments were averaged and, secondly, the D1 was mutated such that 
both sites were of a similar range of affinity. 
• An average of ten ITC experimental fits to the D2 site gave a dissociation 
constant of 86 |iM (SD = 51). The dissociation constant measured for both D1 
and D2 when the Walker A lysine was mutated was 46 p,M, in the error range of 
the wildtype p97 estimates for D2. 
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Table 4.5 A table of average binding parameters of ADP to p97 
A summary of the binding parameters measured for p97 binding to ADP. (FA is an abbreviation for fluorescence anisotropy and n represents stoichiometry) 
D1 domain D2 domain 
p97 variant Method 
n (total) K j (nM) AH (cal.mol ') AS (caLmol ') n (total) K j (^M) AH (cal.mol ') AS (cal.mol ') 
Wildtype p97 ITC 1 0.9 -9400 -4 1 86 -6500 -4 
FA Linear Regression 1.4 
FA Displacement 0.7 
K251Ap97 ITC 1 46 -9800 -13 1 46 -9800 -13 
K524A p97 FA Binding 0.8 
• The stoichiometry of ADP binding to D2 could not be measured directly. In 
conjunction with predictions from heat denaturation experiments, ADP binding 
to K251A mutant suggests that the stoichiometry of ADP binding to D2 is likely 
to be 1:1 (Section 3.5.2). 
• The enthalpy of ADP binding to D2 in wildtype p97 was a third less than D1 
which suggests the difference in affinity for ADP of D1 and D2 may be 
consequence of different enthalpy change associated with binding. While key 
residues are conserved between the two domains, the D1 and D2 active sites are 
related but not identical. 
Calculations of the relative contributions of enthalpy and entropy allow the conclusion 
that both D1 and D2 bind ADP in a similar manner, driven by a strong contribution 
from hydrogen bonding and electrostatic interactions (as the large negative AH has 
greater magnitude than -TAS). The higher dissociation constant and smaller enthalpy of 
ADP binding to D2 may be a result of less of these types of interactions formed. 
Mechanistically, the difference in affinity of D1 and D2 for ADP may account for the 
different ATPase activities observed for these domains (Section 3.4.4). 
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Chapter 5 
The Characterisation of ATP Binding to p97 
5.1 Introduction 
ATPase assays have shown that both D1 and D2 are competent ATPases but with 
differing enzymatic properties (Sections 1.6.1 and 3.4.3). They are clearly both capable 
of binding to ATP, however, as of yet only D2 binding to ATP has been directly 
observed. ATP binding to D2 was shown by monitoring increases in tryptophan 
fluorescence upon the addition of ATP to wildtype p97 and Walker A mutants (Wang et 
al, 2003a). Additionally, p97 has been crystallised with ATP analogue, AMPPNP, 
bound to the D2 domain and HPLC analysis has suggested that AMPPNP may bind to 
p97 when D1 is occupied with ADP (Davies et al., 2005; DeLaBarre and Brunger, 
2003). 
Here, the properties of an ATP analogue binding to the D1 and D2 domains are studied 
by ITC. In addition, preliminary kinetic experiments begin to reveal the dynamics of 
ATP binding to p97. 
5.2 Assessment of ATP analogues 
Ideally, the binding of ATP to p97 would be measured directly but in reality under 
conditions in which the enzyme is active, ATP would be hydrolysed creating a mixed 
population of nucleotides. To prevent hydrolysis, p97 can be mutated or non-
hydrolysable nucleotide analogues may be used. As shown previously in Figure 3.4c, 
mutations designed to decrease the activity of p97 have been unsuccessful at reducing 
the activity to below a tenth of wildtype activity, possibly due to compensation for the 
mutation by other active site residues. While this is a considerable reduction in activity, 
a binding titration lasting several hours would accumulate significant quantities of ADP, 
adding a complex variable to the analysis. 
5.2.1 Hydrolysis of ATP analogues 
ATP analogues have substitutions around the y-phosphate of ATP and are generally 
non-hydrolysable by ATPases, although this is not the case for all (Eccleston et al., 
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2006). To test whether p97 can hydrolyse ATPyS (sulphur substitution of a y phosphate 
oxygen) and AMPPNP (amido substitution of p-y bridging oxygen), ATP was replaced 
with AMPPNP and ATPyS in activity assays (Figure 5.1a). (Controls showed that 
thiophosphate and amidophosphate can also be detected by the colorimetric assay for 
Pi). As shown, AMPPNP and ATPyS are not hydrolysed by p97 (Figure 5.1a) 
5.2.2 Effectiveness of ATP analogues 
To compare the relative affinity of AMPPNP and ATPyS for p97, a competition 
experiment was carried out in which BODIPY-ADP saturated with p97 was displaced 
by increasing concentrations of AMPPNP and ATPyS (Figure 5.1b). This showed that 
ATPyS was a more effective competitor of BODIPY-ADP than AMPPNP. As ATP 
would be predicted to bind with high affinity, it seems that ATPyS represents a more 
ATP-like analogue than AMPPNP. This could be because the y phosphate position of 
AMPPNP is a phospho-amido group, which would be predicted to have a different 
hydrogen bonding pattern around the nitrogen compared to oxygen found in ATP and 
ATPyS. ATPyS may allow more similar hydrogen bonding patterns and therefore 
possibly binding affinities (Figure 5.1c-e). 
These results are similar to a study in which the competition of nucleotides showed 
ATPyS had higher affinity for p97 than AMPPNP (Zalk and Shoshan-Barmatz, 2003). 
All ITC binding experiments therefore used ATPyS to represent ATP. 
5.3 The binding of ATPyS to p97 Wall^er A mutants 
As ADP is pre-bound to wildtype p97, ITC titrations of ATPyS would potentially be a 
competition between the two nucleotides. This potential competition could not be 
prevented by apyrase treatment as the treatment at this stage of the project was not well 
optimised and gave incomplete removal of ADP. To allow analysis of potentially 
complex wildtype binding profiles, the binding properties of ATPyS to p97 carrying the 
Walker A mutant in D1 and D2 individually was first determined. This gave 
information about the properties of D1 and D2 individually which could then used to 
inform the analysis of wildtype p97 ATPyS titrations. 
131 
3 
5.1a 5.1c 5.1 d 5.1e 
Time {mm) 
5.1b 
1 
i inii i 1 1 1 1 Mill 1 l l i l l i l ) 1 11 lliii| 1 1 i i i i i i l 1 
N AMPPNP 
-
0,1 1 10 100 1000 
[Competitor] uM 
0 ' 
H 
P = 0 
I 
0 
.H 
0 ' 
•P=0 
N. 
• 0 V 
Figure 5.1 Comparison of ATP analogues 
a. Colorimetric ATPase activity assay of wildtype p97 in whicfi ATP is substituted for ATPyS and AlVIPPNP. ATPyS is siiown in circles, AMPPNP in triangles and ATP in squares. 
b. Competition of BODIPY ADP using non-labelled nucleotides. 50 nM BODIPY ADP was saturated with wildtype p97 and increasing concentrations of nucleotides added (ATPyS: Blue squares; AMPPNP: 
Green circles). Data is fitted to one site competition equations, assuming that there is a constant effect from pre-bound ADP. 
c. d & e. The structures of ATP (adenosine 5' triphosphate) (c.), AMPPNP (adenosine 5' (P,7-imido) triphosphate), (d.) and ATPyS (adenosine 5' (y-thio) triphosphate) (e.) (Images from www.rcsb.org). 
5.3.1 ATPyS binding to the D1 domain 
As no ATP binding to the Dl domain has previously been shown conclusively, the D2 
Walker A mutation, K524A, used to remove D2 binding to allow binding to Dl only. 
K524A p97 has ADP pre-bound to the Dl domain (Section 3.5.2) so if ATPyS binds to 
Dl , competition will occur. Because apyrase treatment incompletely removed ADP and 
because ADP binding to Dl was already well characterised, experiments were carried 
out with ADP pre-bound to the Dl domain. The binding parameters were then obtained 
from a competition model (Section 7.3.3) (Sigurskjold, 2000). 
The titration of ATPyS into K524A p97 yielded an exothermic profile with an apparent 
stoichiometry of 0.2 (Figure 5.2a). Four repetitions were analysed using the competition 
model with the following assumptions: 
• ADP can bind to 1 site per p97 protomer (6 sites per hexamer) 
• The effect of ADP binding to D2 is considered to be negligible due to the 
presence of the Walker A mutation 
• The Kd of ADP to K524A Dl domain is around 0.4-0.8 |j,M (Section 4.2.4) 
The AH of ADP binding to Dl is approximately -10 000 cal.mole 
All fitting results were in close agreement, giving a stoichiometry for ATPyS binding of 
the Dl domain of close to 1 (w = 1.05, SD = 0.04) (Table 5.1). The affinity of ATPyS 
binding was a little lower than ADP (Kd = 2.1 |iM, SD = 0.06). The enthalpy change of 
binding ATPyS was larger than ADP (AH = -12910 cal.mole'', SD = 784). This increase 
may be contributed to by the additional interaction of the y phosphate group of ATPyS 
with the active site amongst other factors. 
In conclusion, these results show for the first time that an ATP analogue can bind to D1 
and can fully saturate all Dl active sites. Furthermore, the ATP analogue had slightly 
lower affinity for Dl than ADP. 
5.3.2 ATPyS binding to the D2 domain 
To determine whether ATPyS also binds to the D2 domain, the Dl domain was mutated 
with the Walker A mutant, K251A. This mutation reduces the binding affinity of ADP 
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Figure 5.2 ITC profiles of the Wallcer A mutants binding to ATPyS 
a. Competition between ATPyS and ADP for binding to K524A p97. Fitting data to tfie competition model gave dissociation constants of ADP of 600 nM and ATPyS of 2.1 pM. 
b. K251A binding to ATPyS. Data was fitted to a two site model giving high and low affinity sites with dissociation constants of 3 |iM and 74 |aM 
c. K251A-K524A binding to ATPyS. Data was fitted to a one site model giving a dissociation constant of 50 nM, similar to that measured for the low affinity site of K251A in b. 
Tables 5.1 Fitting results from ITC titrations of D1 and D2 Walker A mutants binding to ATPyS 
Section 5.3.1 Competition fits of K524A binding to ATPyS 
ADP n + / - K, (M- ' ) + / - (eZk-') +/- ATPyS It + / - Ka(M-') + / - Kd (nM) 
AH 
(cal.mole"') 
+ / - C h f 
1.00 (Fixed) 1670000 (Fixed) 0,60 -13600 900 1.10 0,01 343000 73300 3.0 -12500 500 17700 
1,00 (Fixed) 1250000 (Fixed) 0,80 -1 1500 200 1.10 0,01 455000 70800 2.2 -12000 100 7300 
1,00 (Fixed) 1670000 (Fixed) 0,60 -11800 200 1,00 0,01 637000 172000 1.6 -13700 200 17100 
1,00 (Fixed) 2350000 1700000 0,43 -10300 2400 1.00 0,01 580000 440000 1.7 -13400 400 48700 
Mean 1,00 1735000 0.60 -11800 1,05 503800 2.1 -12900 
Std Dcv 0,00 45500 0.15 1400 0,04 131400 0.6 800 
Section 5.3.2 K251A p97 binding to ATPyS fitted to a two site binding model 
D2 n + / - K . (M"') + / - + / -
AS 
(cal.mole"') D1 n 
+/- K . (M"') +/- Kd (nM) AH 
(cal.mole"') 
+ / -
AS 
(cal.mole'') 
1,10 0.02 64900 16700 1.5 -10300 100 -8 1,00 (Fixed) 16200 4900 62 -3600 200 8 
0 80 0.01 50000 12700 2.0 -11800 100 -14 1,00 (Fixed) 20800 5900 48 -2200 200 12 
1.20 0.04 18700 31200 5.4 -7600 100 -1 1,00 (Fixed) 8700 2000 114 -4600 200 3 
Mean 1.00 445300 3.0 -9900 -8 1,00 15200 74 -3500 7 
Std Dev 0,02 235800 2.0 2100 6 0,00 6100 34 1200 5 
to Dl , yielding p97 with little ADP pre-bound (less than 0.2 moles per p97 protomer) 
(Section 3.5.2). Titration of ATPyS into K251A p97 gave an exothermic profile with an 
apparent stoichiometry greater than one suggesting that both Dl and D2 sites are 
available for binding in this mutant (Figure 5.2.b). As the sigmoidal curve is 
asymmetric the data can be described by a two site binding model, the high affinity site 
giving the initial sigmoid and the low affinity site causing the incomplete saturation of 
the tail. 
To confirm that the higher affinity site is D2 (Dl is mutated to greatly reduce the 
affinity of nucleotides), the titration was repeated with the same concentration of p97 
but mutated in both Dl and D2 (K251A-K524A). The resulting isotherm was diagonal 
with little sigmoidal character, diagnostic of a low affinity interaction (Figure 5.2c). 
This showed that the additional K524A mutation removed the higher affinity binding 
site allowing the assignment of the high affinity site as D2 and the low affinity mutated 
site as Dl. 
Several repetitions of the K251A ATPyS titration were fitted to the two site binding 
model (Table 5.1). As it has already been shown that ATPyS binds to Dl with a 
stoichiometry of 1, the stoichiometry of the low affinity site (assigned to be Dl) was 
fixed in fitting algorithms. This assumption was used to constrain a two site fit which 
gave dissociation constants for D2 binding ATPyS of 2.5 p,M (SD = 1.9) and mutated 
Dl binding ATPyS of 58 |iM (SD = 41). The mutated Dl site showed a much reduced 
enthalpy change upon ATPyS binding compared to the enthalpy change of non-mutated 
Dl binding to ATPyS in the K524A competition titration (K251A Dl AH = -5130 
cal.mole \ SD = 3340, compared to K524A Dl AH = -12910 cal.mole"', SD = 784). 
This decrease could possibly be due to the key role the K251 residue plays in stabilising 
nucleotide binding by interactions with Mg^^. The stoichiometry of the D2 site 
converged at 1 (« = 0.99, SD = 0.20) suggesting that when Dl is mutated and empty of 
ADP, every D2 domain of the hexamer is able to bind to ATPyS. 
In conclusion, these results show that ATPyS binds to D2 with a similar affinity to Dl, 
both having dissociation constants of around 2 p.M. 
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5.4 Wildtype p97 binding to ATPyS 
The binding of ATPyS to wildtype p97 is more complex than to the Walker A mutants 
individually. The experiments performed on the Walker A mutants have demostrated 
the basic properties of ATPyS binding to p97. Firstly, when ADP is pre-bound to Dl , 
ATPyS can compete with ADP for Dl binding (K524A p97). Secondly, when p97 has 
little ADP pre-bound to the Dl domain, (K251A p97) ATPyS can saturate both Dl and 
D2 simultaneously. Wildtype p97 has ADP pre-bound to the Dl domain, and so 
presents two different sorts of ATPyS binding sites: ADP pre-bound to Dl sites (a 
competitive binding) and vacant D2 sites (simple binding). Therefore, any results are 
predicted to be a composite of these two sorts of interactions. For ease of analysis, two 
assumptions need to be made. 
A. The affinity of Dl and D2 for ATPyS is similar. 
B. ATPyS binding to D2 does not alter the ADP binding properties of Dl 
Assumption A has already been shown to be likely in Walker A mutants as both Dl and 
D2 have dissociation constants of around 2 |iM (Dl Kd = 2.1 piM, D2 Kd = 2.5 |xM ), 
however, the second assumption must be tested (Section 5.2). 
5.4.1 Testing for alteration of D1 properties by nucleotide binding to D2 
As BODIPY-ADP binds specifically to Dl, its dissociation in response to ATPyS 
binding can be measured. First, BODIPY-ADP was saturated with wildtype or K524A 
p97 and then BODIPY-ADP dissociation by increasing concentrations of ATPyS was 
monitored by fluorescence anisotropy measurements. The results, shown in Figure 5.3a, 
suggest that mutation of D2 does not significantly alter the concentration of ATPyS 
required to displace BODIPY ADP. This implies that the properties of ADP binding to 
Dl are not altered by possible ATPyS binding to D2, a result that is consistent with 
published work. In an analysis of nucleotides bound to p97, when AMPPNP was added 
to p97, ADP was also present in p97 even after the excess nucleotide had been removed 
suggesting that AMPPNP binding to the D2 domain does not lower the affinity of ADP 
for Dl (Davies et al, 2005). This evidence imphes that assumption B is valid. 
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Figure 5.3 The binding of ATPyS to wildtype p97 
a. Increasing concentrations of ADP (blue) and ATPyS (red) displace BODIPY-ADP in wildtype p97 (darker shade) and K524A p97 (lighter shade). Data was fitted to a competition model in which the impact 
of pre-bound ADP is assumed to be constant. The apparent dissociation constants of ADP and ATPyS are similar between the two types of p97 preparation: WT ADP = 250 nM and Ky ATPyS = 75 nM; 
K524A Kd ADP = 206 nM and Kd ATPyS = 32 nM. (Data appears staggered on graph due to different initial starting concentrations of p97.) 
b. The ITC profile of ATPyS binding to wildtype p97 with ADP pre-bound to the D1 domain. Binding was exothermic at low concentrations of ATPyS and the dominant peak made a transition to endothermic 
(enlargements of these two events are shown in c.). Data is fitted to a competition model. 
c. Enlargements of the exothermic peak (top) and dominant endothermic peak (bottom) of ATPyS binding to wildtype p97 (Figure 5.4b). The endothermic peak resulting from competition is accompanied by 
a fast exothermic peak probably resulting from energy of solvation of ATPyS and a slow exothermic peak possibly resulting from slow conformational change or micro-aggregation. 
5.4.2 Wildtype p97 binding to ATPyS measured by ITC 
Titration of ATPyS into wildtype p97 containing ADP pre-bound to D1 gives a complex 
thermodynamic profile (Figure 5.3b). Early in the titration, an exothermic process 
dominates the binding energy and as this exothermic process saturates, the dominating 
peak instead becomes endothermic preceded by a small, fast exothermic peak (Figure 
5.3c). 
There are three features to each injection, a small, fast exothermic peak (which at the 
beginning of the titration is combined with the large exothermic peak), a medium 
timescale peak that changes from exothermic to endothermic as the titration progresses 
and a slow shallow exothermic peak. A similar peak to the slow shallow peak was also 
observed in ADP binding to p97 as the D2 domain became saturated. This could be 
resulting from conformational change upon nucleotide binding to the D2 domain. 
Interestingly, this event was decreased following gel filtration of the p97 sample 
suggesting it could also be associated with microaggregation of hexamers. The small, 
fast exothermic peak visible towards the end of the titration is assigned as the energy of 
solvation of ATPyS. This is because solvation of the ligand is expected to occur before 
binding to the protein and the peak is a similar magnitude to the solvation peak 
observed when ATPyS was injected into buffer alone. The dominant peak that is 
initially exothermic and becomes endothermic can therefore be attributed as the binding 
of ATPyS and the dissociation of ADP. As the dissociation of ADP would be likely to 
have an opposite signed enthalpy compared to association, the endothermic peak is 
likely to represent the net positive enthalpy of the combined association of ATPyS 
(negative AH) and dissociation and solvation of ADP (larger positive AH) (both these 
values would also include the energies multiple small rearrangements of the protein as a 
consequence of changes in the nucleotide state). 
As it can be assumed that D1 and D2 have similar affinity for ATPyS, the data was 
fitted to a competition model which allows the stoichiometry of binding of the 
competing ligand (ATPyS) to vary freely with respect to the stoichiometry of the bound 
ligand (in this case, pre-bound ADP) which is defined (Sigurskjold, 2000). The 
stoichiometry of the pre-bound ADP was fixed at 1 (1 molecule ADP per p97 
protomer), as there is neghgible ADP bound to the D2 domain. The dissociation 
constant of ADP bound to the D1 domain was also fixed to constrain the fit to 
appropriate solutions for ADP but the stoichiometry, dissociation constant and enthalpy 
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change of ATPyS binding were varied. The stoichiometry of ATPyS binding sites in 
p97 was 1.59 molecules of ATPyS per p97 protomer (SD = 0.15, n = 4) representing 
ATPyS binding to both D1 and D2 (Table 5.2). The maximal possible stoichiometry if 
ATPyS binds to every D1 and D2 active site would be 2 molecules of ATPyS per 
protomer so a stoichiometry of 1.6 indicates incomplete occupancy p97. The determined 
dissociation constant of ATPyS was a combination of D1 and D2 and was an average of 
1.73 p.M (SD = 0.94, n = 4). This is in line with predictions made by the Walker A 
mutant binding experiments and so vahdates the assumptions made for this analysis. 
These results are discussed in more detail below. 
5.5 Summary of ATPyS binding to p97 
The dissociation constants of ATPyS to D1 and D2 domains 
A remarkable conclusion of this section is that ATPyS can bind with similar affinity to 
the D1 and D2 domains when the Walker A mutants are studied. The Walker A mutants 
in D1 and D2 predicted that the dissociation constant of ATPyS to the D1 domain is 2 
pM (SD = 0.6; n = 4) and to the D2 domain is 3 |iM (SD = 2; n = 3). When ATPyS 
binding to wildtype p97 was modelled as competition with ADP in D1 and binding to 
vacant sites in D2, the dissociation constant measured, 1.7 |iM (SD = 0.9; n = 4), agreed 
excellently with the dissociation constants forecast by the Walker A mutants. This 
corroborates the assumption that the dissociation constant of each domain is practically 
the same in wildtype p97 as well as Walker A mutants. 
The competition experiments in which D1 had ADP pre-bound, gave an opportunity to 
study whether ATPyS binding to the D1 or D2 domain altered the affinity of pre-bound 
ADP. When D2 was mutated, ATPyS competition with ADP was consistent with a 
dissociation constant of ADP of 0.6 p-M (SD = 0.15; n = 4), within the range of 
measurements made when ADP was the only ligand binding to the D1 domain (Section 
4.3.2). This suggests that during the competition, ATPyS binding to protomers within 
the D1 ring does not alter the affinity of ADP bound to other protomers of the same 
ring. 
Similarly when ATPyS binding to wildtype p97 with ADP pre-bound to the D1 domain 
was measured, the dissociation constant of ADP (Kd = 0.85 |J.M) was also consistent 
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Table 5.2 Fitting results from ITC titrations of ATPyS binding to wildtype p97 
Section 5.4.2 Compet i t ion results f rom wi ld type b inding to ATPyS 
ADP n + / - + / - K , ( n M ) 
AH 
(cal.mole"') 
+ / - ATPyS 11 + / - + / - Kd(nM) 
AH 
(cal.mole"') 
+ / - Chi^ 
1,00 (Fixed) 1170000 (Fixed) 0.85 -8600 500 1.61 0.008 520000 76000 1.9 -8032 92 13840 
1.00 (Fixed) 1170000 (Fixed) 0.85 -10800 500 1.81 0.007 2810000 880000 0.4 -9054 126 16740 
1.00 (Fixed) 1170000 (Fixed) 0.85 -12500 2100 1.50 0.018 408000 180000 2.5 -10300 886 61480 
1.00 (Fixed) 1170000 (Fixed) 0.85 -12200 300 1.45 0.003 455000 41000 2.2 -9583 144 3360 
Mean 1.00 1170000 0.85 -11000 1.59 1048200 1.7 -9200 
Std Dev 0 0 0 1800 0.16 1175400 0.9 1000 
with that determined during previous measurements (Section 4.3.2). This not only 
further confirms the prediction made that ATPyS binding to protomers within the D1 
domain does not alter the ADP binding properties of other protomers but also suggests 
that D2 binding of ATPyS does not alter ADP binding properties of Dl. This supports 
the initial assumption made that ATPyS binding to D2 does not change the ADP 
binding properties in Dl. 
Stoichiometry of ATPyS binding 
The stoichiometry of 1.6 molecules of ATPyS binding to a p97 protomer (9.6 molecules 
per p97 hexamer) in wildtype p97 is of particular interest. It is likely that the D1 domain 
has full occupancy of ATPyS as Walker A mutant binding experiments predict that each 
Dl can bind one molecule of ATPyS (Section 5.3.1: K524A ADP-ATPyS competition). 
As wildtype p97 with ADP pre-bound to the Dl domain is comparable to K524A with 
ADP pre-bound, it is likely that the Dl ring can fully bind ATPyS (stoichiometry of 1 
molecule of ATPyS per Dl domain, or 6 molecules per hexamer). By elimination, this 
suggests that for wildtype p97 with ADP pre-bound to the Dl ring, the D2 ring is 
incompletely occupied with ATPyS with around a half to two thirds of all D2 active 
sites available for ATPyS binding (in the hexamer this would mean the D2 ring has 3-4 
sites able to bind to ATPyS and 2-3 prevented from binding ATPyS). 
A related phenomenon has previously been observed for ATP transition state analogue 
ADP-AIF3 in crystallographic structures in which there is variable occupancy of the 
AIF3 moiety (full occupancy in 2 protomers per hexamer, partial occupancy in a further 
two protomers and none in the final two protomers) (DeLaBarre and Brunger, 2005). 
There is, however, no evidence to support a similar stoichiometry for AMPPNP in a 
crystal structure of a different space group (DeLaBarre and Brunger, 2005). Another 
study, observed that modified ATP crosslinked to p97 with a stoichiometry of 2.23 per 
hexamer although the starting state of p97 was not characterised in this instance (Zalk 
and Shoshan-Barmatz, 2003). Taken together this indicates that ATPyS binds with full 
occupancy in the Dl ring but has half to two thirds occupancy in the D2 ring. 
It should be noted though that when Dl is mutated to have low affinity for nucleotides 
causing it to be vacant of pre-bound ADP, each D2 domain can also bind one molecule 
of ATPyS (Section 5.3.2: ATPyS binding to K251A). This discrepancy is discussed 
later. 
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Enthalpy of ATPyS binding 
Comparison of wildtype and K524A ATPyS competition experiments reveals an 
interesting difference. The competition profile of K524A is entirely exothermic, 
suggestive that the net difference between the enthalpy associated with ATPyS binding 
and ADP dissociating is negative (i.e. the exothermic enthalpy of ATPyS binding to p97 
has a greater magnitude than that of ADP dissociation). As the competition profile of 
wildtype p97 shows an endothermic tail, even though the binding of ATPyS to the D2 
domain (like Dl) is also exothermic, the net enthalpy is positive. This indicates that, in 
this case, the enthalpy associated with ADP dissociation from Dl is greater than the 
average enthalpy of association of ATPyS to Dl and D2. This situation wasn't predicted 
by the initial studies of mutants. It could be a consequence of an altered 
microenvironment for ADP release, possibly due to different concentrations of ATPyS 
or could also reflect differences in general motions available to p97 in response to ADP 
release and ATPyS binding when D2 is mutated compared to wildtype p97 with ATPyS 
bound to the D2 domain. 
Inconsistencies between wildtype and K251A data 
Provisional information regarding ATPyS binding to the D2 active site from K251A 
mutant has inconsistencies with the wildtype data. The dissociation constants are similar 
but the stoichiometrics differ: an average of 1 molecule of ATPyS bind per D2 domain 
in K251A p97 whereas an average of 0.6 molecules of ATPyS bind per D2 domain in 
wildtype p97. K251A data does not fit well to models in which the higher affinity D2 
site has a fixed stoichiometry of 0.6. 
Possible reasons to explain this difference could be: 
1. The Dl K251A mutation destabilises p97 
The K251A mutation could alter p97 conformation in a general way, leading to 
decoupling of D2 communication that controls limitation of the stoichiometry to 
0.6 molecules of ATPyS per D2 domain. 
2. K251 residue may be part of a relay that controls ATPyS binding in D2 
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K251 may be a key residue that controls the 0.6 stoichiometiy of D2, possibly in 
response to D1 binding of ADP. Mutation of this residue to alanine may block 
the propagation of a relay. 
3. The presence of ADP in D1 may control the difference in stoichiometry 
ADP bound to the D1 domain may constrain the D2 domain so that the 
stoichiometry of ATPyS binding to D2 is limited to 0.6. Absence of ADP in D1 
of K251A p97 could release this constraint leading full occupancy of D2 
To test whether ADP binding to D1 altered the stoichiometry of ATPyS binding in D2, 
wildtype p97 was apyrase treated and the concentration quantified by heat denaturation. 
Unfortunately, apyrase digests incompletely digested the ADP in D1 (apyrase 
experiments at this stage were not fully optimised), and heat denaturation experiments 
gave ratios of 0.9 molecules of ADP per p97 protomer. These results when fitted to a 
competition fit gave predictably similar results to p97 without apyrase digest 
Summary 
Overall the following conclusions may be drawn; 
• ATPyS binds to the D1 and D2 domains with similar affinity, around 2 p,M 
• ATPyS binds to wildtype p97 hexamers with a 6:6 stoichiometry to the D1 
domains 
• ATPyS binds to the wildtype D2 domain with a 3-4:6 stoichiometry when the 
D1 domain is occupied with ADP. 
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5.6 Stopped flow kinetics of MANT-ATP binding to p97 
Enzymes are dynamic systems but the binding experiments presented in this study only 
observe p97 at equilibrium. In order to investigate the kinetics of ATP binding to p97, 
stopped flow measurements were made. A fluorescent derivative of ATP, N-
methvlanthranilovl ATP (MANT-ATP) was used to probe rates of ATP binding through 
changes in fluorescence intensity and anisotropy. Experiments typically mixed 
equimolar concentrations of MANT-ATP with p97, providing enough MANT-ATP to 
saturate only one AAA ring (if the affinity is very high). What follows is an early stage 
investigation of the kinetics MANT-ATP association and hydrolysis by p97. It must be 
emphasised that this work is incomplete but raises some potentially interesting features 
of ATP binding dynamics 
5.6.1 The kinetics of wildtype p97 binding to IVIANT-ATP 
Equimolar concentrations of MANT-ATP and apyrase treated p97 were rapidly mixed 
(5 |j.M MANT-ATP and 5 |aM p97 protomer). This led to fast binding in which the 
majority of MANT-ATP was bound within 1 s, as shown by the maximal anisotropy 
reaching the level seen for steady state binding titrations (> 0.3) (Figure 5.4a). Binding 
was biphasic with a fast initial phase (< 1 s) followed by a slower phase that peaked at 
around 200-1000 s (Figure 5.4b and c). Intriguingly, this was not followed by a product 
release step following MANT-ATP hydrolysis even when monitored over 4 hours. The 
peak of the second event decayed to the magnitude of the first event only and was not 
caused by photo-bleaching as it was unaltered by use of shutters between readings. 
There are several possible explanations for the lack of product release step. Firstly, 
MANT-ATP could be bound but not hydrolysed and so not released as MANT-ADP. 
This could be because the concentration is insufficient to saturate fully all active sites 
(which may be necessary for hydrolysis) or because the fluorescent tag inliibits 
hydrolysis by steric constraints. Secondly, the MANT-ATP could be bound and 
hydrolysed and remain bound tightly as MANT-ADP, this could be a real phenomenon 
or an artefact of high affinity induced by the fluorescent tag. 
To test the first explanation, ATPase assays were carried out under the same conditions, 
using HPLC to separate MANT-ATP from any MANT ADP. This showed that MANT-
ATP was indeed hydrolysed by wildtype p97 (Figure 5.4d). This suggests that the 
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Figure 5.4 WIANT-ATP binding to and hydrolysis by apyrase treated p97 
a. The anisotropy and total fluorescence Intensity of MANT-ATP recorded over the 5 s following rapid mixing with equlmolar apyrase treated wildtype p97. Anisotropy Is shown In black and total fluorescence 
Intensity Is shown In grey. 
b. & c. Linear and logarithmic plots of MANT-ATP binding to apyrase treated wildtype p97 over 1000 s. (As before anisotropy Is shown in black and total fluorescence Intensity shown in grey.) The majority of 
MANT-ATP binds to p97 In a fast Initial event (completed within 1 s), then slow increases in fluorescence and anisotropy Indicate a second event which peaks at around 200s. The peak of the second event 
decays only to the maximum of the first event over several hours (not shown). 
d. ATPase assay of MANT-ATP hydrolysis by wildtype apyrase treated p97. 5 pM of p97 and MANT-ATP were rapidly mixed and the reaction halted by acid denaturatlon at the time points shown. MANT-
ATP and MANT-ADP were separated by HPLC and detected by MANT fluorescence. 
experimental setup does not prevent the ATPase from hydrolysing, so instead MANT-
ADP must remain bound tightly p97. It seems likely that this is a consequence of 
artefactually high affinity MANX-ADP possibly similar to BODIPY-ADP. In support of 
this, another study also showed that MANT-ADP remained bound following hydrolysis 
to an ABC transporter, SufC (Eccleston et al, 2006). Equilibrium binding experiments 
using ITC or fluorescence anisotropy could test this possibility. 
The second maximum observed by fluorescence and anisotropy (in the time range of 
200-1000 s) was in the same time range as the hydrolysis of MANX-ATP indicating that 
the two phenomena could be correlated. 
The total intensity of MANT-ATP fluorescence increases as it binds to p97, indicating 
that the environment of the fluorophore changes significantly upon being brought in 
close contact with the protein (Figure 5.4abc). This leads to complexities in the analysis 
of the data. Overall changes in fluorescence intensity (such as varying power of the 
excitation lamp) do not impact upon anisotropy measurements, as anisotropy is a ratio 
measurement. However, changes in fluorescence intensity upon binding have an effect 
of biasing anisotropy measurements as the signal from the bound population of 
fluorophores is inflated. This necessitates a different approach for analysis of the data 
compared to that previously used in equilibrium anisotropy measurements. Instead both 
intensity and anisotropy profiles are collected and fitted simultaneously in a global 
fitting regime that describes changes in anisotropy with respect to changes in 
fluorescence (Section 7.2.1). The initial event of MANT-ATP binding (< Is) fitted well 
to a single site equation (Figure 5.5a and 5.5b). Averaging the rate constants of 
association (ki) and dissociation (k.,) determined from five different preparations of 
apyrase treated p97 in experiments of up to 10 s in length gave an average association 
rate constant of 1.84 M"'s"' (SD = 0.7; n = 5) and dissociation rate constant of 7.2 x 10"^  
s"' (SD = 1.3 X 10"^ ; n = 5) (Table 5.3). (The wide range of measurement of the 
dissociation rate constant reflects the fact that this data primarily describes the 
association of MANT-ATP and not the dissociation.) While this data fitted excellently 
to a one site model for early data, it did however deviate over the longer term due to the 
slow phase increase in anisotropy (Figure 5.5c and 5.5d) 
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Figure 5.5 Global 1 site f its of wildtype apyrase treated p97 binding to MANT-ATP 
a. Apyrase treated p97 binding to equimolar MANT-ATP. Anisotropy (black dots) and fluorescence intensity (grey dots) data from a 5 s experiment was fitted to 1 site global fit equation (red line) 
b. Enlargement of the first second of 5.6a 
c. & d. Linear and logarithmic plots of 1 site global fits over a 1000 s timescale. While the 1 site fit describes the first 5 s accurately, it doesn't describe later events. 
Table 5.3 Global fits to wiidtype p97 stopped flow data using a 1 site 
binding model 
Apyrase treated p97 
k AnisOj^ jji AnisOfjijjx 
Mean 1.84 7x10^ 3.0 0 / » 8 0.312 
Std Dev 0.72 1x10^ 0.5 0IG3 0.017 
Untreated p97 
k 1 (M-'s ' ) AnisOmin AnisOmgx 
Mean 0.70 4x10* 2.4 0.070 0.291 
Std Dev 0.55 6x10* 0.4 0.040 0.019 
Results from 1 site global fits to anisotropy (Aniso) and total fluorescence intensity (Int) data collected from equimolar 
MANT-ATP mixed with wiidtype p97 over the first 10 s. Results shown are the average of five independent experiments 
each with a different preparation of p97. As total fluorescence Intensity information is varies specifically with each 
experiment, the averages are not calculated but the ratio between the maximum and minimum is shown for comparison. 
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ADP bound to the D1 domain alters the rate of MANT-ATP association 
The rate of MANT-ATP binding to p97 with pre-bound ADP was compared to apyrase 
treated p97. Both had two phases of binding but when the faster phases of binding were 
compared, apyrase treated p97 bound MANT-ATP at a faster rate than p97 with ADP 
pre-bound to the D1 domain. Like apyrase treated p97, the 1 site model describes the 
initial data accurately but deviates over a longer timescale (Figure 5.6c and 5.6d). When 
fitted to the 1 site binding model, the rate of MANT-ATP association with p97 
containing pre-bound ADP was 0.7 M"^s"' (SD = 0.55; n = 5) and the rate of MANT-
ATP dissociation 3.8 x 10"^  s"'(SD = 5.5 x 10'^; n = 5), indicating that MANT-ATP 
binding to p97 with ADP pre-bound is slower than to apyrase treated p97 (Figures 5.6 
and 5.7). It must be noted that the standard deviation of the association constants of both 
wildtype apyrase treated and with ADP pre-bound are large relative to the mean value 
of the constant. However, when data from experiments made on the same day are 
compared the difference between the two sorts of wildtype p97 is marked (Figure 5.7). 
This variation between preparations could reflect loss of activity between protein 
purification and stopped flow experiment. 
To demonstrate that the presence of ADP in D1 decreases the rate of MANT-ATP 
binding, apyrase treated p97 was rapidly mixed with MANT-ATP and the concentration 
of added ADP was varied between zero and equimolar with p97 (enough to fill D1 
domain alone) (Figure 5.8a). This showed that the rate of MANT-ATP binding slowed 
as the D1 domain became occupied with ADP (Figure 5.8b). To show that this is a 
consequence of ADP binding to the D1 domain and not the D2 domain, the experiment 
was repeated using p97 mutated in D1 to reduce the affinity of ADP (K251A) (This 
mutant has no ADP pre-bound and the dissociation constant of ADP in D1 is around 40 
|iM compared with 1 |iM for wildtype p97.). This mutant showed a negligible decrease 
in the rate of MANT-ATP binding (Figure 5.8 c). 
In conclusion, the presence of ADP in the D1 domain decreases the rate of MANT-ATP 
binding. Until the location of MANT-ATP binding has been determined, it is impossible 
to differentiate between whether this is a consequence of MANT-ATP competition in 
the D1 domain or modulation of the kinetic properties of D2 by the nucleotide binding 
state of Dl. 
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Figure 5.6 Wlldtype p97 containing pre-bound ADP binding to MANT-ATP 
a. p97 witti ADP pre-bound to the 01 domain binding to equimolar MANT-ATP. Anisotropy (black dots) and fluorescence intensity (grey dots) data from a 25 s experiment was fitted to 1 site global fit 
equation (red line) 
b. Enlargement of the first 5 s of 5.7a 
c. & d. Linear and logarithmic plots of 1 site global fits over a 1000 s timescale. While the 1 site model describes the first 25 s accurately, it doesn't describe later events. 
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Figure 5.7 Comparison of rates of IVIANT-ATP binding to wildtype p97 containing pre-bound ADP and with apyrase treatment 
a. & b. Comparison of anisotropy (5.8a) and fluorescence intensity (5.8b) profiles of MANT-ATP binding to apyrase treated p97 (red) and p97 with ADP pre-bound to the D1 domain (lime). Example data is 
shown fitted to the 1 site binding model. 
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Figure 5.8 Addit ion of ADP to the D1 domain decreases the rate of ADP binding 
a. MANT-ATP binding to apyrase treated wildtype p97 at different concentrations of ADP. p97 pre-incubated with different molar ratios of ADP was rapidly mixed with equimolar MANT-ATP. Both anisotropy 
and total fluorescence intensity measurements were collected and fitted to 1 site binding regimes. The molar ratios were 0 (red fitted line), 0.3 (orange fitted line), 0.7 (yellow fitted line) and 1 (lime fitted line), 
the black dots are representative data points. 
b. The association rate constant of MANT-ATP binding to apyrase treated wildtype p97 at different molar ratios of ADP. Points were determined from 1 site fits shown in 5.9a and error bars represent the 
standard error of the mean of two repetitions. 
c. p97 mutated to reduce the affinity of ADP binding (K251A) shows no significant decrease in MANT-ATP binding as the molar ratio of ADP increases. Experiments were carried out as detailed for 5.9a 
substituting K251A p97 in the place of wildtype apyrase treated p97. 
The concentration of MANT-ATP appears to alter the kinetics of 
association 
The rate constant of association should be independent of concentration changes unless 
a complex effect is occurring. To see if the concentration of MANT-ATP alters the rates 
of MANT-ATP association, the concentration of MANT-ATP was titrated from 
equimolar down a sixth of the concentration of both apyrase treated wildtype p97 and 
p97 with ADP pre-bound. If there are no complex effects, the rate constants of 
association would be expected to remain the same (the binding models take into account 
the concentration of ligand and protein). 
Intriguingly as the concentration of MANT-ATP was decreased, the data began to fit 
very poorly to the 1 site model. The fluorescence profile appeared to show two stages of 
fluorescence increase at low MANT-ATP concentrations but this effect declined as the 
concentration of MANT-ATP increased to equimolar. I designed two models to 
speculatively fit the data to: a two site model (1) (where two types of site each had a 
characteristic fluorescence increase) and a one site, two state model (2) (Sections 7.2.2 
and 7.2.3). 
The one site, two state model (2) describes one type of binding site associated with two 
fluorescence intensities of MANT-ATP, allowing the fluorescence of MANT-ATP to 
change upon binding to p97 and again once bound (maybe for example due to 
conformational rearrangement of the environment of the fluorophore'). 
^ An analogy may be drawn with relaxed and tense conformations from mechanisms of induced fit. 
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The two site model fitted the data poorly but the one site, two state fitted well to the 
data including the lowest concentrations of MANT-ATP (Figure 5.9). At equimolar 
concentrations, the one site, two state and one site (one state) models fit to the data 
equally well (Figure 5.9). This is because the impact of the second event was 
diminished as the concentration of MANT-ATP was increased. 
A speculative interpretation of this data could be that there are two possible 
conformations for MANT-ATP once bound to p97, but at higher concentrations of 
MANT-ATP, one conformation dominates, possibly due to the increased rigidity of the 
enzyme binding hgand at multiple sites in the hexamer (Figure 5.10, Table 5.4). 
Whether the second state, which declines as the concentration of MANT-ATP increases, 
represents a productive state in the mechanism remains to be seen. It will be fascinating 
to carry out ATPase assays at these concentrations of MANT-ATP to see how the rate 
of ATP hydrolysis responds to the concentration of MANT-ATP. 
5.6.2 The location of MANT-ATP binding 
To determine the location of MANT-ATP binding. Walker A mutations were used to 
decrease the affinity of MANT-ATP binding and potentially also the association rate. 
As before, equimolar amounts of MANT-ATP and protein were rapidly mixed and 
single site global fits used to determine the association and dissociation constants from 
total fluorescence intensity and anisotropy data (Figure 5.11, Table 5.5). Each value 
presented is an average of data from at least three different preparations of protein. 
The Walker A mutants differ with respect to ADP pre-bound to the D1 domain, K251A 
and K251A-K524A do not have ADP pre-bound whereas K524A does have ADP pre-
bound. Because the presence of ADP in the D1 domain appears to alter the rate of 
MANT-ATP association, K524A binding to MANT ATP was compared directly with 
wildtype p97 with ADP pre-bound whereas K251A and K251A-K524A binding to 
MANT-ATP was compared with apyrase treated p97. Mutation of the D2 domain 
(K524A) decreased the rate of association of MANT-ATP indicating that MANT-ATP 
may bind to this domain (K524A k, = 0.25, SD = 0.1; wildtype p97 k, = 0.7, SD = 0.5) 
(Figure 5.11b). Comparing K251A p97 to apyrase treated p97, both of which have little 
ADP pre-bound in the D1 domain, there is no decrease in the rate of association of 
MANT-ATP but instead a small increase (K251A k, = 3.7 M"'s"', SD = 0.6, n = 3) 
(Figures 5.11a). When p97 was mutated in both D1 and D2, which also has little ADP 
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Figure 5.9 Titration of the concentration of MANT-ATP binding to wildtype p97 with ADR present or removed from the D1 domain 
a. Plots of tfie residuals of fits to MANT-ATP binding to apyrase treated p97. Tfie top graph describes a molar ratio of one sixth MANT-ATP to p97 and the bottom graph describes equimolar MANT-ATP to 
p97. The dashed line is the 1 site model, dotted line the 2 site model and the continuous line is the 1 site 2 state model. Residuals are plotted on a logarithmic scale to emphasise the difficulties in fitting well 
to early data. 
b. & c. Anisotropy and fluorescence intensity data of apyrase treated p97 (b.) and untreated p97 (c.) binding to one sixth concentration of MANT-ATP (top graph, blue fit) and equimolar MANT-ATP (bottom 
graph, red/green fit). Anisotropy and fluorescence intensity data are fitted to 1 site 2 state global fits. Data from intermediate MANT-ATP concentrations is shown in Figure 5.10 and Table 5.4. 
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Figure 5.10 Rate constants of MANT-ATP binding to apyrase treated and untreated wildtype p97 at different MANT-ATP concentrations 
a. & b. Apyrase treated and untreated wildtype p97 was rapidly mixed with different concentrations of MANT-ATP and data fitted to a one site, two state model. Ttie first association rate constant (ki) is 
shown in open circles and the second event rate constant (kg) is shown as filled circles for apyrase treated p97 (a.) and non-apyrase treated p97 (b.). Results of fits are shown on fable 5.4. 
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Figure 5.11 Walker A mutants binding to equimolar MANT-ATP 
a. K251A p97 binding to equimolar MANT-ATP. Representative anisotropy data (black dots) and total fluorescence intensity data (grey dots) are fitted to a 1 site global model (green line) 
b. K524A p97 binding to equimolar MANT-ATP. Representative anisotropy data (black dots) and total fluorescence intensity data (grey dots) are fitted to a 1 site global model (blue line) 
c. K251A K524A p97 binding to equimolar MANT-ATP. Representative anisotropy data (black dots) and total fluorescence intensity data (grey dots) are fitted to a 1 site global model (teal line) 
d. Comparison of anisotropy data of all three Walker A mutants (labelled as before). Note in particular the K251A-K524A maximal anisotropy is below 0.2 whereas the K251A anisotropy is close to 0.3, 
indicating that there is a significant proportion of MANT-ATP not bound to K251A-K524A. 
Tables 5,4 Fitting results from the titration of the concentration of MANT ATP relative to p97 
Apyrase treated p97 
Molar ratio 
(MANT-ATP:D97') k 1 (M-'s"') k. , (s ') k 2(s ' ) k j O r ' ) ^^ m^ax2 AnisOnun Anisomax 
1:6 1.40 5x10 &85 3x10^ 19 53 63 0.092 &333 
2:6 1.55 3x10"" &84 2x10? 34 99 115 0.086 0.337 
3:6 1.63 9x10"'^ 0.75 2x10? 53 161 181 0.034 &339 
4:6 1.74 5x10'° &83 Ix lC^ 71 214 235 &038 0342 
5:6 2J2 3x10'" 0.61 2x10'? 49 170 177 0.012 0326 
6:6 1.92 2x10''^ &43 7x102 65 222 231 0.000 0330 
Untreated p97 
Molar ratio 
fMANT-ATP:D97) k k.] (s ') k 2(s') I n t r n i n I ^ f t m a x 2 AnisOmin A n i s O m a x 
1:6 0.95 1x10"' &66 3x10-2 22 54 59 0.128 0.321 
2:6 0.97 8x10* 0.54 7x10-3 37 96 105 0.095 0322 
3:6 1x10^ 0.44 5xlC^ 57 156 161 0.085 0324 
4:6 &88 8x10"* 0.47 l x l ( ^ 72 197 214 0.076 0325 
5:6 1.21 7x10* 0.12 l x l ( ^ 57 155 163 0.073 0.310 
6:6 1.09 IxlO"* 032 9x10^ 53 154 162 0.057 0313 
The concentration of MANT ATP relative to p97 was titrated for both apyrase treated and untreated p97 (the concentration of p97 remained constant). Total fluorescence Intensity data and anisotropy data 
was fitted to the 1 site, 2 state model. The two states are modeled to each have different Intensity increase, hence two intmax. 
Table 5.5 Stopped flow measurements of Walker A mutants binding to 
equimolar MANT-ATP 
K251A 
k 1 (M"'s-') k - i ( s ' ) AnisOjYiin AnisOmax 
Mean 3.69 I x i o ' z 2U9 0.019 0.280 
Std Dev 0.59 2xlO-'2 0.34 0.012 0.007 
K524A 
k k . i ( s ' ) AnisOj^ i[^  AnisOj^ jjjj 
Mean I x i o ' z 2.15 0.115 0.290 
Std Dev 0.10 2xlO-'2 &26 0.019 0.013 
K251A-K254A 
k k . i ( s ' ) AnisOmin AnisOmax 
Mean 3.61 SxlO'" L82 0.014 0.199 
Std Dev 0.51 SxlO'" 0.16 0.013 0.021 
Total fluorescence Intensity (Int) and anisotropy (AnIso) data from three experiments were fitted to the 1 site binding 
model and the results averaged. 
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pre-bound, the rate of association also didn't decrease (K251A-K524A ki = 3.6 M''s' ' , 
SD = 0.5, n = 3) (Figure 5.11c, Table 5.5). 
The finding that the rates of binding do not decrease despite both domains being 
mutated to reduce the affinity of nucleotide was unexpected. This could possibly be an 
effect of the experimental setup. The mutations used have been shown to increase the 
equilibrium dissociation constant (Kd) of nucleotides. The equilibrium dissociation 
constant (IQ) is defined as the rate constant of dissociation (k-i) divided by the rate 
constant of association (ki). While the setup measures association rates well, the 
dissociation rates are poorly defined. It is plausible that these mutations act through 
increasing the rate of dissociation of the nucleotide by reducing the amount of 
interactions between the nucleotide and protein but have little effect on the rate of 
association. To test this, MANT-ATP dissociation as well as association experiments 
could be performed. However, early trials of MANT-ATP displacement experiments 
suggest that dissociation is complex and composed of multiple phases. An alternative 
possibility is that there is a degree of non-specific binding especially as MANT moiety 
has hydrophobic chemistry. 
Interestingly, the maximal anisotropy of MANT-ATP bound to K251A-K524A was 
markedly reduced by over a third when compared to wildtype apyrase treated p97 
(K251A-K524A AnisOmax = 0.2, SD = 0.02; wildtype apyrase treated AnisOmax = 0.31, 
SD = 0.017). This latter finding could be a consequence of three factors: 
1. K251A-K524A p97 takes on a very different conformation upon MANT-ATP 
binding compared to wildtype p97. This would reduce the maximal anisotropy 
when MANT-ATP is bound. This seems unlikely as the rotational speed would 
need to increase significantly leading p97 to behave like a protein of much lower 
molecular weight (similar to a p97 hexamer of just N and D1 domains). 
2. The fluorescence increase upon MANT-ATP binding may be reduced in the 
mutant compared to wildtype p97. This is not the case as the ratio between the 
maximum and minimum fluorescence intensity is similar to K251A p97 
(K251A-K524A ratio = 1.82; K251A ratio = 2.2). 
3. If the amount of MANT-ATP binding sites available is reduced by the 
mutation, there will be an increased signal from the unbound population with 
fast rotational times leading to a decrease in the maximal anisotropy. This could 
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be tested by decreasing the concentration of MANT-ATP to reduce the free 
population, which should lead to an overall increase in maximal anisotropy if 
this option is true. 
The third suggestion indicates that addition of the K524A mutation to K251A (i.e. 
K251A-K524A) reduces significantly the amount of binding sites available to MANT-
ATP suggesting that a significant proportion of MANT-ATP binds to D2. 
Further supporting evidence of MANT-ATP binding to D2 was provided when the 
ATPase activity of D1 and D2 was reduced using Walker B mutations (Section 1.5.3.1). 
MANT-ATP hydrolysis assays were carried out as previously outlined. These results 
showed that when ADP was bound to the D1 domain, hydrolysis could occur in both 
mutants but was slower in the D2 E578Q mutant (Figure 5.12). This suggests that the 
bulk of ATPase activity may occur in the D2 domain implying that MANT-ATP must 
bind to the D2 domain too. 
These results do not eliminate the possibility of MANT-ATP also binding to the D1 
domain. To further refine the location of MANT-ATP binding, there are several 
experimental avenues that could be explored. Firstly, instead of reducing nucleotide 
binding in D2 by Walker A mutant, p97 could be modified by NEM (Section 1.6.3). 
This selectively oxidises a cysteine residue in the D2 active site preventing ATP 
hydrolysis from this site presumably by impeding nucleotide binding. Placing a NEM 
molecule in the D2 active site rather than removing an interacting residue may reduce 
MANT-ATP association more effectively. A second method of determining the location 
of MANT-ATP binding could utilise three tryptophan residues in D1 and D2. A 
previous study has already monitored nucleotide binding to the D2 domain through 
decreases in fluorescence signal from one tryptophan molecule (Wang et al., 2003). 
Early trials indicate that there is a strong fluorescence resonance energy transfer (FRET) 
signal between these tryptophan molecules and MANT-ATP. If the FRET signal is 
mapped to one of these tryptophan molecules, it will not only confirm the location of 
MANT-ATP binding but also give a non-intrusive method to observe dynamic changes 
in p97 in real-time throughout the ATP hydrolysis cycle, a truly exciting prospect. 
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Figure 5.12 MANT-ATP hydrolysis by Walker B mutants 
Equimoiar MANT-ATP and p97 Walker B mutants were assayed for ATPase activity. Walker B mutation of the D1 domain (E305Q) is shown in red circles and Walker B mutation of the D2 domain (E578Q) 
is shown in green squares. 
Chapter 6 
Discussion 
6.1 Introduction 
p97 AAA ATPase has generated much interest over the last ten years not least because 
of its enigmatic structure and function. Key to p97s proposed function is conformational 
change in response to nucleotide binding and/or hydrolysis. However, as a p97 hexamer 
has twelve active sites, there are many potential mechanisms by which these sites may 
operate to achieve conformational change but little evidence to discriminate between 
these mechanisms. Many structural studies have demonstrated a wide range of 
conformations that p97 may sample in the presence of different nucleotides but there is 
little agreement between apparently analogous structures. Furthermore, the comparison 
of crystallographic structures with EM and SAXS structures is limited because there is 
no specific information identifying the species of nucleotide bound at each site in the 
lower resolution studies. 
This study has sought to understand the basic enzymatic properties of p97s twelve 
active sites in order to inform discussions of the mechanism of p97. The dissociation 
constants and stoichiometry of binding of substrate analogue, ATPyS, and product, 
ADP, have been determined to the D1 and D2 groups of active sites using equilibrium 
measurements. By making preliminary kinetic measurements, this study has begun to 
probe the dynamics of binding and hydrolysis of ATP. 
First, I shall provide an overview of the experimental data in the context of the 
published information about the biochemistry of p97 and then go on to discuss the 
mechanisms proposed for p97 and selected other AAA+ ATPases before venturing my 
own ideas of the mechanism of p97. 
6.2 Overview of biochemical data 
The most detailed information to date regarding what nucleotides may bind to p97s D1 
and D2 domains comes from crystallographic structures. These show at close to atomic 
resolution the identity of nucleotides bound at a particular binding site and in the case of 
the less flexible D1 domain, the interactions made with the protein. However, it is 
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unclear whether these accurately represent p97 in solution or are instead the most 
conformationally stable forms of p97. Limited characterisations of aqueous p97 have 
been published but there are no quantitiative nucleotide binding experiments using p97 
in which the starting state has been properly assessed. For the first time, this study 
systematically characterises the nucleotide binding properties of the D1 and D2 domains 
(Summarised in Tables 6.1-4). These will be discussed prior to going on to discuss 
progress in understanding the passage of p97 through the catalytic cycle. 
The binding properties of the D1 domain 
All crystallographic structures of p97 have shown ADP bound to the D1 domain 
(DeLaBarre and Brunger, 2003, , 2005; Dreveny et al, 2004; Huyton et al, 2003; 
Zhang et al., 2000). Two groups denatured p97 and tested for ADP release but only one 
group identified ADP as present and didn't identify what domain it was present in 
(Davies et al., 2005; Wang et al., 2003b). The work presented here identifies ADP as 
pre-bound to p97 and shows it is bound to the D1 and not the D2 domain. 
Quantification of the amount of ADP pre-bound to the D1 domain showed that almost 
all D1 sites were occupied with ADP (0.9 molecules of ADP per protomer or 5.4 
molecules of ADP per hexamer). 
To quantify the affinity of ADP for the D1 domain, two methods were used. Firstly, a 
high affinity fluorescent ADP analogue was used to compete with ADP for binding to 
the D1 domain and the extent of binding assessed by fluorescence anisotropy 
measurements. Secondly, ADP binding to vacant D1 sites (arising from the small 
amount of ADP that dissociates from D1 during the purification process), was detected 
by ITC. Both techniques gave a dissociation constant for ADP to D1 of around 1 p,M. 
The binding profiles showed no form of cooperativity in binding. To test whether 
binding was cooperative when more D1 sites per hexamer were available, p97 was 
apyrase digested to remove ADP from D1 and ITC binding experiments repeated. There 
was no significant alteration in dissociation constant as the amount of vacant sites was 
increased. When p97 was almost empty of ADP (0.2 molecules ADP per protomer; 1.2 
molecules ADP per hexamer), the dissociation constant was 0.7 pM, well within the 
range of error of previous measurements. (ADP binding to the D1 domains is 
summarised on Table 6.1) 
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Table 6.1 A summary of the ADP binding properties of the D1 domain 
Feature Evidence Reference 
ADP binds tightly to the D1 domain All crystal structures show ADP bound to the D1 domain 
HPLC analysis shows ADP in p97 preparations 
Heat denaturation experiments show ADP pre-bound to the 
D1 domain 
ITC oqjeriments show a high affinity ADP binding site that 
is removed by K251A 
BODIPY-ADP binds with high affinity to wildtype p97 but 
with low affinity to K251A 
(DeLaBarre and Brunger, 2003,, 2005; Dreveny et al., 2004; 
Huyton et al., 2003; Zhang et al., 2000) 
(Davies et al., 2005) 
Section 3.5 
Section 4.3.2 
Sections 4.2.3 and 4.2.3 
The dissociation constant of ADP to the D! domain is 1 )j,M Section 4 
ADP can bind to every D1 site in the hexamer 
simultaneously 
Crystal structures show full occupancy of ADP in D1 
domains 
Heat denaturation experiments show that following 
purification, around 90 % of D1 sites are pre-bound to ADP. 
ITC experiments demonstrate the remaining vacant D1 sites 
may be filled with ADP 
(DeLaBarre and Brunger, 2003,, 2005; Dreveny et al., 2004; 
Huyton et al., 2003; Zhang et al., 2000) 
Section 3.5.1 and 4.3.2 
ADP binds non-cooperatively to the D1 domain The dissociation constant of ADP binding to D1 is 
independent of the number of available sites 
Section 4.3.2 
No published studies have shown any nucleotide species other than ADP bound to the 
D1 domain and ATPase activity profiles of p97 mutants have suggested that little ATP 
hydrolysis is contributed by the D1 domain (Song et al, 2003). For the first time, this 
work shows that ATP analogue, ATPyS, can bind to D1 with relatively high affinity. 
ITC measurements of ATPyS binding to p97 mutated to not bind nucleotide in the D2 
showed that ATPyS can compete with ADP for binding to D1 and has a dissociation 
constant of 2 p.M. The stoichiometry of ATPyS binding to D1 was shown by this 
experiment to be 1:1, indicating that like ADP, ATPyS can bind to all active sites in the 
D1 domain. (ATP binding to the D1 domains is summarised on Table 6.2.) Importantly, 
when ATPyS competes with ADP for binding to the D1 domain, the dissociation 
constant of pre-bound ADP remained consistent with previous measurements 
suggesting that ATPyS binding to the D1 domain does not alter the ADP binding 
properties of Dl. 
The binding properties of the D2 domain 
In contrast to the Dl domain, the D2 domain has been previously shown to bind to ADP 
and analogues of ATP and the transition state in crystal structures (DeLaBarre and 
Brunger, 2003, , 2005). In solution, ADP and ATP have been shown to bind to D2 but 
the stoichiometry and affinity have not been quantified (Wang et ai, 2003b). 
ITC experiments saturating all ADP binding sites in wildtype p97 showed that ADP had 
comparatively low affinity for the D2 domain. As ITC is poorly suited to low affinity 
interactions, estimates of the dissociation constant were around 50 fj.M and the 
stoichiometry is poorly determined. Crystal structures indicate though that the 
stoichiometry is likely to be 1 molecule of ADP per D2 domain (ADP binding to the D2 
domains is summarised on Table 6.3). 
The binding of ATPyS to D2 was also determined by ITC using p97 mutated to reduce 
the affinity of Dl. This showed that D2 binds ATPyS with a similar dissociation 
constant to Dl, around 2 p.M. This finding allowed affinities of Dl and D2 for ATPyS 
to be assumed to be the same allowing a complex competition experiment using 
wildtype p97 with ADP pre-bound to the Dl domain to be analysed. The competition 
experiment was consistent with a dissociation constant of ADP to Dl in the range of 
previous measurements, confirming that ATPyS bound to D2 does not alter the ADP 
binding properties of Dl. 
167 
Table 6.2 A summary of the ATP binding properties of the D1 domain 
Feature Evidence Reference 
A TP-like molecules can bind to the D1 domain Mutating the D1 domain alters the ATPase activity ofp97 (DeLaBarre et al., 2006; Song et al., 2003; Ye et al., 2003) 
Mutating the D1 domain alters the ATPase activity ofp97 Section 3.4. 
Increasing concentrations of ATPyS causes BODIPY-ADP 
release from D1 in a process that is not significantly altered Sections 5.2.2 and 5.4.1 
by K524A mutation 
ATPyS can displace A DP fromDl in K524A ITC 
competition experiments 
Wildtype ITC competition experiments are consistent with 
displacement of A DP bound in D1 by ATPy S 
The dissociation constant of ATPy S to D1 is 2 |iM 
Section 5.3.1 
Section 5.4.2 
Sections 5.3.1 and 5.4.2 
ATPy S can bind to every D1 site in the hexamer The stoichiometry of ATPy S binding to the D1 domain of Section 5 31 
simultaneously K524A is Iperprotomer 
Table 6.3 A summary of the ADP binding properties of the D2 domain OJ CD 
Feature Evidence Reference 
ADP binds with low affinity to the D2 domain ADP is not pre-bound to the D2 domain Section 3.5 
ITC experiments show a low affinity binding site that is not removed by K251A Section 4.3.3 
The dissociation constant of ADP to the 02 domain is approximately 50 |iM Section 4.3.3 
ADP binds to all D2 domains simultaneously Crystal stmctures show full occupancy of ADP in the D2 domain (DeLaBarre and Brunger, 2005) 
The stoichiometry of ADP binding to the D2 domain in K251A p97 is consistent 
with 1 ADP molecule binding per D2 domain 
Section 4.3.3 
This competition gave a surprising stoichiometiy for ATPyS binding to D2 of 0.6, 
equivalent to 3.4 molecules of ATPyS per D2 ring (9.4 molecules of ATPyS per 
hexamer). A stoichiometry of less than 6 ATP-like molecules binding to the D2 ring has 
previously been indicated by two other studies. One study showed that an ATP 
molecule conjugated to crosslinking group (BzATP) bound to p97 with a stoichiometiy 
of 2.23 (Zalk and Shoshan-Barmatz, 2003). A crystallographic structure of p97 bound to 
transition state analogue ADP-AIF3 was also shown to have unequal occupancy of the 
AIF3 moiety with full occupancy in two D2 domains, partial occupancy in two other 
domains and none in the final two domains (DeLaBarre and Brunger, 2005). (ATP 
binding to the D2 domains is summarised on Table 6.4) 
p97 through the catalytic cycle 
Three separate studies have tested the effects of Walker A and Walker B mutations on 
ATP hydrolysis of p97 under steady state conditions with each giving different profiles 
of activity (DeLaBarre et al, 2006; Song et al, 2003; Ye et al, 2003). These 
differences could be accounted for by differences in buffer conditions, method of assay 
and also slight variations in the identity of mutation. In this work, the activity profile of 
the Walker A and B mutants showed that both Walker A and B mutation of D1 had little 
effect upon overall activity compared to mutation of D2 which had a dramatic effect 
upon overall activity. These results were the most similar to those of Song and 
coworkers who interpreted this as 1)1 contributing low rates of ATP hydrolysis relative 
to D2 which showed high rates of hydrolysis (Song et al., 2003). 
No published work has observed the hydrolysis of ATP by p97 under single turnover 
real-time conditions. Here, preliminary kinetic experiments have shown that MANT-
ATP can associate with p97 and the rate of association appears to be modulated by the 
presence of ADP in the D1 domain. The balance of evidence suggests that MANT-ATP 
at these non-saturating quantities binds predominantly to the D2 domain because: 
1. ATPyS competition experiments in wildtype p97 (measured by ITC) showed 
that ADP displacement occurred at higher concentrations of ATPyS 
2. In MANT-ATP hydrolysis experiments, under single turnover conditions 
Walker B mutation of D2 led to a larger reduction in the rate of hydrolysis than 
the analogous mutation in D1 
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Table 6.4 A summary of the ATP binding properties of the D2 domain 
Feature Evidence Reference 
ATP-like molecules can bind to the D2 domain Crystal structures of p97 show AMPPNP and ADP-AIF3 bound to 
the D2 domain 
Added nucleotide causes increases in tryptophan fluorescence that is 
abrogated by Walker A mutation of the D2 domain 
Mutating the D2 domain alters the ATPase activity of p97 
Mutating the D2 domain alters the ATPase activity of p97 
ITC experiments show the affinity of ATPyS binding to K251A is 
decreased by K251A-K524A 
The dissociation constant of ATPyS to the D2 domain is 2 |^M 
Wildtype p97 binds to ATPyS with a stoichiometry greater than 1 
suggesting that more than 1 AAA domain binds to ATPyS 
Mutation of the D2 domain in addition to the D1 domain alters 
MANT-ATP binding properties 
MANT-ATP hydrolysis is decreased more by mutation in the D2 
domain than the D1 domain 
(DeLaBarre and Brunger, 2003,, 2005) 
(Wang et al., 2003b) 
(DeLaBarre et al., 2006; Song et al., 2003; Ye et al., 
2003) 
Section 3.4.2 
Section 5.3.2 
Sections 5.3.2 and 5.4.2 
Section 5.4.2 
Section 5.6.2 
Section 5.6.2 
The D2 domains of wildtype p97 may not bind 
ATP-like molecules equally 
There is unequal occupancy of ADP-AIF3 in the D2 domain of 
crystal structures 
BzATP crosslinked with a stoichiometry of 2.23 to endogenous p97 
Wildtype ITC competition experiments suggest that ATPyS may 
bind to only 3-4 of the 6 D2 active sites per hexamer 
(DeLaBarre and Brunger, 2005) 
(Zalk and Shoshan-Barmatz, 2003) 
Section 5.4.2 
The presence of the K251A mutation and/or 
ADP bound to D1 may cause all D2 domains to 
bind ATPyS equally 
The stoichiometry of ATPyS binding to K251A p97 D2 domain is 1 
per protomer or 6 per hexamer 
Section 5.3.2 
3. Measurement of MANT-ATP association with K251A p97 was most hke 
apyrase treated p97 whereas both Walker A mutants together (K251A-K524A) 
led to a large reduction in the amount of MANT-ATP bound. 
As the single Walker A mutation of D2 (K524A) showed similar ATP binding to 
wildtype p97 with ADP pre-bound, competition between MANT-ATP with ADP in D1 
cannot be excluded. However, a speculative interpretation of the results could be that 
the faster rate of MANT-ATP binding when p97 is empty of ADP in D1 could reflect a 
conformationally more flexible binding site whereas the rigidity introduced into the 
protein by ADP binding in D1 could make the D2 binding site more inaccessible. 
As the concentration of MANT-ATP was reduced below equimolar, there was an 
unusual alteration in the mechanism of binding, as the profile of association no longer 
fitted to a one site binding model due to two phases of fluorescence increase. This was 
modelled as two individual fluorescence states of MANT-ATP associated with one 
binding event but this interpretation of the results is again speculative 
Summary 
In summary, my results show that ADP binds with higher affinity to D1 than D2 but 
ATPyS binds with similar affinity to both domains. These results also show that ADP or 
ATPyS may bind simultaneously to both domains although relatively high 
concentrations of ADP are necessary for saturation of D2. Interestingly, ATPyS binding 
to D1 or D2 does not alter the dissociation constant of ADP in Dl. Unexpectedly, when 
ATPyS binds to the D2 domain of wildtype with p97 ADP pre-bound only 3 to 4 of the 
6 possible D2 sites is available for ATPyS binding. Preliminary kinetics experiments 
suggest that ADP in Dl may alter rate of binding to D2, and there may be a complex 
effect when the concentration of MANT-ATP is reduced to below equimolar but these 
later results remain inconclusive. 
Many mechanisms have been suggested for p97 based on limited experimental 
evidence. These results allow for the first time, discrimination between these 
mechanisms. The following section discusses the mechanisms proposed for p97 in the 
light of those proposed for other AAA+ ATPases. 
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6.3 The mechanisms proposed for p97 and other AAA+ 
ATPases 
6,3.1 The mechanisms proposed for p97 
The functional form of p97 is a stable hexamer with a total of twelve active sites 
arranged in two stacked rings of six. Due to the clear differences between the D1 and 
D2 ring, a mechanism in which all twelve sites simultaneously bind ATP, hydrolyse it 
and release ADP has not been proposed. The simplest mechanism of action of the active 
sites is that all twelve behave as individuals, uninfluenced by neighbouring protomers or 
opposing domain. This stochastic process of action is however at odds with the idea that 
functionally p97 is likely to be a motor protein, requiring a defined motion to be made. 
This instead favours an ordered mechanism of nucleotide binding and hydiolysis 
leading to a specific conformational change. As a consequence, all mechanisms 
proposed for p97 to date have envisaged each AAA ring to act in concert with all six 
active sites in each ring in the same state. This is in line with predictions from 
crystallographic structures (DeLaBarre and Brunger, 2005; Huyton et ai, 2003). The 
mechanisms proposed vary with respect to whether the D1 and D2 cooperate with each 
other to bind and hydrolyse ATP. 
Mechanisms in which D1 and D2 cooperate 
The first mechanism suggested for p97 was the Ratchet model, which was based on a 
comparison of the N-Dl crystal structure bound to ADP and the NSF D2 domain 
structure bound to AMPPNP (Zhang et al, 2000). This revealed a rotation of the 
structures with respect to each other when superimposed. It was suggested that 
rotational motion was generated by hydrolysis by the D1 and D2 domains passing 
through the ATPase cycle in a negatively cooperative manner (i.e. hydrolysis by one 
domain leads to rotational motion, and the formation of ADP in this domain allows 
dissociation of ADP from the opposing domain and binding of ATP to it) (Figure 6.1a) 
(Zhang et al, 2000). This elegant model was a good interpretation of limited data 
available at the time of its proposal. However, more recently it as been shown that the 
NSF domain used for the comparison is likely to be responsible for a minor contribution 
to the ATPase activity, so may restricted in its relevance (Matveeva et al., 1997) 
(Section 6.3.2). 
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6.1a 6.1b 
D2 
D1 
Figure 6.1 Cooperative mechanisms of ATP hydrolysis by p97 
a. The ratchet mechanism proposed by Zhang and coworkers (Zhang eta!., 2000). ATP hydrolysis in one domain is coupled to ADP release in the opposing domain. 
b. The cooperative mechanism proposed by Ye and coworkers (Ye et a/., 2003). ATP hydrolysis in D1 and D2 is coupled, but 01 and 02 differ slightly in their requirements. 
Later experimental evidence has supported a cooperative model. ATPase activity assays 
have been fitted to cooperative equations giving Hill coefficients of 1.2 and 1.5 
(DeLaBarre et al., 2006; Song et al., 2003). Although this could be indicative of 
cooperativity between the D1 and D2 domains or around the D1 or D2 rings. ATPase 
activity assays of Walker A and B mutants showed in one study that all combinations of 
mutations resulted in zero activity p97 except when the D1 domain carried the Walker B 
mutation which had 50 % of wildtype activity (Ye et al., 2003). This led the authors to 
conclude that ATP hydrolysis in D2 requires nucleotide binding in D1 but hydrolysis in 
D1 is dependent upon both nucleotide binding and hydrolysis in D2 (Figure 6.1b) (Ye et 
al., 2003). (It must be noted that similar experiments by other groups have yielded 
different results.) Furthermore, modelling of motions of the p97 hexamer by quantised 
elastic deformation model indicated that D1 and D2 could negatively cooperate 
allowing hydrolysis in only the D1 or D2 ring at once (Beuron et al., 2003). 
Cooperation between the D1 and D2 could occur through the unstructured D1 and D2 
linkers. This linker contacts the adenine binding pocket of the D2 active site through 
hydrophobic residues and contains a pair of conserved glycine residues that may act as 
pivotal points through which conformational change could be transmitted (Smith et al., 
2004; Zhang et al., 2000) 
In contradiction to this model, all crystal structures of p97 have shown ADP pre-bound 
to the D1 domain including when transition state analogue ADP-AIF3 and ADP are 
bound to the D2 domain (DeLaBarre and Brunger, 2003, , 2005; Dreveny et al., 2004; 
Huyton et al, 2003; Zhang et al., 2000). This suggests that ATP hydrolysis in D2 may 
not release product from D1 as predicted by the ratchet model. 
Mechanisms in which D1 and D2 are independent 
The D1 and D2 rings while interlinked by flexible linkers and in close proximity may 
not necessarily cooperate with each other throughout the hydrolysis cycle. Despite the 
homology between the D1 and D2 rings there are some clear differences between the 
biochemical and structural properties of D1 and D2 domains that suggest that if they are 
independent they do not have equal properties. In particular, ADP is observed bound to 
D1 in all crystallographic structures, suggesting that ADP binds to D1 with very high 
affinity (DeLaBarre and Brunger, 2003, , 2005; Dreveny et al., 2004; Huyton et al., 
2003; Zhang et al., 2000). As a consequence, the following mechanism assumes that 
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ADP is bound to the D1 domain throughout the hydrolysis cycle and instead the D2 
domain alone cycles through ATP hydrolysis. 
It was first proposed that the D1 domain was unimportant to the ATPase activity of p97 
as a consequence of ATPase activity assays. Song and co-workers, tested the ATPase 
activity of Walker A and B mutations of p97 in D1 and D2 (Song et al, 2003). This 
showed that with either type of mutation, when the D1 domain was mutated there was 
little alteration in ATPase activity whereas when the D2 domain was mutated, there was 
a large decrease in ATPase activity. This was interpreted as D2 contributing the major 
ATPase activity and placed D1 as a redundant domain that instead is responsible for 
hexamerisation (Song et al, 2003; Wang et al., 2003a). The crystal structures of p97 
agree that D1 appears to form the bulk of the interprotomer contacts and is invariantly 
bound to ADP. The D2 domain in contrast is shown bound to different nucleotides 
suggesting that this domain is the active domain. Figure 6.2 is an interpretation of the 
ideas presented by Song and co-workers and DeLaBarre and Brunger (DeLaBarre and 
Brunger, 2005; Song et al, 2003). 
As the nucleotide states observed in crystal structures support this mechanism, a 
comparison of the structures has led to a description of the motions that may accompany 
it. When the structures of p97 with D2 in different nucleotide states were aligned at the 
D1 a/pdomain, two groups of conformation emerged. The empty and AMPPNP 
structures formed one group and were dubbed pre-activated and ADP-AIF3 and ADP 
formed the other group and were named activated. The differences between the two 
states were small rotations in the N domain, and D l a sub-domain and order-disorder 
transitions in the D1-D2 linker and D2a sub-domain. However, these changes were 
small and the interpretation limited by differences in crystallisation conditions, 
asymmetric units and space groups. 
While this model fits some of the available data well, it doesn't explain why the D1 
domains have well conserved residues in the active site rather than evolving as a 
degenerate domain. This model also does not account for Hill coefficients greater than 
1, observed in some ATPase assays. 
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6.2 
Figure 6.2 The non-cooperative mechanism of ATP hydrolysis by p97 
A composite of ideas presented by Song and coworkers and DeLaBarre and Brunger (DeLaBarre and Brunger, 2005; Song et a/., 2003). ADP remains bound to the D1 domain throughout while the D2 
domain hydroiyses ATP. There is no proposed cooperativity between the D1 and D2 domains. 
Mechanisms in which D1 and D2 are independent but there is cooperation 
within the D2 domain 
While D1 and D2 domains may not cooperate with each other, the D2 ring may exhibit 
cooperativity. A possible mechanism for this cooperativity is through the SRH arginine 
fingers. The crystal structure of the D1 domain has shown that each protomer 
contributes two arginine residues to the neighbouring active site which are predicted to 
interact with the y-phosphate and assist in hydrolysis (Ogura et al, 2004; Zhang et al, 
2000). The flexibility of the D2 domain has made it difficult to unambiguously assign 
the positions of these residues in the D2 domain but mutational analysis has indicated 
that they are crucial for ATPase activity (DeLaBarre and Brunger, 2005; Wang et al., 
2005). 
To test whether the arginine residues mediate cooperation of the D2 active sites in 
hydrolysing ATP, mixed hexamers were made by coexpression of p97 mutated in the 
D2 domain Walker A motif, K524T, and at the SRH arginine residues, R635A or 
R638A (To make K524A, R635A and K524A, R638A hybrid hexamers). All three 
mutations showed almost undetectable ATPase activity individually but the hybrids 
showed 10 % of wildtype activity (Wang et al., 2005). This indicates that the arginine 
residues of K524T are part of the active site of R635A or R638A allowing ATP 
hydrolysis in mixed hexamers. 
A similar study also made mixed hexamers by a different method. Hexamers of K524T 
and wildtype p97 were chemically disassembled and reassembled together. The 
concentration of wildtype protomers was maintained the same but the concentration of 
K524T increased. It was reasoned that if there was no communication between the D2 
active sites, the ATPase activity would remain the same as when no K524T was added. 
Interestingly though, as the concentration of K524T was increased in the mixed 
hexamers ATPase activity declined to 50 % of wildtype when five times the amount of 
K524T p97 was present compared to wildtype p97 (Wang et al., 2003a). 
Both of these experiments suggest that D2 domains do not act independently and may 
cooperate to hydrolyse ATP. An intriguing insight into how this may possibly work was 
shown by a crystal structure of p97 bound to the ATP transition state analogue ADP-
AIF3 which showed unequal occupancy of AIF3, suggestive of a rotational mechanism 
of ATP hydrolysis (DeLaBarre and Brunger, 2005). This view of p97s action is also 
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supported by incomplete saturation of p97 by BzATP molecules in crosslinking 
experiments (Zalk and Shoshan-Bannatz, 2003). 
Summary 
In conclusion, each of these models are supported by limited data, which in some cases 
is ambiguous. Similar mechanisms have been proposed for other AAA+ ATPases which 
share some characteristics with p97 in terms of structure and function. 
6.3.2 The proposed mechanisms of other AAA+ ATPases 
Variations on the three sorts of mechanisms proposed for p97 have been proposed for 
other AAA+ ATPases, of which three have been chosen to illustrate this: NSF, Hspl04 
and ClpX. It must be noted though that these AAA+ ATPases differ in function, 
stability of oligomeric state, whether there are one or two AAA domains or the 
arrangement of AAA tandem domains. So while direct comparisons are impossible, 
they do inform how an ATPase such as p97 may act. 
NSF 
NSF is a eukaryotic protein (Sec 18 in S. cerevisiae) which shares 20 % sequence 
identity with p97 and functions in almost all vesicular transport events. It has been 
shown to associate with SNAP-SNARE complexes and, using ATP hydrolysis, to prime 
them for membrane fusion by separating the SNARE protein complex (Section 1.2.2). 
NSF shows similar domain composition to p97, containing an adaptor binding N 
domain followed by tandem AAA domains also named D1 and D2 (although the 
arrangement of D1 and D2 may not be head to tail as observed for p97) (Furst et al, 
2003). The oligomerisation state of NSF is less stable than p97 with trimer and hexamer 
forms reported dependent upon conditions (Matveeva et al, 1997; Whiteheart et al., 
1994). 
When nucleotide binding affinities of D1 and D2 were measured using nitrocellulose 
filter binding assays, two tiers of binding sites were revealed, a low affinity site in D1 
(Kd ATP = 15-20 pM; IQ ADP 140 |j,M) and a high affinity site in D2 (Kd ATP = 30-40 
nM; Kd ADP 2 |^M) (Matveeva et al., 1997). The D1 and D2 domains are essentially 
independent of each other as a Hill plot showed there was no cooperadvity present 
between them (Matveeva et al., 1997). As could be predicted from the relative affinities, 
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analysis of ATPase activity of the D1 and D2 domains showed that the DI domain 
contributed the majority of ATPase activity (Nagiec et al, 1995; Wliiteheart et al., 
1994). The D2 domain by comparison has little ATPase activity and is thought to be 
responsible for maintenance of the oligomeric state (Matveeva et al., 1997). It was 
shown through hybrids of wildtype and D1 nucleotide binding mutant that all protomers 
must be wildtype for any activity to be detected, suggesting that ATP hydrolysis 
requires full occupancy of all Dl domains in the oligomer (Whiteheart et al., 1994). 
Crystal structures of the D2 domain have been determined with ATP and AMPPNP 
bound, the low activity of the D2 domain underscored by the presence of ATP in the 
active site even after the ten days necessary for crystal growth (Lenzen et al., 1998; Yu 
et al., 1998). The atomic structure of the Dl domain has remained elusive perhaps 
because of the high degree of conformational motion it can undergo, however, the 
mechanism by which it modulates SNARE disassembly is better defined (Hanson et al., 
1997). The presence of ATP in the low affinity Dl site allows the adaptor a-SNAP to 
bind, causing stimulation the ATPase activity of NSF fivefold (Matveeva et al., 1997; 
Steel and Morgan, 1998). Hydrolysis of ATP leads to separation of the SNARE 
complex in a motion propagated through Dl trans elements and allowing NSF to then 
dissociate (Matveeva et al., 2002). 
The understanding of the action of NSF has informed discussion of the ATPase 
mechanism of p97 and inspired the non-cooperative model of p97 action. There are 
many superficial similarities between the two ATPases but more differences upon 
detailed examination (Brunger and DeLaBarre, 2003). 
Both ATPases bind adaptors through the N domain and are thought to use 
conformational change in response to ATP hydrolysis to facilitate membrane fusion. 
The adaptor binding sites on the N domain though are likely to be different as the NSF 
aSNAP site is buried on the p97 N domain (Dreveny et al., 2004). Where Dl 
contributes the majority of ATPase activity in NSF, it is D2 in p97. This means that 
conformational change in p97 must be transmitted through Dl to have effect upon the N 
domain of p97 whereas NSF need only propagate conformational change from Dl to the 
adjacent N domain. Furthermore, interactions between the Dl and D2 domains are 
likely to be very different if the domain architecture of Dl and D2 is inverted in NSF 
compared to p97 as has been suggested (Furst et al., 2003). 
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Both ATPases have two classes of nucleotide binding sites, a low affinity site that is 
responsible for the bulk of ATPase activity and high affinity site that appears to 
contribute relatively lower ATPase activity. The comparatively more inert domains in 
both cases are stably bound to a nucleotide, apparently ATP in NSF D2 and ADP in p97 
D1 as shown by crystal structures (Lenzen et al, 1998; Yu et al, 1998). The difference 
between occupying nucleotides is revealed through study of relative nucleotide 
affinities, NSF D2 has higher affinity for ATP than ADP whereas p97 D1 has higher 
affinity for ADP than ATP as shown in this study (Matveeva et al, 1997). Interestingly, 
Hspl04 like p97 also has higher affinity for ADP rather ATP in one domain, but a very 
different mechanism has been proposed. 
Hsp104 
Hspl04 is involved in the rescue of protein aggregates such as prions and is found in S. 
cerevisiae and has orthologues in prokaryotes too (ClpB in E. coli) (reviewed by (Lee et 
al., 2004)). Like p97 and NSF, Hspl04 is composed of an N domain and two AAA 
domains, NBDl and NBD2, but has an extraordinarily long linker between NBDl and 
NBD2 which forms an extended coiled coil propeller (Lee et al., 2003). Like NSF, 
HspI04 is can exist in multiple oligomeric states including a stable hexamer. The 
disaggregation properties of Hspl04 have been suggested to be mediated by the large 
relatively rigid linkers acting as a 'molecular crowbar' or alternatively substrate proteins 
may be threaded through the central pore (Lee et al., 2004; Lum et al, 2004)). 
Like both NSF and p97, the two AAA domains of Hspl04 do not have equivalent ATP 
binding and hydrolysis properties. A detailed titration of the effect of ATP 
concentration on hydrolysis rates of Hspl04 revealed that there are two types of active 
sites, a low affinity, high turnover site and a high affinity, low turnover site (Hattendorf 
and Lindquist, 2002b). Mutational analysis show the low affinity site is NBDl and the 
high affinity site is NBD2 (Hattendorf and Lindquist, 2002b). Interestingly, the high 
affinity site has higher affinity for ADP than ATP (Kd ADP = 9 p.M, Kd ATP 69 p,M) 
similar to p97 (Hattendorf and Lindquist, 2002a). Within the AAA rings, nucleotide 
binding to NBD2 is positively cooperative as is ATP hydrolysis in both NBDl and 
NBD2 (Hattendorf and Lindquist, 2002a, 2002b). Additionally, there is also evidence of 
cooperativity between NBDl and NBD2 as mutation of Sensor 1 or 2 of NBD2 
(decreasing ATPase activity and ATP binding in these domains respectively) have 
profound effects on NBDl activity (Hattendorf and Lindquist, 2002a, 2002b). This 
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leads to the suggestion that the nucleotide state of NBD2 (low turnover) may influence 
the rate of NBDl (high turnover) (Hattendorf and Lindquist, 2002b). 
The mechanism of Hspl04 is an example of a cooperative AAA+ ATPase mechanism 
in which there is evidence of cooperation between the two AAA domains and also 
within the AAA rings. Unlike the negative cooperative mechanisms proposed for p97 it 
seems that the nucleotide states of one AAA domain can influence the opposing AAA 
domain but there is no evidence for absolute coordination of them as has been suggested 
for p97 in the Ratchet mechanism. 
ClpX 
ClpX is a prokaryotic protein that unfolds protein substrates through the its central pore 
and feeds them to ClpP for proteolysis (Reviewed by (Zolkiewski, 2006)). It is 
composed of a single AAA domain and forms a homohexamer. 
ATP binding studies of hydrolysis deficient ClpX (containing the Walker B mutation) 
using a nitrocellulose filter binding assay showed positively cooperative binding. ITC 
data revealed an apparent stoichiometry of 3.4 molecules of ATP per hexamer each with 
an affinity of 0.6 (although data was fitted to a model which assumed all sites were 
of equal affinity), similar to the stoichiometry and affinity observed for p97 (Hersch et 
al., 2005). Kinetics of dissociation of ATP from ClpX show that there are two rates of 
dissociation of ATP suggesting that within the ATP molecules that do bind there are 
two classes of sites (Hersch et al., 2005). This led to the suggestion of a symmetrical 
sequential rotary mechanism of ATP hydrolysis in which there are three types of sites, 
two of which are bound to ATP and the third bound to ADP or empty (Hersch et al., 
2005). This form of mechanism would be similar to the binding change mechanism 
proposed for the FiFo ATPase (reviewed by (Boyer, 1993)). 
To test this mechanism, ClpX dimers or trimers were expressed as a single poly-peptide 
and assembled into hexamers. This allowed the construction of many different 
geometric combinations of wildtype ClpX and two ClpX mutants that were hydrolysis 
deficient (and one also lacked conformational change). ATPase assays and substrate 
unfolding/degradation assays showed that many arrangements of ClpX could support 
these properties (Martin et al., 2005). This indicated that a concerted mechanism (all 
six monomers acting at once) or a rotary mechanism with a particular firing order 
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(suggested by the stoichiometry of nucleotide binding) is not necessary for overall 
enzyme activity. 
Instead, the results indicated a probabilistic mechanism in which properties of 
neighbouring protomers influence but do not determine nucleotide binding and 
hydrolysis. This stochastic mechanism allows a more flexible approach to random 
variables, such as how and to which protomer the widely varying substrate proteins may 
interact with, and is suggested to prevent stalling of the mechanism. 
The example of ClpX was chosen to emphasise how other AAA+ ATPases that are 
homohexamers may bind less than six molecules of ATP and illustrate the illusion of 
attractive geometric mechanisms. 
6.4 The mechanism of p97 
A range of mechanisms have been proposed for p97 and other AAA+ ATPases 
containing two AAA rings. These mechanisms differ primarily in whether the two rings 
cooperate to bind and hydrolyse ATP or not. The results presented in this study are the 
first to methodically characterise the nucleotide binding properties of the D1 and D2 
rings of p97 individually and together, giving a unique opportunity to assess the 
consistency of the mechanisms proposed with the properties of the D1 and D2 rings 
(Summarised in Table 6.5). 
Do the D1 and D2 domains cooperate? 
The ratchet mechanism proposes that the D1 and D2 domains negatively cooperate to 
bind and hydrolyse ATP (Figure 6.1a) (Zhang et al, 2000). This mechanism was 
supported by controversial ATPase assay evidence which proposed a similar 
mechanism and molecular modelling which suggested that p97 could undergo 
negatively cooperative motions (Figure 6.1b) (Ye et al, 2003; Beuron et ai, 2003). 
The data presented in this study shows that this form of mechanism is unlikely as both 
cooperative reaction schemes require that the nucleotide binding state of D2 alters the 
binding properties of D1 (the transition between steps 1 and 2 of both mechanisms of 
Figure 6.1b). Specifically, the ratchet mechanism hypothesises that ADP binding to D2 
causes release of ADP from Dl, however, ITC experiments don't support this. In 
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Table 6.5 A summary of the evidence supporting different mechanisms of ATP hydrolysis 
Feature Evidence Reference 
p97 may have an interdomain (between DI and D2) 
cooperative mechanism of A T P hydrolysis 
A T P activity assays have given Hill coefficients of 1.2 and 1.5 
Mutagenesis studies suggest that mutation of one domain alters the activity of 
the opposing domain 
A D P pre-bound to the Dl domain alters the rate of M A N T - A T P association 
(DeLaBarre et al., 2006; Song et al., 2003) 
(DeLaBarre et al., 2006; Ye et al., 2003) 
Section 5.6.1 
D1 and D2 may not cooperate to hydroly se A T P Crystal structures of p97 show AM PPNP, ADP-AIF3 and ADP bound to the 
D2 domain but always ADP bound to the Dl domain 
Mutagenesis studies s u ^ s t that mutation of the Dl domain doesn't 
significantly alter the activity o f D 2 
The dissociation constant of A D P bound to the D1 domain is not altered by 
ATPyS binding to the D2 domain 
The dissociation constant of A D P bound to the Dl domain is not altered by 
ATPyS binding to other D l active sites 
The dissociation constant of ATPyS bound to the D2 domain is the same 
whether A D P is bound to Dl or not 
A D P can bind to D l and D2 simultaneously 
ATPyS can bind to D1 and D2 simultaneously 
(DeLaBarre and Brunger, 2003 , , 2005; Huyton et al., 
2003) 
Section 3.4.3 and (Song et al., 2003) 
Section 5.4.2 
Section 5.3.1 
Sections 5.3.2 and 5.4.2 
Section 4.3 and (DeLaBarre and Brungpr, 2005) 
Sections 5.3.2 and 5.4.2 
p97 may have an intradommn (between D2 pmtomers) activity assays have given Hill coefRcients of 1 ^  and 1.5 
cooperative mechanism of A T P hydrolysis 
Hybrid hexamer studies show a dependence on the neighbouring D2 protomer on 
ATPase activity 
There is unequal occupancy of ADP-AIF3 in the D2 domain of crystal structures 
B z A T P crosslinked with a stoichiometry of 2.23 to endogenous p 9 7 
Wildtype ITC competition experiments suggest that ATPyS may bind to only 3-
4 of the 6 D2 active sites per protomer 
The rate of M A N T - A T P association with p 9 7 varied with M A N T - A T P 
concentration 
(DeLaBarre et al., 2006; Songet al., 2003) 
(Wang et al., 2003a; Wang et al., 2005) 
(DeLaBarre and Brungpr, 2005) 
(Zalk and Shoshan-Barmatz, 2003) 
Section 5.4.2 
Section 5.6.1 
wildtype p97, progressive saturation of the D2 domain with ADP does not cause any 
discemable dissociation event from D1 (Section 4.3.3). When D1 is mutated to have 
similar affinity to D2, D1 appears to bind ADP simultaneously with D2 (Section 4.3.3). 
Similarly, the cooperative mechanism proposed by Ye and coworkers proposes that 
ATP binding to D2 causes dissociation of ADP from Dl. Fluorescence anisotropy 
experiments, though, show that any ATPyS binding to D2 does not cause BODIPY-
ADP dissociation from Dl (Section 5.3.1). Importantly, in wildtype p97 ITC 
competition experiments, the dissociation constant of ADP to Dl does not change in 
response to ATPyS binding in D2 and subsequent binding of ATPyS to D1 is through 
competition with pre-bound ADP (Section 5.3.2). Furthermore, ADP has higher affinity 
for Dl than ATPyS, even when D2 has ATPyS bound (Section 5.3.2). 
While those nucleotide states proposed in the mechanism that require ADP bound to D1 
or ATP bound to both Dl and D2 have been shown to be possible in this work, others 
are less clear (Figure 6.1a, states 1 and 4; Figure 6.1b, states 1 and 2). State 2 of the 
ratchet mechanism, in which ADP is bound to the D2 domain alone is likely to exist as 
a transient state, comprising only a minor population of molecules, as the binding 
affinity of ADP is relatively low (Section 4.3.3). It could be argued that the binding 
affinity of ADP to D2 may be increased when D1 has no ADP bound however this 
seems unlikely because when the amount of ADP bound to Dl was decreased (by 
mutation or apyrase digest), preferential ADP binding to D2 was not observed (Section 
4.3.3). State 3 in both mechanisms has not been directly tested in this study but the 
predicted low affinity of ADP to D2 may also suggest that this could be a minor 
population of molecules. 
The cooperative mechanism presented by Ye and coworkers was based upon ATPase 
activity measurements of p97 Walker A and B mutants. The profile of activity of these 
mutants was controversial as another study by Song and coworkers had shown already 
that mutation of Dl had less effect upon activity than mutation of D2. The results of 
ATPase assays carried out in this work are not consistent with those proposed by Ye 
and coworkers, and instead hke those of Song and coworkers, suggest that Dl may 
contribute significantly less ATPase activity than D2. 
In support of a semi-cooperative mechanism, there is preliminary evidence from 
stopped flow measurements supporting a model in which the nucleotide state of D1 may 
alter the binding properties of D2, reminiscent of the mechanism of Hspl04. When Dl 
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was freed of ADP by apyrase digest, there was an increase in the rate of MANT-ATP 
association compared to when D1 was pre-bound to ADP (Section 5.5.1). This work is 
limited though by the ambiguity surrounding the location of MANT-ATP binding as the 
lines of evidence supporting MANT-ATP binding to predominantly D2 are open to 
doubt. This decrease in rate of association with an increase in ADP concentration could 
therefore represent competition of MANT-ATP with ADP in D1 or alternatively, an 
effect in which ADP bound to D1 makes p97 globally less flexible and so binds MANT-
ATP less rapidly. As currently there is no evidence to suggest that p97 empty of ADP is 
physiologically relevant, this could represent a non-specific effect. 
In conclusion, this work does not support the cooperative mechanisms proposed for the 
major reason that ADP dissociation from the D1 domain has not been shown to be a 
consequence of actions in the D2 domain. In vivo binding partners of p97 may alter the 
properties of D1 allowing ADP to be released although none has yet been identified. It 
also remains formally possible though that the action of hydrolysis in D2 may cause 
ADP dissociation from Dl, a possibility not studied here. Contrary to this though, the 
crystal structure of ATP transition state analogue bound to D2 shows ADP bound to Dl 
(DeLaBarre and Brunger, 2003, , 2005). I, therefore, propose on the basis of current 
evidence that it is most likely that Dl and D2 do not cooperate. To refine the model that 
Dl and D2 are independent further, the ATPase activity of the individual domains must 
be considered. 
ATP hydrolysis by the D1 and D2 domains 
The profile of ATPase activity of p97 Walker A and B mutants in this work supports 
that of Song and coworkers. This suggests that the D2 domain contributes the majority 
of ATPase activity of p97 as mutation of this domain had the greatest impact upon 
ATPase activity whereas Dl mutation had comparatively less (Section 3.4.3). As 
mutation of D1 does have an impact upon overall ATPase activity and ITC binding 
experiments show that ATPyS may bind with relatively high affinity to Dl, the Dl 
domain is not likely to be inert as has been suggested for p97 and the D2 domain of 
NSF (DeLaBarre and Brunger, 2003; Matveeva etai, 1997; Song et al, 2003). 
The suggestion that the D2 domain contributes the majority of activity is consistent with 
the dissociation constants determined for ADP and ATPyS. Substrate analogue, ATPyS, 
binds to p97 with very similar dissociation constants to Dl and D2 however, the 
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product, ADP, binds to D1 with a lower dissociation constant than ATPyS and to D2 
with much higher dissociation constant. This suggests that when ATP is hydrolysed in 
Dl, ADP is likely to remain bound, whereas when ATP is hydrolysed by D2, ADP is 
likely to dissociate more readily. This suggests that the minor ATPase activity of the Dl 
domain is a consequence of product inhibition. At insufficient ATP concentrations to 
compete with ADP in Dl , this domain may be effectively inactive. 
Interestingly, the profile of dissociation constants in p97 has some similarity to Hsp 104. 
Like p97 Dl domain, the high affinity, low turnover site of Hsp 104, NBD2, has higher 
affinity of ADP than ATP (Hattendorf and Lindquist, 2002a). Hsp 104 NBD2 domain 
may not be affected by product inhibition to such a great an extent as p97 though 
because the dissociation constant of ADP is an order of magnitude greater than that of 
p97 Dl domain. 
Cooperativity within the D2 ring 
There are several published studies that indicate that positive cooperativity may exist 
within the Dl and D2 rings. Positive cooperative binding of nucleotide can facilitate a 
concerted mechanism increasing the probability of all sites in an oligomeric protein to 
be in the bound or free state simultaneously. However, other mechanisms may 
coordinate nucleotide hydrolysis, for example arginine fingers protruding into the 
neighbouring active site may synchronise hydrolysis. 
ATPase activity studies have reported Hill coefficients greater than one, indicative of a 
positively cooperative mechanism (DeLaBarre et al, 2006; Song et al., 2003). Hybrid 
hexamer studies have shown that ATP hydrolysis rates by the D2 domains are altered 
by mutating the neighbouring protomer. However, all equilibrium measurements 
presented in this study have shown no positively cooperative binding characteristics. 
Curves instead have fitted well to non-cooperative equations. This is suggestive that the 
effects reported by these studies are not caused by cooperative binding (where ligands 
binding progressively to the protein have altered dissociation constants) and may 
instead be due to cooperative ATP hydrolysis. Alternatively, a form of kinetic 
cooperativity may exist. Exploratory stopped flow kinetics experiments presented here 
suggest there could possibly be a form of kinetic cooperativity in ATP binding as the 
rate constants of MANT-ATP association appeared to alter with MANT-ATP 
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concentration (Section 5.5.1). This effect would not be observed during equilibrium 
measurements as they are not time resolved. 
Unexpectedly, though, my results instead show an unusual effect when ATPyS binds to 
the D2 domain. The D2 ring in wildtype p97 can only bind to between 3 and 4 
molecules of ATP per hexamer. The finding that the remaining 2 or 3 empty sites are 
completely blocked from binding ATPyS despite all sites being essentially identical, 
may represent an extreme form of negative cooperative binding. This would suggest 
that following normal binding of 3 to 4 molecules of ATPyS, the remaining D2 sites 
would be conformationally changed to prevent (rather than reduce) further nucleotide 
binding. When D1 was mutated to reduce nucleotide binding (K251A), the incomplete 
saturation D2 was removed. At present, it is unclear whether this effect is due to the 
mutation or absence of ADP in D1. 
The partial occupancy of the D2 domain of p97 with ATP-like molecules has been 
previously implied by other studies. When ATP transition state analogue ADP-AIF3 was 
bound to the D2 domain, crystal structures showed that there was unequal occupancy of 
the AIF3 moiety. (Although a similar pattern was not observed in crystal structures of 
AMPPNP but this may be an artefact of the ATP analogue.) Also, when an ATP 
derivative was covalently attached to p97, a molar stoichiometry of 2.23 molecules per 
hexamer were attached, possibly to the D2 domain (Zalk and Shoshan-Barmatz, 2003). 
There is also a precedent for incomplete occupancy of the AAA ring of other 
homohexameric AAA+ ATPases. For example, ClpX unfoldase can bind 3 to 4 
molecules of ATP per hexamer, RuvB hydrolyses two molecules of ATP in a single 
burst and Rho helicase can bind 3 molecules of ATP (Hersch et al, 2005; Marrione and 
Cox, 1995, , 1996; Stitt and Xu, 1998; Stitt, 2001). Outside the AAA+ family, the F, 
ATPase is the best known example of an ATPase that has six putative ATP binding sites 
of which only 3 are catalytically active (reviewed by (Boyer, 1993)). 
While there is a precedent already for incomplete occupancy of ATP-like molecules in 
p97, other AAA+ ATPases and more widely in other oligomeric ATPases, this finding 
in p97 would be more certain if supported by a similar stoichiometry measurement 
using different technique such as nitrocellulose filter binding assays, equilibrium 
dialysis or tryptophan fluorescence binding measurements. This is especially important 
because it is at odds with the apparent six-fold symmetry observed in the low resolution 
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EM structures of p97 (although AMPPNP instead of ATPyS was used in these 
strucures). (Beuron et al, 2003; Rouiller et al, 2000; Rouiller et al, 2002). Intriguingly 
though, the apparent six-fold symmetry was no longer present upon adaptor binding and 
was replaced with three-fold symmetry upon p47 binding (Beuron et al, 2006). The full 
occupancy of AMPPNP in the D2 domain shown in crystal structures is also contrary to 
these results but may be a consequence of the less ATP like features of AMPPNP 
compared to ATPyS (DeLaBarre and Brunger, 2005). 
A stoichiometry of 3 to 4 ATP molecules binding to D2 has far reaching consequences 
on the mechanism of ATP hydrolysis by the D2 domain. The three or four filled sites 
may be theoretically arranged in several geometric conformations and it remains to be 
seen whether the residual vacant sites may be instead filled with ADP. In other 
ATPases, such as the Fi ATPase, a binding change mechanism (sometimes mis-named 
sequential) has been proposed (reviewed by (Boyer, 1993; Weber and Senior, 2000)). In 
this form of mechanism, only three of the six potential sites are active and these sites all 
have differing affinities of ATP. Binding of ATP is associated with a large release of 
energy generating rotational motion. Only one of the three active sites may hydrolyse 
ATP at a time leading to another rotation of a central core unit and synchronised switch 
of affinities of the active subunits (Milgrom and Cross, 2005). A strong catalytic 
positive cooperativity is central to this mechanism. 
Geometrically-constrained rotary hydrolysis mechanisms are highly attractive 
particularly for a motor protein such as the Fi ATPase, which generates rotary motion. 
However, as mentioned, this form of mechanism was tested for ClpX, a AAA+ ATPase 
that unfolds substrate proteins and threads them through its central pore. It was found 
that many arrangements of active protomers could support ATP hydrolysis and the 
substrate unfolding. This showed very clearly that there was no ordered mechanism of 
ATP hydrolysis. Like ClpX, p97 has rather controversially been proposed to thread 
substrate proteins through its central pore (DeLaBarre et al, 2006; Ye et al., 2003). A 
similar mechanism of ATP hydrolysis may facilitate a similar functional mechanism. 
In order to shed further light on the mechanism of the hydrolysis mechanism, it would 
be fascinating to test single turnover hydrolysis in D2 at different molar ratios of ATP to 
p97 to see whether ATP turnover is most efficient at high or low ATP concentrations. 
Additionally, further experiments are necessary to determine whether ATP hydrolysis in 
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p97 is geometrically constrained such as development of a controlled hybrid hexamer 
assay, as carried out for ClpX. 
Summary 
In summary, the results of this study suggest that the D1 and D2 domains do not 
cooperate with each other to bind nucleotides. The D1 domain while able to bind and 
hydrolyse ATP, remains predominantly bound to ADP, and instead the D2 domain 
contributes the majority of ATPase activity. The non-equivalence of the D1 and D2 
domains is likely to be a consequence of differential affinities for ADP as the affinities 
of an ATP analogue are very similar. Other groups have proposed that the D1 domain 
mainly functions to promote hexamerisation. While this is certainly one of its properties 
structurally, the high affinity for ATPyS and conserved catalytic residues leave other 
possibilities open for D1 in the catalytic and functional cycle of p97 that may emerge 
through future work. 
Interestingly, the stoichiometry of ATPyS binding to D2 indicates that while all D2 
domains are theoretically the same, binding of ATPyS to 3 or 4 sites completely inhibits 
binding to the remaining sites. This aspect raises interesting possibilities of a 
geometrically constrained, rotary mechanism of hydrolysis operating in the D2 domain 
and of how this stoichiometry could be relevant to p97s function. 
6.5 Perspectives of p97s function in vivo 
p97 is involved in diverse pathways and interacts with many different proteins leading 
to various biochemical functions to be proposed for p97. Of all functions suggested, the 
most unifying function is the segregation or disassembly of protein complexes. In this 
role, conformational changes resulting from ATP hydrolysis may act to separate protein 
complexes. It has been shown in multiple low resolution studies, that the presence of 
different nucleotides causes p97 to sample different conformations. The lack of 
consistency between structures makes definition of the exact changes difficult, but 
indicates that the N domains, the D2 domains and the central pore are the major areas of 
conformational movement throughout the ATP hydrolysis cycle (Table 6.6). 
As the N domains are regarded as the primary site of adaptor interaction, it is thought 
that motion of N domains is transmitted to the adaptor and concurrently to the bound 
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Table 6.6 A summary of the structural properties of p97 
Feature Evidence Reference 
N domains are flexible especially in position SAXS structures 
EM structures 
(Davies et al., 2005) 
(Beuron et al., 2003; Rouiller et al., 2000; Rouiller et al., 
2002) 
DI domains facilitate hexamerisation Hexamer reassembly aided by D1 ADP binding 
Mutation of arginine fingprs in D1 disrupts hexamerisation 
D1 domains have close interprotomer contacts 
(Wang et al., 2003a) 
(Wang et al., 2005) 
(DeLaBarre and Brunger, 2003,, 2005; Huyton et al., 
2003) 
D2 domains are flexible Vulnerable to trypsin digest 
Poorly ordered in crystal structures 
(Wang et al., 2003b) 
(DeLaBarre and Brunger, 2003,, 2005; Huyton et al., 
2003) 
D1-D2 pore alters throughout hydrolysis cycle SAXS structures 
EM structures 
Limited crystallographic changes 
(Davies et al., 2005) 
(Beuron et al., 2003; Rouiller et al., 2000; Rouiller et al., 
2002) 
(DeLaBarre and Brunger, 2005) 
N domain position varies during hydrolysis cycle SAXS structures 
EM structures 
Limited crystallographic changes 
(Davies et al., 2005) 
(Beuron et al., 2003; Rouiller et al., 2000; Rouiller et al., 
2002) 
(DeLaBarre and Brunger, 2005) 
02 domains positions vary throu^ hydrolysis cycle Limited crystallographic changps 
EM structures 
(DeLaBarre and Brunger, 2005) 
(Beuron et al., 2003) 
substrate. In support of this, the position of N domains and confomiation of bound p47 
adapter differ significantly in the presence of different nucleotides (Beuron et al, 2006). 
This paradigm may not be complete, however, as recently, several adaptors, including 
Ufd2 and Ufd3, have been shown to not interact with N domains and instead may 
interact with the Dl, D2 domains or even the C terminal extension (Richly et al, 2005; 
Rumpf and Jentsch, 2006). Furthermore, it is unclear whether the substrate protein (for 
example, a ubiquitinated ERAD substrate) interacts directly with p97 or indirectly 
through adaptors. One group propose that a putative substrate, Synaptotagmin 1, 
interacts directly with the D2 domain (DeLaBarre et al., 2006). 
As the N domain and therefore bound adaptors/substrate, are physically remote from the 
D2 domain, changes in conformation of the D2 domain in response to ATPase activity 
must be propagated through the structurally less flexible Dl domain. An advantage 
therefore of participation of the Dl and D2 domains in adaptor binding is that the 
conformational changes are closer to the adaptor and substrate and may enable 
modification of the activity of p97. Indeed, Synaptotagmin 1 binding to the D2 domain 
was shown to enhance the ATPase activity of p97 (DeLaBarre et al., 2006). 
As discussed there are many open questions regarding p97s action and function. 
Difficulties in identification of the necessary participants of a p97-mediated segregation 
reaction have prevented in vitro assays demonstrating p97s action. In a membrane 
bound process such as ERAD, in which many components are potentially involved, it is 
not only difficult to identify which components are the putative substrates but also what 
the minimum necessary components are. Consequentially, the majority of studies that 
demonstrate p97s action have used cell extracts or in vivo assays and therefore fail to 
unambiguously define the process. 
However, p97s action in an ATP dependent manner upon protein complexes has been 
demonstrated in three isolated cases in vitro. 
1) p97s action in membrane fusion of Golgi vesicles after mitosis requires the 
action of p97-p47 complex which also interacts with VCIP135 and Syntaxin 5 
(Kondo et al., 1997; Uchiyama et al., 2002) (Section 1.2.2). Addition of ATP 
and VCIP135 causes dissociation of p97-p47, a process not observed when ADP 
or AMPPNP is added (Uchiyama et al., 2002). Similarly, a complex of p97, p47, 
VCIP135 and Syntaxin 5 may be constructed in the presence of AMPPNP but 
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addition of ATP to this complex causes dissociation of p47 and Syntaxin 5, 
leaving p97-VCIP135 complex (Uchiyama et ciL, 2002). 
2) p97 has been shown to interact with Werner syndrome protein, WRN, a RecQ 
helicase, that hydrolyses ATP to provide DNA and RNA unwinding activities 
(Partridge et al, 2003) (Section 1.3.2). The interaction between WRN and p97 
has been shown to be dependent upon the presence of ATP (but not ADP) 
although it is unclear whether ATP present was hydrolysed by p97 or WRN 
(Indig et al., 2004). 
3) Both p97 and binding partner, HDAC6, are able to bind poly-ubiquitin and 
the three components form a complex together (Boyault et al., 2006) (Section 
1.2.1.2). However, addition of ATP excludes HDAC6 from this complex leaving 
just p97 and poly-ubiquitin bound (Boyault et al., 2006). 
These three in vitro assays suggest that addition of ATP causes separation of existing 
complexes or formation of new ones, potentially giving directionality to multiprotein 
processes that p97 is involved in. Traditionally, p97 has been described as actively 
pulling apart protein complexes to cause their segregation. To be effective, this form of 
motion would require physical anchoring of p97 and/or interacting proteins. This could 
be a function of membrane anchors such as Ubx2 in the ERAD process. An alternative 
view could involve p97 assuming different conformations through the hydrolysis cycle 
and therefore having different affinities for binding partners, favouring the formation of 
specific complexes. This could allow a substrate to be transferred from one complex to 
the next. Clearly, to absolutely demonstrate the nature of p97s action, functional assays 
must be taken from in vivo to in vitro, use purified proteins and not only show the ATP 
dependence of p97s action (as above), but as is now more possible, extend this to steps 
through the ATP hydrolysis mechanism and conformations of p97. 1 look forward with 
great anticipation to the development of this aspect of the p97 story. 
The opinion of the function of p97 and yeast orthologue Cdc48 has changed 
considerably over the past decade, from a protein that was regarded as the minor cousin 
of NSF mediating a subset of specialized membrane fusion events, to a dominant if not 
enigmatic member of the ubiquitin proteasome system. One wryly wonders whether the 
researchers of the 1980s who first identified valosin peptide in pig intestines had any 
idea of the Pandora's box they inadvertently opened. 
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Chapter 7 
Appendices 
7.1 Fluorescence anisotropy equilibrium binding models 
7.1.1 One site binding model 
The equilibrium between a protein (P) and ligand (L) may be described by the equilibrium 
dissociation constant, K^. 
PL A P + L (1) 
K, = ^ (2) 
Data from the fluorescence anisotropy titrations was fitted to a one site model. This defines 
the dissociation constant as a function of the known parameters of total ligand concen-
tration, [Ltoi\, total protein concentration, [Ptot] and the concentration of ligand bound to 
protein which is proportional to the anisotropy reading. The derivation of the model is 
shown below. 
The fraction of bound hgand is defined as: 
[PL] [PL] 
[i„] [L] + [PL] (3) 
The value [PL] is defined by rearrangement of equation (2) which is then substituted into 
equation (3). 
[PL] = ^ (4) 
M = ™ (5) 
[ L „ ] [L] + m 
This may be simplified by multiplying top and bottom of the right hand side of the equation 
Ed 
[L] 
M = M (6) 
M K i + [ P ] 
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The equation can then be expressed in terms of [PL]. 
[PL] - g L (7) 
The anisotropy (Aniso) is assumed to vary hnearly with [PL], so [PL] can be calculated 
from anisotropy as shown in equation (8). (Note, [PL] was calculated before fitting and so 
the y-axis on figures is labelled '[Bound]'.) 
^ [LtotljAniso - Anisomin) 
ATiisOfng^x Aniso^ifi 
For binding reactions of lower affinity (leading to a large excess of protein used compared 
with ligand), it can be assumed that [P] is equivalent to [Ptot]- The final expression (9) is 
then used to find K^. 
r p r i ^ [Ltot] [Ptot] /n\ 
7.1.2 One site tight binding model 
The assumption of the one site binding equation ([Ptot] = [-P]) breaks down when the 
protein has high affinity for the ligand. This is because the titration uses concentrations of 
protein close to the concentration of the ligand, as the equilibria lies largely to the bound 
side (left hand side of equation (1)). A more precise method of measuring the dissociation 
constant has been therefore been derived for this situation. The standard definition of the 
dissociation constant is described in equation (10). 
[P] and [L] can be eliminated by their empirical definitions. 
[Ptot] = [PL] + [P] .-. [P] = [Ptot] - [PL] (11) 
[Ltot] = [PL] + [L] [L] = [Ltot] - [PL] (12) 
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Which means that Kd can be written as 
^ ([f,„l - [PI,])([-t,„,] - [PL\) 
i [ft] ('3) 
This leads to a quadratic equation in terms of [PL]. 
0 = [PL]^ — {Kd + [Lto^ + [Ptot])[PL] + (14) 
As [PL] can be assumed to be related to anisotropy, as described in equation (8), equation 
(14) can be solved to give K<i 
[PL] = (15) 
where 
b = —Kd — [Ltot] — [Ptot] (16) 
c = [Ptot][Ltot] (17) 
This equation fits excellently to high affinity binding data, provided the ligand binds only 
to one type of site, there is no cooperative mechanism of binding and there is no change in 
total fluorescence following binding. 
7.1.3 One site competition model 
To analyse data in which there are two ligands competing for a single site, such as in a 
displacement titration, I developed a model to determine the equilibrium dissociation con-
stants of both ligands. In this model the ligand will be referred as L, the competitor as I 
and the corresponding equilibrium dissociation constants as KdL and Kdi-
K L 
PL + I ^ P + L + I ^ P I + L (18) 
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^ («) 
K , = 1 ® (20) 
The fractional saturation of protein bound to ligand, 0, is defined as: 
(21, 
[Pto,] M + [P i ] + IPi] ^ ' 
Substituting rearrangements of equations (19) and (20) into equation (21) gives: 
[pm 
dL K 
r PI , m m , m 
Multiplying top and bottom by gives 
(22) 
To eliminate [L], its definition (12) is substituted into equation (23). 
[L] = [Ltot] - [PL] ( 2 4 ) 
^ li^K, (25) 
KdL + [Ltot] - [PL] + 
The free inhibitor concentration, [/], is immeasurable and large, especially in displacement 
experiments, so is assumed to be equal to the total inhibitor concentration, [Itot]- Substitut-
ing this, along with the definition of 9, into equation (25) and rearranging, gives a quadratic 
equation describing how [PL] changes with [Itot]-
0 = [PL]"^ + ^—K^l — ^ [Ltot] — [PL] + [Pto£][Ltot] (26) 
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This equation may be then solved using the quadratic solution. 
[ p q = (27) 
where 
b — —KdL — -—— [Ltot] — [Ptot] (28) 
c = [Ptot] [Ltot] ( 29 ) 
As before, [PL] was calculated from anisotropy data using equation (8), although for this 
model, it was calculated during the fitting process. 
The underlying assumptions of this model are that [Ltot], [Ptot] and total fluorescence inten-
sity remain the same throughout the experiment and that there is only one sort of binding 
site for L and / . The assumption that [/] is approximately equal to [Itot] does not hold true 
in particular when [Itot] < [Ptot]-
7,1.4 Linear regression method 
Using the linear regression method, the apparent dissociation constants obtained from titra-
tions of p97 into BODIPY-ADP were plotted against the constant concentration of ADP at 
which the titration was performed. The equation of the line of best fit was determined from 
a relationship defined by Cheng and Prusoff (Cheng and Prussoff, 1973). This relationship 
was derived by comparison of the rate of a single substrate reaction under Michaelis-Menten 
conditions (30) with the rate of reaction when a competitive inhibitor is present (31). In this 
case, Vo represents velocity in the absence of an inhibitor, V/ is velocity in the presence of 
an inhibitor, Vmax is the maximum velocity. Km the Michaelis constant of the substrate, L, 
and K(i: the dissociation constant of inhibitor, / . 
T/ Vmax[Ltot\ 
^ TTT—T (30) 
•^M + [J^totl 
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y ^max (31) 
Km + [Ltot] 
Comparison of equations (30) and (31) shows that the presence of the inhibitor modulates 
the expression of Km by (l + ) such that the following relationship may be written. 
f (32) 
Km is commonly defined as (33) where ki and k- i are the rate constants of ligand associ-
ation and dissociation respectively and k2 is, in this case, the catalytic rate constant. 
Km = (33) 
ki 
But the pre-equilibrium assumption proposes that Km may approximated to the definition 
of the dissociation constant of substrate. 
Km = —r^  (34) 
ki 
This allows equation (32) to be rewritten 
App.Ki^ = A + (35) 
This equation is linear (has the form y = mx + c) and describes the line of best fit. The 
^-intercept is K^l and the gradient is 
7.2 Fluorescence anisotropy kinetic binding models 
7.2.1 One site binding model 
Stopped flow experiments with MANT-ATP showed a large increase in overall fluores-
cence intensity upon binding of MANT-ATP to p97, necessitating a different approach to 
analysis of anisotropy data. Total fluorescence intensity data was instead fitted simultane-
200 
ously to anisotropy data using a single fitting regime within the Berkeley-Madonna pro-
gram (vS.O.l). The one site model defined rate constants of MANT-ATP association (ki) 
and dissociation (/c-i) as follows. 
P + L ^ P L (36) 
k-i 
The rates of accumulation of PL and decline of P and L with time (t) are defined by the 
following rate equations. 
=HP][L]-k.,[PL] (37) 
dt 
d [ f | 
dt 
m 
= k^i[PL]-ki[P][L] (38) 
= k^,[PL]-k,[P][L] (39) 
dt 
The initial concentrations (at t = 0) are predefined (in /iM) and linked to the total concen-
tration. 
M o = 5 (40) 
\L\q = 5 (41) 
[PL]o = 0 (42) 
[Ptot] = [P] + [PL] (43) 
M = [L] + [P i : ] (44) 
The fractions of free ligand and bound ligand present are scaled to the minimum and max-
imum fluorescence intensities {Intmin) and (Intmax) to describe how the intensity changes 
as the free ligand becomes bound after mixing. 
I n t f = ^ 4" ^ (45) 
The anisotropy minimum and maximum (AnisOmin and AnisOmax) are then scaled to the 
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magnitude of the fluorescence intensities. 
X rJ \ X AnisOmin^ ~1~ (^ I'^ tmax ^ Ir j X AjlisOxjiax) 
Anisot = ^ ^ (46) 
7.2.2 Two site binding model 
The two site binding model describes MANT-ATP binding to two sorts of site on the pro-
tein (P^ and P^), each with different association and dissociation properties and a different 
magnitude of fluorescence increase. 
P + 2 L ^ P L ^ + L ^ P L ^ 2 (47) 
fc-l fe-2 
P + 2 L ^ P L ^ + L P L ^ 2 (48) 
k-2 fc-i 
The rates of change of [PL}], [PL\ [PL^^] and [L] are described similarly to the one site 
model of the previous section. 
d{[PL'] + [PLJJI _ - k^i[PL'] + h[PL''][L] - k^i[PLl^] (49) 
dt 
i{[PL^] + [PLl']) 
dt 
= + A;2[PZ,']M - (50) 
= k-i[PL'] + k_2[PL^] - h[P][L] - k2[P][L] (51) 
- A;2[P][L] (52) 
The initial concentrations of protein and ligand and the total concentrations are defined 
similarly to the one site model 
[P]o = 5 (53) 
[L]o = 5 (54) 
[PL% = 0 (55) 
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== 0 (5(5) 
[Ptot] = [P] + [PL'] + [PL'] + [PLl'] (57) 
[Ltot] = [L] + [PL'] + [PL'] + 2[PLl'] (58) 
Each site has an individual fluorescence intensity increase and scaled to 
the proportion of ligand bound to this site. 
Int, = X j M j ) + X + ( / < „ X 
(59) 
The anisotropy minimum and maximum {Anisomin and AnisOmax) are then scaled to the 
magnitude of the fluorescence intensities from each site. 
/ Intmin X ^ AniS0^in\ X [Lit] ^ ^ \ 
^ I ) +1 hit ) 
y 
(60) 
7.2.3 One site, two state binding model 
This model describes two fluorescence environments available to the ligand following bind-
ing ( f and P^) and can be described as 
P + L ^ P L ' ^ P L * (61) 
k-i k-2 
The rates of change between the four components are described by 
diP] 
dt 
i w 
dt 
= fc_i[PL'] - ki[P][L] (62) 
^ k ^ i [ P V ] - h [ P ] [ L ] (63) 
= ki[P][L] - k-i[PV] - k2[PV] + k^2[PL^ (64) 
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(65) 
The initial and total concentrations are defined as 
[P]o = 5 (66) 
[L]o = 5 (67) 
[PL% = 0 (68) 
[PL% = 0 (69) 
[P,oA = [P] + [PL'] + [PL^ (70) 
[Lto^ = [L] + [PL'] + [PL^ (71) 
The fluorescence intensity and anisotropy were scaled to each other similarly to previously. 
mu = X X | g ) + ( / < . . X 0 ) (72) 
'IntmAn X 7 ^ X AniSOm.in\ / IntL„^ X 1 ^ X AniSOrr,.n^\ 
V / V 
+ ' 
(73) 
7.3 ITC Binding IVIodels 
7.3.1 ITC one site binding model 
The method for analysis of ITC data is through least squares fitting of the integrated data 
to binding models using the Levenburg-Marquadt algorithm. The one site model presented 
here was derived by Wiseman and is pre-programmed as part of the MicrocaF^Origin^^ 
analysis software (Wiseman,T, 2000). The experimental parameter measured through ITC 
is the heat change, Q, as the volume of ligand, L, increases in the reaction cell. This is re-
lated to the molar concentration of ligand bound to protein, PL, multiplied by the enthalpy 
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change of the reaction, A i f . 
d(3 = X 14] X (/\j5r°) (-74) 
The concentration of [PL] may be related to the equilibrium association constant and total 
concentrations of protein and ligand by a similar method to previous sections. 
For a single one site binding reaction, the total concentrations of protein and ligand {[Ptot] 
and [Ltot] respectively) are intuitively defined as: 
[Ptot] = [PL] + [PI (75) 
1L„] = [PL] + [L] (76) 
The free concentration of protein may be eliminated using the definition of the association 
constant, Ka-
" iWi 
Rearranging equation (79) for [L], and substituting into equation (76) gives 
° mpL] - [PL]) 
[L„ | = [PL| + J i [Pi]) (81) 
This can be written as a quadratic equation, for which there is only one real root for [PL]. 
0 = [PLf' + [PL]{~—— [Ltot] — [Ptot]) + [Ltot] X [Ptot] (82) 
[PL] = (83) 
205 
where 
b = — [Lto^ — [Ptot] (84) 
c = [Ptot\ (85) 
As the concentration of PL changes with the total concentration of L in the titration, equa-
tion (83) can be differentiated with respect to {Ltot\- Simplification then gives 
4 ^ 4 1 , (SQ 
d[ iwl 2 - 2L,(1 - r) + (1 + r)^ 
where 
^ ^ X [Ptot] (87) 
i r = M (88) 
[J^totl 
This relationship between the concentration of bound protein, total concentration of ligand 
and protein and association constant may then be substituted into equation (74). 
^ V o x A f f x ( U , _ "l (89) 
d[Ltot] \2 ^^-2Lril-r) + {l + ry 
Thus giving an expression fitting the experimental data points - 5 ^ ^ in kcal/mol as [Ltot] 
increases (molar ratio [Ltot] '• [Ptot]) to give the association constant and enthalpy. The 
entropy (AS) is determined from: 
-RTlnKa = A H - TAS (90) 
7.3.2 ITC two site binding model 
While the two site binding model is more complex, the basic derivation is detailed, al-
though for simplicity the possible stoichiometry of each site is assumed to be one (for ease, 
it will also be assumed that the concentration of the cell remains constant). Each protein 
molecule is assumed to have two independent sites for binding a single ligand molecule 
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with no imphed order of binding. 
P + 2 L 4 ^ P L ^ + L ^ P L ^ 2 (91) 
P + 2 L J ^ P L 2 + L ^ P L ^ 2 (92) 
The equilibrium association constants for binding sites 1 and 2 (ATgi and Kap.) are defined 
as; 
^ [PL^] + [PL\^] 
' [L](\P,„] - [PLi] - \PL?]) 
^ [P£^] + [PLj^] 
' [i]([P,„] - [ P P ] - [PL12]) 
The total ligand concentration is defined as: 
[Ltot] = [L] + [PL^] + [PL'^] + 2[PI/2^] (95) 
Solving equations (93) and (94) for their numerators and then substituting into equation 
(95) gives; 
[PL'] + ypLf] = (96) 
1 + Agi [LJ 
[PL^l + [ P i « ] = (97) 
1 + AgZ [LJ 
[Ltot] = [ ^ ] + + {[PL"^] + ( 9 8 ) 
m (99) 
Clearing equation (99) of fractions gives a cubic equation in [L]. 
Q = [Lf +p[Lf + q[L]+r ( 1 0 0 ) 
where 
P = T 1" TT' + 2[Ptot] — [Ltot] (101) 
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q — {[Ptot] - [Ltot]) ( j H 7—1 + TTl— (102) 
r = (103) 
The concentration of hgand bound to each binding site is linked to the energy consumed/released 
by each injection and the enthalpy change by equation (104). 
Q = + [ f (104) 
These equations may then be solved numerically to give Kai, K p^-, AHi, AH2 and stoi-
chiometry. 
7.3.3 ITC competitive binding model 
The competitive binding model was derived by Sigurskjold and provides an exact method of 
determining the the dissociation constant, enthalpy change and stoichiometry of binding of 
a competing ligand, given the concentration of the unchanging ligand is known absolutely 
(Sigurskjold, B. W., 2000). For completeness, the equations used are summarised below 
but the reader is referred to the published article for further detail. Cubic equation (108) 
defines the mole fraction of free protein to total protein, in terms of the following 
mole fractions and simplifications (abbreviations are as section 1.1.4). 
% = = (106) 
[•t totj [•ttotl 
0 — pX'p H" qXP + T (108) 
208 
where 
P = - ^ + - ^ + R l + R i - 1 (109) 
As determined by Wang (Wang, 1995), the only real root is 
^ ^ ^ 2 V P ^ - 3 9 C o s W 3 ) - P (112) 
where 
V, = aiccos (113) 
2^{p^ - 3«)3 
The heat evolved from binding of hgand to protein is related to the enthalpy change as 
Q = Vo{AHL[PL] + A H i [ P I ] ) ( 1 1 4 ) 
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